Россия, г. Королев.

eburdiyg@gmail.com

8 (903) 781-84-63

  • Главная
  • Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders

Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders

Номер патента: SG185067A1
Опубликовано: 28-12-2012
Автор(ы): Bernd Giese, Matthias Wymann, Natasa Cmiljanovic, Vladimir Cmiljanovic
Принадлежит: Univ Basel
Получить PDF файл: Открыть в новом окне

Вам могут быть интересны следующие патенты

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

Pyridiazinone derivatives for the treatment of tumours

Номер патента: CA2632217C. Автор: Dieter Dorsch,Andree Blaukat,Oliver Schadt. Владелец: Merck Patent GmBH. Дата публикации: 2014-07-08.

Quinoxaline and pyridopyrazine derivatives as pi3k-beta inhibitors

Номер патента: US20200181132A1. Автор: Patrick René Angibaud,Didier Jean-Claude Berthelot,Lieven Meerpoel,Christophe Meyer,Alexis Georges Querolle Olivier,François Alain Jean JOUSSEAUME Thierry,Victor WILLOT Matthieu Philippe. Владелец: Novalix SAS. Дата публикации: 2020-06-11.

Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases

Номер патента: AU2005286521B2. Автор: Philipp Lustenberger,Andreas Schnapp,Ingo Konetzki,Thierry Bouyssou,Christoph Hoenke,Enzo Cereda. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2011-11-17.

Aza-heteroaryl compounds as PI3K-gamma inhibitors

Номер патента: US09586949B2. Автор: Andrew P. Combs,Andrew W. Buesking,Ge Zou. Владелец: Incyte Corp. Дата публикации: 2017-03-07.

Oxazolidin-2-one-pyrimidine derivatives for use in the treatment of skin fibrosis, scleroderma, hypertrophic scars or keloids

Номер патента: EP3199158A1. Автор: Pascal Furet,Robin Alec Fairhurst,Heinrich Rueeger,Andreas Lerchner,Frank Stephan Kalthoff. Владелец: NOVARTIS AG. Дата публикации: 2017-08-02.

Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer

Номер патента: US20110306662A1. Автор: Nadia Dahmane,Jeffrey D. Winkler. Владелец: Wistar Institute of Anatomy and Biology. Дата публикации: 2011-12-15.

1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders

Номер патента: CA2488202C. Автор: James B. Aggen,Andrew M. K. Pennell,J. J. Kim Wright,Subhabrata Sen,Brian E. Mcmaster,Daniel Joseph Dairaghi,Valeri V. Martichonock. Владелец: Chemocentryx Inc. Дата публикации: 2011-03-08.

Bicyclic lactams and methods for use thereof

Номер патента: RU2716136C2. Автор: Хуэйфэнь Чэнь,Крейг СТИВАЛА,Гуйлин Чжао,Снахель Патель,Грегори ГАМИЛЬТОН. Владелец: Ф. Хоффманн-Ля Рош Аг. Дата публикации: 2020-03-06.

3-(6-pyridin-3-yl)-2-[4-(4-methyl-4h-1,2,4-triazol-3-yl)piperidin-1-yl]benzonitrile derivatives and similar compounds as qpctl and qpct inhibitors for the treatment of cancer

Номер патента: WO2024020517A1. Автор: Jeffrey A. Stafford,Donald S. Karanewsky,James M. Veal,Shyama HERATH. Владелец: 858 Therapeutics, Inc.. Дата публикации: 2024-01-25.

DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE.

Номер патента: AR072297A1. Автор: . Владелец: NOVARTIS AG. Дата публикации: 2010-08-18.

Process for the preparation of tricyclic pi3k inhibitor compounds and methods of using the same for the treatment of cancer

Номер патента: CA3008394A1. Автор: Andreas Stumpf,Remy Angelaud,Herbert Yajima,Chudi Ndubaku,Alan Olivero,Andrew MCCLORY. Владелец: Genentech Inc. Дата публикации: 2017-06-22.

4-benzimidaz0lyl-6-m0rph0lin0-2-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders

Номер патента: WO2008032091A1. Автор: Sam Butterworth,Edward Jolyon Griffen,Martin Pass. Владелец: AstraZeneca UK Limited. Дата публикации: 2008-03-20.

Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases

Номер патента: US09434722B2. Автор: Patrick Chaltin,Arnaud Marchand,Gerard Griffioen,Amuri Kilonda,Sara Allasia,Tom Van Dooren,Veronica Rojas De La Parra. Владелец: REMYND NV. Дата публикации: 2016-09-06.

2-benzimidazolyl-6-morpholino-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders

Номер патента: US20090233926A1. Автор: Sam Butterworth,Edward Jolyon Griffen,Martin Pass. Владелец: AstraZeneca AB. Дата публикации: 2009-09-17.

2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders

Номер патента: EP2064203A1. Автор: Sam Butterworth,Edward Jolyon Griffen,Martin Pass. Владелец: AstraZeneca AB. Дата публикации: 2009-06-03.

6-benzimidaz0lyl-2-m0rph0lin0-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders

Номер патента: WO2008032036A1. Автор: Sam Butterworth,Edward Jolyon Griffen,Martin Pass,George Beresford Hill. Владелец: AstraZeneca UK Limited. Дата публикации: 2008-03-20.

Compounds useful in the treatment of inflammatory diseases

Номер патента: EP1324991A1. Автор: Xiao Qing GlaxoSmithKline LEWELL,Caroline Mary GlaxoSmithKline COOK,Stephen GlaxoSmithKline SWANSON,Colin David GlaxoSmithKline ELDRED,Paul Martin GlaxoSmithKline GORE,Lee Andrew GlaxoSmithKline HARRISON,Simon Teanby GlaxoSmithKline HODGSON,Duncan Bruce GlaxoSmithKline JUDD,Suzanne Elaine GlaxoSmithKline KEELING,Graeme Michael GlaxoSmithKline ROBERTSON,Rachael Anne GlaxoSmithKline ANCLIFF. Владелец: Glaxo Group Ltd. Дата публикации: 2003-07-09.

Monocarboxylate transporter 4 (MCT4) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer

Номер патента: AU2016363683B2. Автор: Yuzhuo Wang,Stephen Yiu Chuen CHOI. Владелец: University of British Columbia. Дата публикации: 2023-04-27.

Monocarboxylate transporter 4 (mct4) antisense oligonucleotide (aso) inhibitors for use as therapeutics in the treatment of cancer

Номер патента: WO2017091885A8. Автор: Hui Xue,Colin C. Collins,Martin E. Gleave,Peter Wilhelm Gout,Yuzhuo Wang,Stephen Yiu Chuen CHOI. Владелец: The University of British Columbia. Дата публикации: 2018-06-07.

Monocarboxylate transporter 4 (mct4) antisense oligonucleotide (aso) inhibitors for use as therapeutics in the treatment of cancer

Номер патента: EP3384028A1. Автор: Yuzhuo Wang,Stephen Yiu Chuen CHOI. Владелец: University of British Columbia. Дата публикации: 2018-10-10.

DERIVATIVES OF QUINAZOLINDIONA AS PARP INHIBITORS; METHODS FOR PREPARATION; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE INGREDIENT AND ITS USE IN MEDICATIONS FOR THE TREATMENT OR PREVENTION OF CANCER.

Номер патента: AR049540A1. Автор: . Владелец: Janssen Pharmaceutica NV. Дата публикации: 2006-08-09.

NEW TRIAZOLO-PYRIMIDINE DERIVATIVES, THEIR PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAID COMPOUNDS WHICH ARE USEFUL IN PARTICULAR FOR THE TREATMENT OF PSORIASIS

Номер патента: FR2347367A1. Автор: . Владелец: Scherico Ltd. Дата публикации: 1977-11-04.

Benzopyrimidin-4(3h)-ones as pi3k inhibitors

Номер патента: WO2023239710A1. Автор: Qian Zhao,James F. Blake,Mark Laurence Boys,Bryan Yestrepsky,Joshua Nathaniel Payette,Christie A. Schulte,David A. MARKESKA. Владелец: OnKure, Inc.. Дата публикации: 2023-12-14.

Benzopyrimidin-4(3h)-ones as pi3k inhibitors

Номер патента: WO2023239710A8. Автор: Qian Zhao,James F. Blake,Mark Laurence Boys,David A. Mareska,Bryan Yestrepsky,Joshua Nathaniel Payette,Christie A. Schulte. Владелец: OnKure, Inc.. Дата публикации: 2024-04-04.

Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer

Номер патента: US20240327394A1. Автор: Martin Schwill,Charles-Henry Fabritius,Stefanie FLÜCKIGER-MANGUAL,Rutger Folmer,Dorothea GRUBER,Thomas Bohnacker,Koen HEKKING,Debora SCHMITZ-ROHMER. Владелец: Tolremo Therapeutics AG. Дата публикации: 2024-10-03.

Pyrazole derivative suitable as pi3k inhibitor

Номер патента: RU2710549C2. Автор: Ашвани Кумар ВЕРМА,Йогеш Бабан СУРАСЕ,Кирандип Каур САМБИ,Сагар Рамдас АМАЛЬ,Суреш Кумар ГОРЛА,Приайанка ПАТЕЛ. Владелец: Дайити Санкио Компани, Лимитед. Дата публикации: 2019-12-27.

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Номер патента: US09815839B2. Автор: Yun-Long Li,Andrew P. Combs,Eddy W. Yue,Thomas P. Maduskuie, Jr.,Richard B. Sparks. Владелец: Incyte Holdings Corp. Дата публикации: 2017-11-14.

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Номер патента: US09527848B2. Автор: Thomas P. Maduskuie,Yun-Long Li,Andrew P. Combs,Eddy W. Yue,Richard B. Sparks. Владелец: Incyte Holdings Corp. Дата публикации: 2016-12-27.

Pyrimidine derivative as pi3k inhibitor and use thereof

Номер патента: RU2448109C2. Автор: Хацуо КАВАДА,Нобуо СИММА,Хиросато ЕБИИКЕ,Дзун ОХВАДА,Кендзи МОРИКАМИ,Мицуаки НАКАМУРА,Миюки ЙОСИДА,Нобуя ИСИИ,Масами ХАСЕГАВА,Сун ЯМАМОТО,Кохеи КОЯМА. Владелец: Чугаи Сейяку Кабусики Кайся. Дата публикации: 2012-04-20.

Use of pi3k inibitors for the treatment of obesity, steatosis and ageing

Номер патента: EP2629771A1. Автор: Julen Oyarzabal Santamarina,Sonia Martinez Gonzalez,Joaquin Pastor Fernandez,Ana Ortega Molina,Manuel Serrano Marugan,James R Bischoff. Владелец: Centro Nacional de Investigaciones Oncologicas CNIO. Дата публикации: 2013-08-28.

Use of Pl3K Inhibitors for the Treatment of Obesity, Steatosis and Ageing

Номер патента: US20140154232A1. Автор: Julen Oyarzabal Santamarina,Sonia Martinez Gonzalez,Joaquin Pastor Fernandez,James R. Bischoff,Ana Ortega Molina,Manuel Serrano Marugan. Владелец: Centro Nacional de Investigaciones Oncologicas CNIO. Дата публикации: 2014-06-05.

Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and ageing

Номер патента: US09993554B2. Автор: Julen Oyarzabal Santamarina,Sonia Martinez Gonzalez,Joaquin Pastor Fernandez,James R. Bischoff,Ana Ortega Molina,Manuel Serrano Marugan. Владелец: Centro Nacional de Investigaciones Oncologicas CNIO. Дата публикации: 2018-06-12.

N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors

Номер патента: CA2822070C. Автор: Yun-Long Li,Andrew P. Combs,Eddy W. Yue,Thomas P. Maduskuie, Jr.,Richard B. Sparks. Владелец: Incyte Holdings Corp. Дата публикации: 2019-09-17.

Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors

Номер патента: WO2012125629A1. Автор: Andrew P. Combs. Владелец: INCYTE CORPORATION. Дата публикации: 2012-09-20.

N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors

Номер патента: CA2822070A1. Автор: Yun-Long Li,Andrew P. Combs,Eddy W. Yue,Thomas P. Maduskuie, Jr.,Richard B. Sparks. Владелец: Incyte Corp. Дата публикации: 2012-06-28.

Azaindazole compounds for use in injuries of tendons and/or ligaments

Номер патента: RU2758256C2. Автор: Томас Улльрих,Пегги Уссельманн,Ханк Майкл Джеймс ПЕТРАССИ,Бадри БУРСУЛАЯ,Андреас ФИШ,Джеймс Пол Лэджинесс,Райнер Махауэр,Свапнил Малекар,Фаршад Рамазани,Анне-Кэтрин Ремонд,Эрик Вангревелинге. Владелец: НОВАРТИС АГ. Дата публикации: 2021-10-27.

Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitors

Номер патента: US09403779B2. Автор: MIN Yang,Simon S. Jones,David Lee TAMANG. Владелец: Acetylon Pharmaceuticals Inc. Дата публикации: 2016-08-02.

Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by p. acnes

Номер патента: US20200383973A1. Автор: Vincent Calvez,Nicolas Dupin,Anne-Geneviève MARCELIN,Philippe GRANGE. Владелец: Universite Paris 5 Rene Descartes. Дата публикации: 2020-12-10.

Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by p. acnes

Номер патента: EP3484476A1. Автор: Vincent Calvez,Nicolas Dupin,Anne-Geneviève MARCELIN,Philippe GRANGE. Владелец: Universite Paris 5 Rene Descartes. Дата публикации: 2019-05-22.

Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by p. acnes

Номер патента: PH12019500076A1. Автор: Vincent Calvez,Nicolas Dupin,Anne-Geneviève MARCELIN,Philippe GRANGE. Владелец: Univ Sorbonne. Дата публикации: 2019-07-24.

Pyrrolotriazinone derivatives as PI3K inhibitors

Номер патента: US09388189B2. Автор: Montserrat Erra Sola,Marta Mir Cepeda,Joan Taltavull Moll,Juan Francisco Caturla Javaloyes,Lluis Miquel Pages Santacana,Francisco Javier Bernal Anchuela,Marta Carrascal Riera,Gaspar Casals Coll,Maria Begoña Hernandez Olasagarre. Владелец: Almirall SA. Дата публикации: 2016-07-12.

A sortilin antagonist for use in the prevention or treatment of hearing loss

Номер патента: AU2021356121A9. Автор: Anders Nykjaer,Mads Fuglsang KJØLBY,Paul Little,Manuel Cases. Владелец: Insusense Aps. Дата публикации: 2024-10-31.

Parp-inhibiting compounds and compositions, and methods for using them

Номер патента: RU2485122C2. Автор: Цзе ЧЖАН,Вэйчжэн СЮЙ,Грег ДЕЛАХАНТИ,Лин ВЭЙ. Владелец: Эйсэй Инк.. Дата публикации: 2013-06-20.

Tertiary alcohols as PI3K-γ inhibitors

Номер патента: US11926630B2. Автор: Brent Douty,David M. Burns,Andrew P. Combs,Nikoo Falahatpisheh,Daniel Levy,Padmaja Polam,Lixin Shao,Stacey Shepard,Artem Shvartsbart,Eddy W. Yue,Andrew W. Buesking,Richard B. Sparks,Ravi Kumar Jalluri. Владелец: Incyte Corp. Дата публикации: 2024-03-12.

Multifunctional conjugates of tacrine and its analogues with derivatives of 1,2,4-tiadiazole, the way of their synthesis and application for the treatment of neurodegenerative diseases

Номер патента: RU2675794C1. Автор: Сергей Олегович Бачурин,Владимир Викторович Григорьев,Игорь Викторович Серков,Алексей Николаевич Прошин,Елена Владимировна Рудакова,Галина Файвелевна Махаева,Наталья Павловна Болтнева,Надежда Владимировна Ковалёва,Софья Владимировна Лущекина. Владелец: Федеральное Государственное Бюджетное Учреждение Науки Институт Физиологически Активных Веществ Российской Академии Наук (Ифав Ран). Дата публикации: 2018-12-25.

Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders

Номер патента: US20050107347A1. Автор: Peter Brandt,Andrei Sanin,Konrad Koehler,Johan Malm,Sandra Gordon,Karin Edvinsson. Владелец: Individual. Дата публикации: 2005-05-19.

Alotaketal compounds and derivatives thereof for use as antiviral agents

Номер патента: WO2023173232A1. Автор: David Williams,Raymond Andersen,Francois Jean,Polina BLAGOJEVIC,Jimena PEREZ VARGAS. Владелец: The University of British Columbia. Дата публикации: 2023-09-21.

Pi3 kinase gamma inhibitors for the treatment of anaemia

Номер патента: CA2580480A1. Автор: Christian Rommel,Reinhard Wetzker,Angelika Mueller. Владелец: Angelika Mueller. Дата публикации: 2006-04-20.

1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders

Номер патента: EP1531822B1. Автор: James B. Aggen,Andrew M. K. Pennell,J. J. Kim Wright,Subhabrata Sen,Brian E. Mcmaster,Daniel Joseph Dairaghi,Valeri V. Martichonok. Владелец: Chemocentryx Inc. Дата публикации: 2009-08-05.

1-aryl-4-substituted piperazine derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders

Номер патента: AU2003236500A1. Автор: James B. Aggen,Andrew M. K. Pennell,J. J. Kim Wright,Subhabrata Sen,Brian E. Mcmaster,Daniel Joseph Dairaghi,Valeri V. Martichonok. Владелец: Chemocentryx Inc. Дата публикации: 2003-12-31.

NOVEL COMPOUNDS OF THE FAMILY OF IMINOSUCRES, THEIR USES, IN PARTICULAR FOR THE TREATMENT OF LYSOSOMAL DISEASES, AND THEIR PROCESS OF PREPARATION

Номер патента: FR2887549B1. Автор: Naoki Asano,Olivier Richard Martin,Philippe Compain,Charlotte Boucheron. Владелец: Universite dOrleans. Дата публикации: 2009-07-10.

New compound which can be used in particular for the treatment of inflammatory and / or painful manifestations

Номер патента: BE628497A. Автор: . Владелец: Roussel Uclaf. Дата публикации: 1963-08-16.

PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT D-2-BROMO-1,6-DIMETHYL-8B- (PERHYDROAZEPINYLCARBONYLOXYMETHYL) -ERGOLINE, USEFUL IN PARTICULAR FOR THE TREATMENT OF PSYCHOGENIC DISORDERS

Номер патента: FR2414334A2. Автор: . Владелец: Siphar SA. Дата публикации: 1979-08-10.

Stabilized forms of dimethylcarboxy-alkylsulfonium used, in particular, for the treatment of hepatic and vascular disorders.

Номер патента: FR1783M. Автор: . Владелец: ILE DE RECH S ET D APPLIC SCIE. Дата публикации: 1963-04-22.

5-Hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia

Номер патента: US6121330A. Автор: Gunter Schmidt,Carsten Schmeck,Klaus-Dieter Bremm,Rolf Angerbauer,Hilmar Bischoff,Delf Schmidt,Michael Lögers,Matthias Muller-Gliemann,Arndt Brandes. Владелец: Bayer AG. Дата публикации: 2000-09-19.

2-((1-(6-methyl-4-oxo-3,4-dihydroquinazolin-8-yl)ethyl)amino)benzoic acid derivatives and similar compounds as pi3k inhibitors for the treatment of e.g. cancer

Номер патента: WO2024000401A1. Автор: Xin Hua,Wenge Zhong,Kailiang Wang,Teng FENG,Zhenglin Wang,Tianlun WU. Владелец: Qilu Regor Therapeutics Inc.. Дата публикации: 2024-01-04.

Heterocyclic derivatives as pi3k inhibitors

Номер патента: WO2020102150A1. Автор: Yanran Ai,Andrew P. Combs,Stacey Shepard,Artem Shvartsbart. Владелец: INCYTE CORPORATION. Дата публикации: 2020-05-22.

Compounds useful in the treatment of inflammatory diseases

Номер патента: EP1140837A1. Автор: David Brown,Paul Martin Gore,Duncan Robert IPC 92 Pfizer Limited ARMOUR,Miles S. Glaxo Wellcome Cambridge Lab CONGREAVE,Darren Victor Steven Glaxo Wellcome plc GREEN,Stuart Glaxo Wellcome plc HOLMAN,Torquil Iain Maclean Glaxo Wellcome plc JACK,Steven Philip Glaxo Wellcome plc KEELING,Andrew McMurtrie Glaxo Wellcome plc MASON,Karen Glaxo Wellcome plc MORRISS,Nigel Grahame Glaxo Wellcome plc RAMSDEN,Peter Glaxo Wellcome plc WARD. Владелец: Glaxo Group Ltd. Дата публикации: 2001-10-10.

Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors

Номер патента: CA2715550C. Автор: Carol Bachand,Makonen Belema,Daniel H. Deon,Andrew C. Good,Jason Goodrich,Clint A. James,Rico Lavoie,Omar D. Lopez,Alain Martel,Nicholas A. Meanwell,Van N. Nguyen,Jeffrey Lee Romine,Edward H. Ruediger,Lawrence B. Snyder,Denis R. St. Laurent,Fukang Yang,David R. Langley,Gan Wang,Lawrence G. Hamann. Владелец: Bristol Myers Squibb Co. Дата публикации: 2016-09-20.

Piperidine derivatives and their use in compositions for the treatment of theeth and the oral cavity

Номер патента: IE43685B1. Автор: . Владелец: Ferrosan Ab. Дата публикации: 1981-05-06.

BARETTIN and derivatives thereof for medical use, in particular for the treatment of diseases related to oxidative stress or inflammation, and for preserving or washing organs

Номер патента: CN105120851A. Автор: J.H.安德森,E.汉森,K-E.埃勒特森,K.F.林德,B.奥斯特拉德,T.霍弗. Владелец: ABC Bioscience As. Дата публикации: 2015-12-02.

Bicyclic azaheterocyclobenzylamines as PI3K inhibitors

Номер патента: US09944646B2. Автор: Andrew P. Combs,Thomas P. Maduskuie, Jr.,Richard B. Sparks. Владелец: Incyte Holdings Corp. Дата публикации: 2018-04-17.

Heterocyclylamines as pi3k inhibitors

Номер патента: US20240216377A1. Автор: Wenqing Yao,Yun-Long Li,Brent Douty,Andrew P. Combs,Eddy W. Yue,Chunhong He,Wenyu Zhu,Song Mei,Joseph Glenn,Thomas P. Maduskuie, Jr.,Richard B. Sparks. Владелец: Incyte Holdings Corp. Дата публикации: 2024-07-04.

Pyrimidinones as PI3K inhibitors

Номер патента: US09975907B2. Автор: Yun-Long Li,Andrew P. Combs,Brian W. Metcalf. Владелец: Incyte Holdings Corp. Дата публикации: 2018-05-22.

Heterocyclylamines as PI3K inhibitors

Номер патента: US09707233B2. Автор: Yun-Long Li,Brent Douty,Andrew P. Combs,Eddy W. Yue,Song Mei. Владелец: Incyte Holdings Corp. Дата публикации: 2017-07-18.

Pyrazolopyrimidine compound as pi3k inhibitor and use thereof

Номер патента: RU2726202C1. Автор: Баохуан Е. Владелец: Шеньжень Бо Ли Цзянь Медисине Ко., Лтд.. Дата публикации: 2020-07-09.

Benzopyrimidin-4(3h)-ones as pi3k inhibitors

Номер патента: WO2024081345A1. Автор: Qian Zhao,James F. Blake,Mark Laurence Boys,David A. Mareska,Bryan Yestrepsky,Joshua Nathaniel Payette,Christie A. Schulte. Владелец: OnKure, Inc.. Дата публикации: 2024-04-18.

Heterocyclylamines as pi3k inhibitors

Номер патента: NZ735378A. Автор: Wenqing Yao,Yun-Long Li,Brent Douty,Chunhong He,Wenyu Zhu,Song Mei,Joseph Glenn,Andrew Combs,Thomas MADUSKUIE,Eddy Yue,Richard Sparks. Владелец: Incyte Holdings Corp. Дата публикации: 2019-04-26.

Heterocyclylamines as PI3K inhibitors

Номер патента: US9730939B2. Автор: Wenqing Yao,Yun-Long Li,Brent Douty,Andrew P. Combs,Eddy W. Yue,Chunhong He,Wenyu Zhu,Song Mei,Joseph Glenn,Thomas P. Maduskuie, Jr.,Richard B. Sparks. Владелец: Incyte Holdings Corp. Дата публикации: 2017-08-15.

Pyrimidinones as pi3k inhibitors

Номер патента: CA2766100C. Автор: Yun-Long Li,Andrew P. Combs,Brian W. Metcalf. Владелец: Incyte Holdings Corp. Дата публикации: 2018-05-22.

Heterocyclylamines as PI3K inhibitors

Номер патента: US11819505B2. Автор: Yun-Long Li,Brent Douty,Andrew P. Combs,Eddy W. Yue,Song Mei. Владелец: Incyte Holdings Corp. Дата публикации: 2023-11-21.

Fused pyrrole derivatives as pi3k inhibitors

Номер патента: WO2011163195A1. Автор: Yun-Long Li,Andrew P. Combs. Владелец: INCYTE CORPORATION. Дата публикации: 2011-12-29.

Method for preparing compound as pi3k inhibitor and intermediate compound for preparing same

Номер патента: US20230295158A1. Автор: Ji Han Kim,Joon Kwang Lee,Yong Ho Sun,Ok Kyoung CHOI. Владелец: Boryung Corp. Дата публикации: 2023-09-21.

Semicarbazide-sensitive amine oxidase inhibitors for use as analgesics in traumatic neuropathy and neurogenic inflammation

Номер патента: US09790193B2. Автор: Peter Matyus,Zsuzsanna TAMÁSIKNÉ HELYES,Bálint SCHEICH,Valéria DEZSÖ-TÉKUS. Владелец: PÉCSI TUDOMÁNYEGYETEM. Дата публикации: 2017-10-17.

Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions

Номер патента: US09949948B2. Автор: Christoph Thiemermann. Владелец: Queen Mary University of London. Дата публикации: 2018-04-24.

Imidazopyridine amides and related compounds for use in the treatment of bacterial infections

Номер патента: AU2022377203A1. Автор: José Manuel Bartolomé-Nebreda,María Luz Martín-Martín,Katie Ingrid Eduard Amssoms,Bart Henri Theresia STOOPS,Dirk Antonie LAMPRECHT,Guido Alfons F Verniest. Владелец: Janssen Sciences Ireland ULC. Дата публикации: 2024-06-13.

Chk1/2 inhibitors for use in the treatment of neuroblastomas and/or soft tissue sarcomas

Номер патента: EP3325468A1. Автор: Louis Frank Stancato. Владелец: Eli Lilly and Co. Дата публикации: 2018-05-30.

Chk1/2 inhibitors for use in the treatment of neuroblastomas and/or soft tissue sarcomas

Номер патента: US20220378745A1. Автор: Louis Frank Stancato. Владелец: Eli Lilly and Co. Дата публикации: 2022-12-01.

CHK1/2 Inhibitors for Use in the Treatment of Neuroblastomas and/or Soft Tissue Sarcomas

Номер патента: US20180369202A1. Автор: Louis Frank Stancato. Владелец: Eli Lilly and Co. Дата публикации: 2018-12-27.

Imidazopyridine amides and related compounds for use in the treatment of bacterial infections

Номер патента: EP4423097A1. Автор: José Manuel Bartolomé-Nebreda,María Luz Martín-Martín,Katie Ingrid Eduard Amssoms,Bart Henri Theresia STOOPS,Dirk Antonie LAMPRECHT,Guido Alfons F Verniest. Владелец: Janssen Sciences Ireland ULC. Дата публикации: 2024-09-04.

Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder

Номер патента: EP3356337A1. Автор: David Cavalla. Владелец: Healx Ltd. Дата публикации: 2018-08-08.

Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder

Номер патента: US20220265676A1. Автор: David Cavalla. Владелец: Numedicus Ltd. Дата публикации: 2022-08-25.

Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder

Номер патента: US20190381065A1. Автор: David Cavalla. Владелец: Healx Ltd. Дата публикации: 2019-12-19.

Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder

Номер патента: CA3000070C. Автор: David Cavalla. Владелец: Numedicus Ltd. Дата публикации: 2024-01-02.

Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder

Номер патента: US20180271876A1. Автор: David Cavalla. Владелец: Healx Ltd. Дата публикации: 2018-09-27.

Compounds useful in the treatment or prevention of a prmt5-mediated disorder

Номер патента: US20240287036A1. Автор: Andrew Morley,Nicholas La Thangue,Shonagh MUNRO. Владелец: Argonaut Therapeutics Ltd. Дата публикации: 2024-08-29.

Heterocyclic compounds as PI3K-γ inhibitors

Номер патента: US11773102B2. Автор: Andrew P. Combs,Nikoo Falahatpisheh,Lixin Shao,Stacey Shepard,Artem Shvartsbart,Eddy W. Yue,Andrew W. Buesking,Richard B. Sparks,Ravi Kumar Jalluri,Ge Zou. Владелец: Incyte Corp. Дата публикации: 2023-10-03.

Glucocorticoid receptor ligands for the treatment of metabolic disorders

Номер патента: CA2488535C. Автор: Chunqiu Lai,Noah Tu,Philip R. Kym,Thomas W. Von Geldern,James T. Link,Steven J. Richards,Richard D. Bishop,Bradley D. Gates,Peer B. Jacobson. Владелец: KARO BIO AB. Дата публикации: 2012-02-07.

Anti-TNF Antibody Compositions for Use in Methods for the Treatment of Psoriatic Arthritis

Номер патента: US20220064278A1. Автор: HARRISON Diane D.,Hsia Elizabeth C.,Kim Lee-Lian,Lo Kim Hung. Владелец: . Дата публикации: 2022-03-03.

Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis

Номер патента: EP3914618A1. Автор: Diane D. Harrison,Elizabeth C. Hsia,Lee-Lian KIM,Kim Hung Lo. Владелец: Janssen Biotech Inc. Дата публикации: 2021-12-01.

Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis

Номер патента: WO2020152544A1. Автор: Diane D. Harrison,Elizabeth C. Hsia,Lee-Lian KIM,Kim Hung Lo. Владелец: JANSSEN BIOTECH, INC.. Дата публикации: 2020-07-30.

Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer

Номер патента: US20220372028A1. Автор: Caroline Springer,Richard Marais,Dan Niculescu-Duvaz,Haoran TANG,Leo Leung,Deborah SMITHEN,Cedric CALLENS. Владелец: Institute of Cancer Research. Дата публикации: 2022-11-24.

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

Номер патента: EP3416956A1. Автор: Caroline Springer,Richard Marais,Dan Niculescu-Duvaz,Haoran TANG,Leo Leung,Deborah SMITHEN,Cedric CALLENS. Владелец: Institute of Cancer Research. Дата публикации: 2018-12-26.

Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer

Номер патента: US20210040078A1. Автор: Caroline Springer,Richard Marais,Dan Niculescu-Duvaz,Haoran TANG,Leo Leung,Deborah SMITHEN,Cedric CALLENS. Владелец: Institute of Cancer Research. Дата публикации: 2021-02-11.

Heterocyclic compounds as calcium sensing receptor modulators for the treatment of hyperparathyroidism, chronic renal failure and chronic kidney disease

Номер патента: WO2015162538A1. Автор: Venkata P. Palle,Rajender Kumar Kamboj,Sanjeev Anant Kulkarni,Sachin MADAN,Prashant Vitthalrao TALE,Seema Prabhakar ZADE,Amolsing Dattu PATIL. Владелец: Lupin Limited. Дата публикации: 2015-10-29.

Tyrosine kinase inhibitors for the manufacture of drugs in the treatment of cell proliferation-related disorders

Номер патента: NO334209B1. Автор: Eddy Jean Edgard Freyne,Frederik Jan Rita Rombouts,Peter Ten Holte,Marco Willems,Peter Jacobus Johannes Antonius Buijnsters,Gaston Stanislas Marcella Diels,Timothy Pietro Suren Perera,Carsten Shultz-Fademrecht,Weerner Constant Johan Embrechts. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2014-01-13.

Phenanthrene derivatives for use as medicaments

Номер патента: WO2014091020A1. Автор: Jose Ruben Tormo Beltran,Rubén ARTERO ALLEPUZ,Manuel Pérez Alonso,Irma García Alcover,Arturo López Catel,María del Carmen Álvarez Abril,Diego Miguel Cortés Martínez. Владелец: Valentia Biopharma. Дата публикации: 2014-06-19.

Phenanthrene derivatives for use as medicaments

Номер патента: EP2931374A1. Автор: Jose Ruben Tormo Beltran,Rubén ARTERO ALLEPUZ,Manuel Pérez Alonso,Irma García Alcover,Arturo López Catel,María del Carmen Álvarez Abril,Diego Miguel Cortés Martínez. Владелец: Valentia Biopharma. Дата публикации: 2015-10-21.

PURINE DERIVATIVES FOR USE AS MEDICINAL PRODUCTS FOR THE TREATMENT OF VIRAL INFECTIONS

Номер патента: FR2342972A2. Автор: Howard John Schaeffer. Владелец: Wellcome Foundation Ltd. Дата публикации: 1977-09-30.

PYRANONE DERIVATIVES, THEIR PREPARATION METHOD AND THEIR THERAPEUTIC USE, IN PARTICULAR FOR THE TREATMENT OF CANCER

Номер патента: FR2864959B1. Автор: Pierre Potier,Joanna Bakala,Jerome Bignon,Denyse Herlem,Emile Benechie,Huu Francoise Kuong. Владелец: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS. Дата публикации: 2006-03-17.

DERIVATIVES OF PRIMARY HALOBIPHENYL ALCOHOLS THAT CAN BE USED IN THERAPEUTICS FOR THE TREATMENT OF ARTERIAL CALCIFICATION.

Номер патента: DE3672538D1. Автор: Gilbert Mouzin,Andre Delhon,Henri La Foun De Los No Cousse,Jean-Pierre La Vixere Hau Rieu. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1990-08-16.

Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis

Номер патента: US09656949B2. Автор: Markus Klein,Sven Lindemann. Владелец: Merck Patent GmBH. Дата публикации: 2017-05-23.

Kl1333 for use in medicine

Номер патента: US20240238255A1. Автор: Alvar GRÖNBERG,Magnus Joakim HANSSON,Matilda Hugerth. Владелец: Abliva AB. Дата публикации: 2024-07-18.

Bicyclic pyridine, pyrazine, and pyrimidine derivatives as pi3k beta inhibitors

Номер патента: CA3025594C. Автор: Laurence Anne Mevellec,Patrick René Angibaud,Virginie Sophie Poncelet,Didier Jean-Claude Berthelot,Lieven Meerpoel,Christophe Meyer,Elisabeth Therese Jeanne Pasquier,Sophie Coupa,Christophe Gabriel Marcel Demestre,Guillaume Jean Maurice Mercey,Isabelle Noelle Constance Pilatte,Olivier Alexis Georges Querolle. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2024-06-18.

Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the nrf2-beta-trcp interaction for use in the treatment of nrf2-related diseases

Номер патента: EP4029500A1. Автор: Rafael Leon Martinez,Manuela Garcia Lopez,María Isabel RODRIGUEZ FRANCO,Antonio CUADRADO PASTOR,Raquel FERNÁNDEZ GINÉS,José Antonio ENCINAR,Juan Felipe FRANCO GONZÁLEZ,Ana Isabel ROJO SANCHÍS. Владелец: Universidad Miguel Hernandez de Elche UMH. Дата публикации: 2022-07-20.

Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza

Номер патента: US20240277680A1. Автор: Paul Andrew Whittaker,Adrian Huw DAVIES,Pui-Man CHOY,Vinay SAUNDERS,Basma BAHSOUN,Surender VASHIST,Neil Edward TORBETT. Владелец: Poolbeg Pharma UK Ltd. Дата публикации: 2024-08-22.

Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders

Номер патента: WO2016089304A1. Автор: Entzeroth Michael,Anil Kumar RATTY. Владелец: Cennerv Pharma (S) Pte. Ltd.. Дата публикации: 2016-06-09.

Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders

Номер патента: EP3226865A1. Автор: Entzeroth Michael,Anil Kumar RATTY. Владелец: Cennerv Pharma (s) Pte Ltd. Дата публикации: 2017-10-11.

Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders

Номер патента: US20170355676A1. Автор: Michael Entzeroth,Anil Kumar RATTY. Владелец: Cennerv Pharma (s) Pte Ltd. Дата публикации: 2017-12-14.

2-amino-5,5-dimethylhexanoic acid derivatives as sortilin modulators for use in the treatment of disease of the central nervous system

Номер патента: EP4395776A1. Автор: Anders Nykjaer,Paul Brian Little,Manuel Javier Cases-Thomas,Mads Fuglsang KJØLBY. Владелец: Insusense Aps. Дата публикации: 2024-07-10.

Sglt2 inhibitors for treatment of metabolic disorders in canine animals

Номер патента: EP4234012A3. Автор: Saskia Kley,Dania Birte REICHE. Владелец: BOEHRINGER INGELHEIM VETMEDICA GMBH. Дата публикации: 2023-09-20.

Compounds for use in the treatment of fascioliasis

Номер патента: US12060355B2. Автор: Andrew Simon Bell,John Mark Francis Gardner. Владелец: Merck Patent GmBH. Дата публикации: 2024-08-13.

P38 and JNK MAPK inhibitors for the treatment and prophylaxis of degenerative diseases of the nervous system

Номер патента: US09908896B2. Автор: Miguel VEGA,Angel Messeguer,Esther Carrasco,Patricia Gómez,Pedro Campos,Juan Jesús Pérez,Juan Jesús GÓMEZ-REINO,Ignacio TORRES. Владелец: ALLINKY BIOPHARMA. Дата публикации: 2018-03-06.

Pharmaceutical combination of an ep4 antagonist and immune checkpoint inhibitors for the treatment of tumours

Номер патента: US20220142996A1. Автор: Lucio Claudio Rovati,Antonio Giordani,Gianfranco Caselli,Tiziana Piepoli,Daniele MAGGIONI,Albino BONAZZI,Filippo MAGARAACI. Владелец: Rottapharm Biotech SRL. Дата публикации: 2022-05-12.

Pharmaceutical combination of an ep4 antagonist and immune checkpoint inhibitors for the treatment of tumours

Номер патента: EP3953393A1. Автор: Lucio Claudio Rovati,Antonio Giordani,Gianfranco Caselli,Filippo Magaraci,Tiziana Piepoli,Daniele MAGGIONI,Albino BONAZZI. Владелец: Rottapharm Biotech SRL. Дата публикации: 2022-02-16.

Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours

Номер патента: AU2020273246A1. Автор: Lucio Claudio Rovati,Antonio Giordani,Gianfranco Caselli,Filippo Magaraci,Tiziana Piepoli,Daniele MAGGIONI,Albino BONAZZI. Владелец: Rottapharm Biotech SRL. Дата публикации: 2021-11-25.

Pharmaceutical combination of an ep4 antagonist and immune checkpoint inhibitors for the treatment of tumours

Номер патента: CA3136164A1. Автор: Lucio Claudio Rovati,Antonio Giordani,Gianfranco Caselli,Filippo Magaraci,Tiziana Piepoli,Daniele MAGGIONI,Albino BONAZZI. Владелец: Rottapharm Biotech SRL. Дата публикации: 2020-10-15.

Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours

Номер патента: AU2020273246B2. Автор: Lucio Claudio Rovati,Antonio Giordani,Gianfranco Caselli,Filippo Magaraci,Tiziana Piepoli,Daniele MAGGIONI,Albino BONAZZI. Владелец: Rottapharm Biotech SRL. Дата публикации: 2022-12-01.

Pharmaceutical combination of an ep4 antagonist and immune checkpoint inhibitors for the treatment of tumours

Номер патента: WO2020208088A1. Автор: Lucio Claudio Rovati,Antonio Giordani,Gianfranco Caselli,Filippo Magaraci,Tiziana Piepoli,Daniele MAGGIONI,Albino BONAZZI. Владелец: Rottapharm Biotech S.R.L.. Дата публикации: 2020-10-15.

Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia

Номер патента: US20210363121A1. Автор: Mattia MORI,Bruno Botta,Francesca GHIRGA,Cinzia INGALLINA,Deborah QUAGLIO,Isabella Screpanti,Luca Tottone,Nadezda Zhdanoskaya,Francesca Giulimondi,Rocco Palermo. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2021-11-25.

Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia

Номер патента: EP3562803A1. Автор: Mattia MORI,Bruno Botta,Francesca GHIRGA,Cinzia INGALLINA,Deborah QUAGLIO,Isabella Screpanti,Luca Tottone,Nadezda Zhdanoskaya,Francesca Giulimondi,Rocco Palermo. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2019-11-06.

Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia

Номер патента: WO2018122689A1. Автор: Mattia MORI,Bruno Botta,Francesca GHIRGA,Cinzia INGALLINA,Deborah QUAGLIO,Isabella Screpanti,Luca Tottone,Nadezda Zhdanoskaya,Francesca Giulimondi,Rocco Palermo. Владелец: Università Degli Studi Di Roma "La Sapienza". Дата публикации: 2018-07-05.

Compounds for use in the treatment of hyperproliferative disorders

Номер патента: US20240208998A1. Автор: Xavier BARRIL ALONSO,Josep TABERNERO CATURLA,Carlos GALDEANO CANTADOR,Héctor GARCíA PALMER,Diego MUÑOZ-TORRERO LÓPEZ-IBARRA,Isabel PUIG BORREIL,Sergio RUIZ CARMONA. Владелец: Fundacio Privada Institut dInvestigacio Oncologica Vall dHebron VHIO. Дата публикации: 2024-06-27.

Tryptophan- and phenylethylamine-derived betaxanthins for use in the treatment and/or prevention of cancer

Номер патента: WO2021009029A1. Автор: Francisco Garcia Carmona,Fernando Gandía Herrero,Paula Henarejos Escudero,Samanta Hernández García,María Alejandra Guerrero Rubio. Владелец: Universidad De Murcia. Дата публикации: 2021-01-21.

Idebenone derivatives and their use in treating plants

Номер патента: AU2022347098A1. Автор: Mark Wood,Matthew Whiteman,Roberta TORREGROSSA. Владелец: Mitorx Therapeutics Ltd. Дата публикации: 2024-04-04.

Idebenone derivatives and their use in treating plants

Номер патента: EP4396174A1. Автор: Mark Wood,Matthew Whiteman,Roberta TORREGROSSA. Владелец: Mitorx Therapeutics Ltd. Дата публикации: 2024-07-10.

Idebenone derivatives and their use in treating plants

Номер патента: WO2023041906A1. Автор: Mark Wood,Matthew Whiteman,Roberta TORREGROSSA. Владелец: Mitorx Therapeutics Limited. Дата публикации: 2023-03-23.

Quinuclidine-3-one derivatives and their use in cancer treatment

Номер патента: CA3111356A1. Автор: Rune Ringom,Lars Hagberg,Tim BLIZZARD. Владелец: Aprea Therapeutics AB. Дата публикации: 2020-03-26.

Compositions for the treatment of Fragile X syndrome

Номер патента: US10435366B2. Автор: Sylvain Briault,Olivier Perche. Владелец: CENTRE HOSPITALIER REGIONAL D'ORLEANS. Дата публикации: 2019-10-08.

Aminopyrazine diol compounds as PI3K-γ inhibitors

Номер патента: US11926616B2. Автор: Andrew P. Combs,Nikoo Falahatpisheh,Lixin Shao,Stacey Shepard. Владелец: Incyte Corp. Дата публикации: 2024-03-12.

"method for treating hyperproliferative dysfunction, pharmaceutical composition, use of a therapeutic combination in the manufacture of a medicament for treating cancer, article of manufacture for treating a hyperproliferative dysfunction, method for determining compounds to be used in combination for the treatment of cancer". cancer treatment and method for determining a therapeutic combination to be used for cancer treatment "

Номер патента: BRPI0906181A2. Автор: Mark X Sliwkowski,Leanne Berry,Gail Lewis Phillips. Владелец: Genentech Inc. Дата публикации: 2015-06-30.

Therapeutic combinations comprising trastuzumab-mcc-dmi and pertuzumab for use in methods for the treatment of erbb2 expressing cancer

Номер патента: IL234065B. Автор: . Владелец: Genentech Inc. Дата публикации: 2018-06-28.

Pharmaceutical compositions and their use, in particular for the treatment of neurodegenerative diseases.

Номер патента: FR2707880B1. Автор: REVAH Frederic,MALLET Jacques,Robert Jean-Jacques. Владелец: Rhone Poulenc Rorer SA. Дата публикации: 1995-10-06.

Pharmaceutical compositions and their use, in particular for the treatment of neurodegenerative diseases.

Номер патента: FR2707880A1. Автор: REVAH Frederic,MALLET Jacques,Robert Jean-Jacques. Владелец: Rhone Poulenc Rorer SA. Дата публикации: 1995-01-27.

Pharmaceutical compositions and their use, in particular for the treatment of neurodegenerative diseases

Номер патента: AU696644B2. Автор: Jacques Mallet,Jean-Jacques Robert,Frederic Revah. Владелец: Rhone Poulenc Rorer SA. Дата публикации: 1998-09-17.

Imidazolidone and succinimide derivatives for use as alpha v beta 3 integrin inhibitors for the treatment of cancer

Номер патента: WO2024165831A1. Автор: Helen Margaret SHELDRAKE,Arianna DELL'ALBANI. Владелец: University of Bradford. Дата публикации: 2024-08-15.

7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, analogs thereof, and salts thereof and methods for their use in therapy

Номер патента: NZ772080A. Автор: Martin Stogniew,Richard S Pottorf,Yanjun SUN,Bhaskara Rao Nallaganchu,Gary L Olson,Joshua E Allen. Владелец: Oncoceutics Inc. Дата публикации: 2024-07-05.

7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, analogs thereof, and salts thereof and methods for their use in therapy

Номер патента: NZ772369A. Автор: Martin Stogniew,Richard S Pottorf,Yanjun SUN,Bhaskara Rao Nallaganchu,Gary L Olson,Joshua E Allen. Владелец: Oncoceutics Inc. Дата публикации: 2024-07-05.

5,6,7,8-tetrahydro-2,6- and 2,7-naphthyridine derivatives for use in the treatment of diseases responsive to citrate transporter modulation

Номер патента: EP4370519A1. Автор: Cristina Lecci,Julia Marie Bainbridge,Christopher John Yarnold,Steven Mark Bromidge,Kevin Michael Thewlis,Grit Zahn,Adam James Davenport,Laura Jane Gleave,Mark Anthony KERRY,Patrick Ross WALKER,Colin Haig MACKINNON,Robert Edward ARNOLD,Giacomo Beretta,Emily Catherine DOCTON,Verity Nicole DOWLING,Stuart Robert FLANAGAN,Paula Cristina DE AGUIARPENA. Владелец: Eternygen Uk Ltd. Дата публикации: 2024-05-22.

Glucagon/glp-1 agonists for the treatment of obesity

Номер патента: RU2671088C2. Автор: Дэвид ФЭРМАН,Баладжи АГОРАМ,Маделейне АНТОНССОН,Мария БЕДНАРЕК,Николь БУРМЕЙСТЕР,Ламбертус БЕНТХЕМ,Мария ФРИТШ-ФРЕДИН,Роналд ДЖЕКСОН,Расмус Джанссон ЛОФМАРК,Жаклин МЕТКАЛФ. Владелец: Медиммьюн Лимитед. Дата публикации: 2018-10-29.

Complement split product C4d for the treatment of inflammatory conditions

Номер патента: US09944685B2. Автор: Peter Steinberger,Florian Forster,Johannes Hofer,David E. Isenman,Johannes KOVARIK,Markus HÖLZL,Gerhard Zlabinger,Georg Böhmig,Judith Leitner,Markus Wahrmann,Margarethe Merio. Владелец: MEDIZINISCHE UNIVERSITAET WIEN. Дата публикации: 2018-04-17.

Novel anti-cd38 antibodies for the treatment of cancer

Номер патента: MY159374A. Автор: MIKOL Vincent,TAVARES Daniel,BLANC Veronique,DECKERT Jutta,SKALETSKAYA Anna,U Park Peter,M Bartle Laura,S Golmakher Viktor. Владелец: SANOFI-AVENTIS. Дата публикации: 2016-12-30.

Antagonist antibody against epha2 for the treatment of cancer

Номер патента: MY157757A. Автор: Han Jiawen,FROMOND Claudia,PARKER Fabienne,BLANC Veronique. Владелец: Sanofi Aventis. Дата публикации: 2016-07-15.

Methods and compositions for using activated lymphocytes in the treatment of disease

Номер патента: CA3227891A1. Автор: Ivan Petrov,Aladar A. Szalay,Ignazio Caruana,Elena Ekrami. Владелец: Immunolux International Corp. Дата публикации: 2023-02-02.

Methods and compositions for using activated lymphocytes in the treatment of disease

Номер патента: EP4376863A1. Автор: Ivan Petrov,Aladar A. Szalay,Ignazio Caruana,Elena Ekrami. Владелец: Immunolux International Corp. Дата публикации: 2024-06-05.

Use of il-17 in the treatment of fertility-related disorders

Номер патента: EP1765083A2. Автор: David Kagan,Stephen S. Palmer,Ann M. Clark. Владелец: Applied Research Systems ARS Holding NV. Дата публикации: 2007-03-28.

Modification of feline calicivirus (FCV) capsid gene in the consensus sequence preventing further alterations by splicing machinery within eukaryotic cells

Номер патента: NZ501579A. Автор: Didier Colau,Joel Roos. Владелец: Dimminaco Ag S. Дата публикации: 2001-11-30.

Dye molecule and dye preparations, in particular for use in surgical methods of ophthalmic surgery and for dyeing proteins

Номер патента: US20180104361A1. Автор: Enrico Bettini,Mauro Beccaro,Paolo Signori. Владелец: AL CHI MI A Srl. Дата публикации: 2018-04-19.

Dye molecule and dye preparations, in particular for use in surgical methods of ophthalmic surgery and for dyeing proteins

Номер патента: WO2016189475A1. Автор: Enrico Bettini,Mauro Beccaro,Paolo Signori. Владелец: Al.Chi.Mi.A. S.R.L.. Дата публикации: 2016-12-01.

Monohydroxy-benzoyl peroxide and compositions for the treatment of acne

Номер патента: NZ209109A. Автор: D Yeung,A I Dines,S Nacht. Владелец: Richardson Vicks Inc. Дата публикации: 1987-08-31.

Methods and compositions for using activated lymphocytes in the treatment of disease

Номер патента: AU2022317540A1. Автор: Ivan Petrov,Aladar A. Szalay,Ignazio Caruana,Elena Ekrami. Владелец: Immunolux International Corp. Дата публикации: 2024-02-15.

Methods and compositions for using activated lymphocytes in the treatment of disease

Номер патента: AU2022317540A8. Автор: Ivan Petrov,Aladar A. Szalay,Ignazio Caruana,Elena Ekrami. Владелец: Immunolux International Corp. Дата публикации: 2024-03-14.

Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration

Номер патента: IL117645A. Автор: . Владелец: Genentech Inc. Дата публикации: 2005-08-31.

Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin

Номер патента: EP3377637B1. Автор: Suma Krishnan,Pooja Agarwal. Владелец: Krystal Biotech Inc. Дата публикации: 2020-03-18.

Anti-cancer drugs for the treatment of melanomas and method for preparing thereof

Номер патента: US4414148A. Автор: Pierre Gros,Franz K. Jansen. Владелец: SANOFI SA. Дата публикации: 1983-11-08.

Anti-cancer drugs for the treatment of melanomas and method for preparing thereof

Номер патента: CA1195248A. Автор: Pierre Gros,Franz K. Jansen. Владелец: SANOFI SA. Дата публикации: 1985-10-15.

Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin

Номер патента: PL3377637T3. Автор: Suma Krishnan,Pooja Agarwal. Владелец: Krystal Biotech, Inc.. Дата публикации: 2020-09-07.

Novel antibody useful in neurological or neurodegenerative disorders

Номер патента: EP2805972A1. Автор: designation of the inventor has not yet been filed The. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2014-11-26.

Application of il-18 inhibitor for healing and/or prevention of atherosclerosis

Номер патента: YU82602A. Автор: Yolande Chvatchko,Alain Tedgui,Ziad Mallat. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2006-01-16.

Recombinant-defective viral genomic vectors and methods for using these vectors in the formulation of vaccines

Номер патента: KR100360327B1. Автор: 산체즈 루이스 엔후아네스,듀란 후안 플라나,빌라뉴에바 사라 알론소,하레뇨 마 루이사 발레스테로스,카스트릴론 호아퀸 카스틸라,마르티네즈 호세 마뉴엘 곤잘레즈,파르메산 안데르 이제타,준주네구이 안나 멘데즈,사엔즈 마리아 문티온,졸탄 펜제스,모르가도 호세 마뉴엘 산체즈,산체즈 카를로스 미구엘 산체즈,피카조 크리스티안 스메르도우,구르페구이 이사벨 솔라. Владелец: 사이아나미드 이베리카, 에스.에이.. Дата публикации: 2003-03-28.

3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders

Номер патента: ZA202103284B. Автор: Vallee Monique,Marsicano Giovanni,Cota Daniela,Revest Jean-Michel,Maldonado Rafael,FABRE Sandy,METNA Mathilde,MONLEZUN Stephanie,Piazza Pier-Vincenzo,Marighetto Aline,Ozaita Andrés. Владелец: Aelis Farma. Дата публикации: 2024-09-25.

Bufalin derivatives useful in therapy

Номер патента: WO2023275052A1. Автор: Weidong Zhang,Yaping Hua,Karl-Henning KALLAND,Xisong KE,Yunheng SHEN,Anne Margrete ØYAN. Владелец: VESTLANDETS INNOVASJONSSELSKAP AS. Дата публикации: 2023-01-05.

HETEROCYCLIC COMPOUNDS AS PI3Kα INHIBITORS

Номер патента: WO2024151759A1. Автор: CHAO QI,Wenqing Yao,Liangxing Wu. Владелец: Synnovation Therapeutics, Inc.. Дата публикации: 2024-07-18.

HETEROCYCLIC COMPOUNDS AS PI3Kα INHIBITORS

Номер патента: WO2024163752A1. Автор: CHAO QI,Wenqing Yao,Liangxing Wu,Yu Bai. Владелец: Synnovation Therapeutics, Inc.. Дата публикации: 2024-08-08.

Certain steroids and methods for using the same in the treatment of cancer

Номер патента: US09676813B2. Автор: Xiangping Qian. Владелец: Neupharma Inc. Дата публикации: 2017-06-13.

Isoquinolones as pi3k inhibitors

Номер патента: WO2024054469A1. Автор: Qian Zhao,James F. Blake,Mark Laurence Boys,David A. Mareska,Bryan Yestrepsky,Joshua Nathaniel Payette,Christie A. Schulte. Владелец: OnKure, Inc.. Дата публикации: 2024-03-14.

Benzo[h][1,6] naphthyridin-2(1h)-ones as bmx inhibitors, for use against cancer

Номер патента: EP3980126A1. Автор: Goncalo Bernardes,João SEIXAS. Владелец: Instituto de Medicina Molecular Joao Lobo Antunes. Дата публикации: 2022-04-13.

Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors

Номер патента: WO2011075630A1. Автор: Yun-Long Li,Andrew P. Combs,Eddy W. Yue,Hui-Yin Li. Владелец: INCYTE CORPORATION. Дата публикации: 2011-06-23.

New triazine substance for use in the treatment of cancer, specifically in the treatment of non-small cell cancer

Номер патента: WO2018177784A1. Автор: Jean-Michel Robert,Christos Roussakis. Владелец: UNIVERSITE DE NANTES. Дата публикации: 2018-10-04.

Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases

Номер патента: EP2563788A1. Автор: Stephen Joseph Shuttleworth,Franck Alexandre Silva. Владелец: Karus Therapeutics Ltd. Дата публикации: 2013-03-06.

Quinolines as pi3k inhibitors

Номер патента: EP2588477A1. Автор: Paul John Dransfield. Владелец: AMGEN INC. Дата публикации: 2013-05-08.

Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Номер патента: US20120035200A1. Автор: Mads Clausen,Blanka Leber,Thomas Larsen,Alwin Kraemer,Mads Roennest,Kasper Worm. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2012-02-09.

Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Номер патента: EP2379520A2. Автор: Mads Clausen,Blanka Leber,Thomas Larsen,Alwin Kraemer,Mads Roennest,Kasper Worm. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2011-10-26.

New catecholamine prodrugs for use in the treatment of parkinson's disease

Номер патента: EP4247793A1. Автор: Morten JØRGENSEN,Klaus Gjervig Jensen,Lena Gustavsson,Jette Bisgaard BOLL,Jarkko Tapani Rautio,Anja Nørgaard Kjeldsen,Christoffer Gerner Bavnhøj HANSEN. Владелец: H Lundbeck AS. Дата публикации: 2023-09-27.

Heterocyclic derivatives as PI3K inhibitors

Номер патента: US12006320B2. Автор: Yanran Ai,Andrew P. Combs,Nikoo Falahatpisheh,Lixin Shao,Stacey Shepard,Artem Shvartsbart. Владелец: Incyte Corp. Дата публикации: 2024-06-11.

HALOGENO BIPHENYL TERTIARY ALCOHOLS USEFUL IN THERAPEUTICS FOR THE TREATMENT OF ATHEROSCLEROSIS

Номер патента: FR2585350A1. Автор: Henri Cousse,Jean-Pierre Rieu,Jean-Francois Patoiseau,Andre Delhon. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1987-01-30.

5,5'-AZOBIS-SALICYLIC ACID AND ITS SALTS USEFUL IN PARTICULAR FOR THE TREATMENT OF INFLAMMATORY INTESTINAL CONDITIONS

Номер патента: FR2500824B1. Автор: . Владелец: Pharmacia AB. Дата публикации: 1985-07-19.

Process for the selective blocking of the amino AMINOCYCLITOLAMINOGLYCOSIDER GROUPS AND SELECTIVE amine blocked AMINOCYCLITOLAMINOGLYCOSIDER, which may be prepared by the process, for use as intermediates in the preparation of 1-N-substituted derivatives of 4,6-di-O-) aminoglycosyl) -1,3-DIAMINOCYCLITOLER

Номер патента: DK165451B. Автор: Alan Cooper,Tattanahalli Laksh Nagabhushan,William Nelson Turner. Владелец: Scherico Ltd. Дата публикации: 1992-11-30.

Analogues of bicalutamide or (s)-bicalutamide as exocytosis activating compounds for use in treatment of lysosomal storage disorder or glycogenosis

Номер патента: RU2685269C2. Автор: МОНТЬЕЛЬ Антонио ФЕРРЕР,ОБИОЛЬС Берта ПОНСАТИ,Хосеп ФАРРЕРА-СИНФРЕУ,БОРРЕЛЬ Леслье МАТАЛОНГА,МАС Лаура ГОРТ,МАРТИНЕС Роберто ПАСКУАЛЬ,РУБИО Антония РИБЕС. Владелец: БКН Пептидес, С.А.. Дата публикации: 2019-04-17.

Combination of tasquinimod or its pharmaceutically acceptable salt and pd-1 and/or pd-l1 inhibitor for use as a medicinal agent

Номер патента: RU2742373C2. Автор: Хосе Амаури СОАРЕС,Эрик ШЕТАЙ,Джессика НЭКЛ,Фабьен Шмидлен. Владелец: Эктив Байотек Аб. Дата публикации: 2021-02-05.

Inhibitor of interleukin-1 receptor type 1 for use in the treatment of cancer

Номер патента: AU2022445159A1. Автор: Georgios Theodoros STATHOPOULOS. Владелец: Buzzard Pharmaceuticals AB. Дата публикации: 2024-09-26.

Combination of gold complexes with olaparib or other parp1/2 inhibitors for use in the treatment of cancer resistant to said parp1/2 inhibitors

Номер патента: CA3118820A1. Автор: James Harrison,Melinda DUER,Uliana BASHTANOVA. Владелец: Varsity Pharmaceuticals Ltd. Дата публикации: 2021-04-01.

Combination of gold complexes with olaparib or other parp1/2 inhibitors for use in the treatment of cancer resistant to said parp1/2 inhibitors

Номер патента: EP3852741A1. Автор: James Harrison,Melinda DUER,Uliana BASHTANOVA. Владелец: Varsity Pharmaceuticals Ltd. Дата публикации: 2021-07-28.

Niclosamide and its derivatives for use in the treatment of solid tumors

Номер патента: US09844522B2. Автор: Björn Scheffler,Martin Glas,Anja WIELAND. Владелец: Life and Brain GmbH. Дата публикации: 2017-12-19.

C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Номер патента: EP4397306A1. Автор: Ralf Ludwig,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Enno Schmidt,Pasquale COCCHIARO,Nicola DETTA,Sabrina Patzelt. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2024-07-10.

Combinations comprising mek inhibitors for use in the treatment of cancer

Номер патента: WO2024173761A1. Автор: Alfredo C. Castro,Thomas A. Wynn,Michael J. Burke,Sabine K. RUPPEL,Eric HAINES. Владелец: Ikena Oncology, Inc.. Дата публикации: 2024-08-22.

C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Номер патента: WO2024146922A1. Автор: Ralf Ludwig,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Enno Schmidt,Pasquale COCCHIARO,Nicola DETTA,Sabrina Patzelt. Владелец: Dompe' Farmaceutici Spa. Дата публикации: 2024-07-11.

4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain

Номер патента: US8785504B2. Автор: Roy Arlington Jordan. Владелец: Individual. Дата публикации: 2014-07-22.

4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain

Номер патента: US20100292329A1. Автор: Roy Arlington Jordan. Владелец: Individual. Дата публикации: 2010-11-18.

4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain

Номер патента: WO2008155520A3. Автор: Roy Arlington Jordan. Владелец: Roy Arlington Jordan. Дата публикации: 2009-02-19.

4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain

Номер патента: US20150005383A1. Автор: Roy Arlington Jordan. Владелец: Individual. Дата публикации: 2015-01-01.

4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain

Номер патента: US9090555B2. Автор: Roy Arlington Jordan. Владелец: Individual. Дата публикации: 2015-07-28.

4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain

Номер патента: WO2008155520A2. Автор: Roy Arlington Jordan. Владелец: Roy Arlington Jordan. Дата публикации: 2008-12-24.

New compositions for the treatment of chemioresitant and/or potentially chemioresistant leukaemias

Номер патента: WO2011058508A2. Автор: Annarosa Arcangeli,Andrea Becchetti,Marika Masselli,Serena Pillozzi,Emanuele De Lorenzo. Владелец: Noi Per Voi Onlus. Дата публикации: 2011-05-19.

Compositions for the treatment of chemoresistant leukaemia and/or of potentially chemoresistant leukaemia

Номер патента: EP2498773A2. Автор: Annarosa Arcangeli,Andrea Becchetti,Marika Masselli,Serena Pillozzi,Emanuele De Lorenzo. Владелец: Noi Per Voi Onlus. Дата публикации: 2012-09-19.

Novel compounds for the treatment and prevention of neurological complications of viral infections

Номер патента: US20240307339A1. Автор: Yuhong DONG. Владелец: SunRegen Healthcare AG. Дата публикации: 2024-09-19.

A pharmaceutical combination for use in the treatment of cancer

Номер патента: WO2024199557A1. Автор: Jan ŽENKA,Andrea FREJLACHOVÁ,Radka LENCOVÁ. Владелец: Biocanim A.S.. Дата публикации: 2024-10-03.

Azithromycin derivatives for use in the treatment of eosinophil-related diseases

Номер патента: WO2024194494A1. Автор: Jennifer Kricker,Virginia NORRIS. Владелец: EpiEndo Pharmaceuticals ehf. Дата публикации: 2024-09-26.

Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer

Номер патента: US09655915B2. Автор: Christopher Mcguigan,Jan Balzarini,Blanka GONCZY,Paola MURZIANI,Magdalena Slusarczyk. Владелец: Nucana Biomed Ltd. Дата публикации: 2017-05-23.

Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant

Номер патента: EP2714066A1. Автор: Francisco Lozano Soto,Vanessa Gabriela MARTÍNEZ,Rafael FENUTRIA AUMESQUET. Владелец: Fundacio Clinic per a la Recerca Biomedica FCRB. Дата публикации: 2014-04-09.

Composition comprising ttf-ngr for use in treating soft-tissue sarcoma

Номер патента: US20230321205A1. Автор: Wolfgang E. Berdel. Владелец: Anturec Pharmaceuticals GmbH. Дата публикации: 2023-10-12.

Composition comprising ttf-ngr for use in treating soft-tissue sarcoma

Номер патента: EP4203959A1. Автор: Wolfgang E. Berdel. Владелец: Anturec Pharmaceuticals GmbH. Дата публикации: 2023-07-05.

Composition comprising tTF-NGR for use in treating soft-tissue sarcoma

Номер патента: AU2021334093A1. Автор: Wolfgang E. Berdel. Владелец: Anturec Pharmaceuticals GmbH. Дата публикации: 2023-02-09.

Composition comprising ttf-ngr for use in treating soft-tissue sarcoma

Номер патента: WO2022043245A1. Автор: Wolfgang E. Berdel. Владелец: Anturec Pharmaceuticals GmbH. Дата публикации: 2022-03-03.

Multivalent compounds for use in the treatment and prevention of brain damage

Номер патента: EP3201173A1. Автор: Adrian Harel. Владелец: Individual. Дата публикации: 2017-08-09.

Process for making bicyclic lactone derivatives for use as intermediates in the synthesis of prostaglandins

Номер патента: US4204999A. Автор: Csaba Szantay,Gabor Kovacs,Istvan Szekely,Istvan Stadler,Vilmos Simonidesz,Istvan Tomoskozi,Marianna Lovasz nee Gaspar,Julia Remport nee Radoczi,Zsuzsa Visky nee Gombos,Borbala Keresztesnee Ordog. Владелец: Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt. Дата публикации: 1980-05-27.

3-(5-AMINO-PYRAZIN-2-YL)-BENZENESULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PI3K-GAMMA KINASE INHIBITORS FOR TREATING E.G. CANCER

Номер патента: US20200331903A1. Автор: Combs Andrew P.,Shepard Stacey,Falahatpisheh Nikoo,Shao Lixin,Shvartsbart Artem,Polam Padmaja. Владелец: . Дата публикации: 2020-10-22.

Papd5 and papd7 inhibitors for treating a hepatitis b infection

Номер патента: EP4219767A1. Автор: Song Yang,Xingchun Han,Hassan JAVANBAKHT,Henrik Mueller,Yongguang Wang. Владелец: F Hoffmann La Roche AG. Дата публикации: 2023-08-02.

Cd146 and uses thereof as a biomarker and as a therapeutic target in the diagnosis and treatment of fibrosis

Номер патента: EP3857233A1. Автор: Christoph Thiemermann,Nathalie Bardin,Marcel Blot-Chabaud,Françoise DIGNAT-GEORGE,Benjamin Guillet,Aurélie LEROYER,Christos CHADJICHRISTOS,Alexandrine BERTAUD,Guillaume HACHE. Владелец: Assistance Publique Hopitaux de Marseille APHM. Дата публикации: 2021-08-04.

Cd146 and uses thereof as a biomarker and as a therapeutic target in the diagnosis and treatment of fibrosis

Номер патента: WO2020064897A1. Автор: Christoph Thiemermann,Nathalie Bardin,Marcel Blot-Chabaud,Françoise DIGNAT-GEORGE,Benjamin Guillet,Aurélie LEROYER,Christos CHADJICHRISTOS,Alexandrine BERTAUD,Guillaume HACHE. Владелец: Assistance Publique Hôpitaux De Marseille. Дата публикации: 2020-04-02.

Genetic structure for use in the treatment of neurodegenerative disorder or stroke

Номер патента: RU2757932C2. Автор: Кит МАРТИН,Питер УИДДОУСОН. Владелец: Куэтера Лимитед. Дата публикации: 2021-10-25.

Kobitolimod for use in treatment of inflammatory bowel disease

Номер патента: RU2766356C2. Автор: Арезу ЗАРГАРИ,Шарлотта ЭДМАЙР,Пернилла СЭНДУОЛЛ,Томас КНИТТЕЛЬ,Петер ЗЕРХУНИ. Владелец: Индекс Фармасьютикалс Аб. Дата публикации: 2022-03-15.

Antagonists and agonists of the transferrin receptor-2 for use in the treatment of diseases of the bone

Номер патента: US20240199755A1. Автор: Volker Germaschewski,Martina Rauner,Lorenz HOFBAUER,Uwe Platzbecker,Ulrike Baschant,Igor THEURL. Владелец: Kymab Ltd. Дата публикации: 2024-06-20.

A new combination for use in the treatment of malignant neoplasms

Номер патента: RU2742494C2. Автор: Джон КЭМЕРОН,Мари-Луиз ФЬЕЛЛСКОГ,Чжу ЦАО,Даниэла Чиполлетта,Кензи МАКАЙЗЕК. Владелец: НОВАРТИС АГ. Дата публикации: 2021-02-08.

Novel peptides and analogs for use in the treatment of oral mucositis

Номер патента: RU2668963C2. Автор: Ореола ДОНИНИ,Аннетт РОЗЕК,Джексон ЛИ,Джон НОРТ,Майкл АБРАМС. Владелец: Солидженикс, Инк.. Дата публикации: 2018-10-05.

Fibronectin or ilk inhibitors for use in the treatment of leukemia

Номер патента: US20190374618A1. Автор: Rahul Kumar,Daniela KRAUSE,Melanie MEISTER. Владелец: Chemotherapeutisches Forschungsinstitut Georg Speyer Haus. Дата публикации: 2019-12-12.

Fibronectin or ilk inhibitors for use in the treatment of leukemia

Номер патента: EP3509626A1. Автор: Rahul Kumar,Daniela KRAUSE,Melanie MEISTER. Владелец: Chemotherapeutisches Forschungsinstitut Georg Speyer Haus. Дата публикации: 2019-07-17.

Compounds for use in treatment of carcinomas

Номер патента: WO1996005220A1. Автор: Denis Raymond Stanworth,Valerie Jones. Владелец: Peptide Therapeutics Limited. Дата публикации: 1996-02-22.

Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Номер патента: US20110033380A1. Автор: Haixun Guo,Yubin Mlao. Владелец: STC UNM. Дата публикации: 2011-02-10.

Liver-specific car for use against immunologic rejection

Номер патента: EP4442322A1. Автор: Michael Hust,Elmar Jäckel,Matthias HARDTKE-WOLENSKI. Владелец: Technische Universitaet Braunschweig. Дата публикации: 2024-10-09.

Liver-specific car for use against immunologic rejection

Номер патента: WO2024208756A1. Автор: Michael Hust,Elmar Jäckel,Matthias HARDTKE-WOLENSKI. Владелец: TECHNISCHE UNIVERSITAT BRAUNSCHWEIG. Дата публикации: 2024-10-10.

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Номер патента: US09493537B2. Автор: Yubin Miao,Haixun Guo. Владелец: STC UNM. Дата публикации: 2016-11-15.

A medicinal product for use in administering in the treatment, control and/or prevention of pain

Номер патента: WO2024153981A1. Автор: Vyacheslav Stanislavovich KOSORUKOV,Guzal Rafailovna Abuzarova,Olesya Yuryevna Gamzeleva. Владелец: PVP LABS PTE. LTD.. Дата публикации: 2024-07-25.

Use of DDX3X inhibitors for the treatment of pneumovirus infections

Номер патента: US09884812B2. Автор: Andrew Marsh,Andrew Easton,Phillip GOULD. Владелец: University of Warwick. Дата публикации: 2018-02-06.

Plasma-derived immunoglobulin for use in the treatment and prevention of immune reconstitution inflammatory syndrome (iris)

Номер патента: WO2011124668A1. Автор: Ludwig Kappos,Jens Kuhle. Владелец: UNIVERSITÄTSSPITAL BASEL. Дата публикации: 2011-10-13.

A hydroxycarboxylic acid for the treatment of cancer

Номер патента: US20240217911A1. Автор: Michael Scharl,Yasser MORSY,Ana MONTALBAN-ARQUES,Egle KATKEVICIUTE. Владелец: Universitaet Zuerich. Дата публикации: 2024-07-04.

Composition for the treatment of heart failure

Номер патента: EP1267905A2. Автор: Egil Lien,John Kjekshus,Thor Ueland,Svein Simonsen,Halfdan Aass,Jan Fjeld,Arne Andreassen,Halfdan Ihlen,Sigurd Nitter-Hauge,Lars Gullestad,P l AUKRUST,Stig FR LAND. Владелец: MEDINNOVA AS. Дата публикации: 2003-01-02.

Composition for the treatment of heart failure

Номер патента: WO2001066124A3. Автор: Egil Lien,John Kjekshus,Thor Ueland,Paal Aukrust,Svein Simonsen,Halfdan Aass,Jan Fjeld,Arne Andreassen,Halfdan Ihlen,Sigurd Nitter-Hauge,Lars Gullestad,Stig Froeland. Владелец: Nitter Hauge Sigurd. Дата публикации: 2002-03-28.

Compositions comprising secreted extracellular vesicles of cells expressing nfatc4 useful for the treatment of cancer

Номер патента: US20190117688A1. Автор: Sebastien Jauliac,Livia CAMARGO. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2019-04-25.

Compositions comprising secreted extracellular vesicles of cells expressing nfatc4 useful for the treatment of cancer

Номер патента: EP3436056A1. Автор: Sebastien Jauliac,Livia CAMARGO. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2019-02-06.

Compositions comprising secreted extracellular vesicles of cells expressing NFATC4 useful for the treatment of cancer

Номер патента: US11154598B2. Автор: Sebastien Jauliac,Livia CAMARGO. Владелец: Université de Paris. Дата публикации: 2021-10-26.

Compositions comprising secreted extracellular vesicles of cells expressing nfatc4 useful for the treatment of cancer

Номер патента: WO2017167788A1. Автор: Sebastien Jauliac,Livia CAMARGO. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2017-10-05.

Bromelain protease, bromelain, jacalin-like lectin, extract from the stem and/or the fruit of a pineapple plant, combination preparation, bromelain protease inhibitor, protein/protease mix, and glycated bromelain protein formed by exogenous non-enzymatic glycation, for use in the treatment or prophylaxis of virus infections caused by coronaviruses in a human or animal

Номер патента: US20240216484A1. Автор: Rolf Müller,Peter Gross,Frank Holzer,Peter Meiser,Holger Seelert. Владелец: Helmholtz Institut Fuer Pharmazeutische Forschung Saarland. Дата публикации: 2024-07-04.

Fusion protein for use in the treatment of hvg disease

Номер патента: EP3478710A1. Автор: Michael Hust,Elmar Jäckel,Fatih Noyan. Владелец: Technische Universitaet Braunschweig. Дата публикации: 2019-05-08.

Fusion protein for use in the treatment of hvg disease

Номер патента: EP3865506A1. Автор: Michael Hust,Elmar Jäckel,Fatih Noyan. Владелец: Technische Universitaet Braunschweig. Дата публикации: 2021-08-18.

Fusion protein for use in the treatment of hvg disease

Номер патента: EP3892631A1. Автор: Elmar Dr. Jäckel,Fatih Dr. Noyan,Michael Prof. Dr. Hust. Владелец: Technische Universitaet Braunschweig. Дата публикации: 2021-10-13.

Fusion protein for use in the treatment of hvg disease

Номер патента: EP4098660A1. Автор: Michael Hust,Elmar Jäckel,Fatih Noyan. Владелец: Technische Universitaet Braunschweig. Дата публикации: 2022-12-07.

Fusion protein for use in the treatment of hvg disease

Номер патента: WO2018001874A1. Автор: Dr. Fatih Noyan,Dr. Elmar JÄCKEL,Prof. Dr. Michael HUST. Владелец: TECHNISCHE UNIVERSITAT BRAUNSCHWEIG. Дата публикации: 2018-01-04.

Anti-BAFF Antibodies for use in a Method of Treatment of Long Covid and/or Post-Acute Sequelae SARS-CoV-2 Infection (PASC)

Номер патента: US20240254247A1. Автор: Jeremy SOKOLOVE,Andre Van Maurik,Robert Brian HENDERSON. Владелец: GlaxoSmithKline Intellectual Property Development Ltd. Дата публикации: 2024-08-01.

Human antibodies to PCSK9 for use in methods of treating particular groups of subjects

Номер патента: US12083176B2. Автор: Corinne HANOTIN,Laurence Bessac,Umesh CHAUDHARI. Владелец: Sanofi Biotechnology SAS. Дата публикации: 2024-09-10.

Inhibitor of surface protein (SP-D) / SIRPα / SHP2 pathway for use in the prevention and/or treatment of secondary infection

Номер патента: AU2020304796B2. Автор: Cedric Jacqueline,Karim Asehnoune,Antoine Roquilly. Владелец: Centre Hospitalier Universitaire De Nantes. Дата публикации: 2024-07-18.

Itih5 for use in the treatment of obesity

Номер патента: WO2024115424A1. Автор: Edgar Dahl,Tim RUHL,Sophia VILLWOCK,Jana KEIMES. Владелец: Rheinisch-Westfälische Technische Hochschule Aachen, Körperschaft des öffentlichen Rechts. Дата публикации: 2024-06-06.

Synthetic retinoids for use in rar activation

Номер патента: NZ779699A. Автор: Andrew Whiting,Iain Greig,David Chisholm,Thabat KHATIB,Peter MCCAFFERY. Владелец: Univ Durham. Дата публикации: 2024-05-31.

Synthetic retinoids for use in rar activation

Номер патента: NZ779699B2. Автор: Andrew Whiting,Iain Greig,David Chisholm,Thabat KHATIB,Peter MCCAFFERY. Владелец: University of Durham. Дата публикации: 2024-09-03.

Method for use in the treatment of aneurysm

Номер патента: US09573997B2. Автор: Alain Tedgui,Ziad Mallat,Soraya Taleb. Владелец: Universite Paris 5 Rene Descartes. Дата публикации: 2017-02-21.

Modified bont/a for use in the treatment of cervical dystonia

Номер патента: EP4401759A1. Автор: Nicolae GRIGORE,Laurent PONS. Владелец: Ipsen Biopharm Ltd. Дата публикации: 2024-07-24.

A medicinal product for use in administering in the treatment, control and/or prevention of pain

Номер патента: EP4403181A1. Автор: Vyacheslav Stanislavovich KOSORUKOV,Guzal Rafailovna Abuzarova,Olesya Yuryevna Gamzeleva. Владелец: PVP Labs Pte Ltd. Дата публикации: 2024-07-24.

Combination of antibodies, or antigen-binding fragments thereof, for the treatment of cancer and composition thereof

Номер патента: EP4434586A1. Автор: designation of the inventor has not yet been filed The. Владелец: XENOTHERA. Дата публикации: 2024-09-25.

Aminostatin derivatives for the treatment of arthrosis

Номер патента: US09839665B2. Автор: Markus Klein,Hans Guehring,Christos Tsaklakidis,Birgitta Leuthner. Владелец: Merck Patent GmBH. Дата публикации: 2017-12-12.

Hydroxystatin derivatives for the treatment of arthrosis

Номер патента: US09624264B2. Автор: Markus Klein,Christos Tsaklakidis. Владелец: Merck Patent GmBH. Дата публикации: 2017-04-18.

Heptapeptide amides for the treatment of hmgb1-dependent diseases

Номер патента: RU2760133C1. Автор: Владислав Николаевич Каркищенко,Вероника Игоревна Скворцова,Игорь Анатольевич Помыткин,Николай Николаевич Каркищенко. Владелец: Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства".. Дата публикации: 2021-11-22.

Anti-cd38 antibodies for use in the treatment of antibody-mediated transplant rejection

Номер патента: US20240228654A9. Автор: Stefan Steidl,Stefan Hartle,Rainer Boxhammer. Владелец: MORPHOSYS AG. Дата публикации: 2024-07-11.

Alpha-1 antitrypsin produced from yeast for use in the treatment of viral infections

Номер патента: CA3241852A1. Автор: Manfred Stangl. Владелец: Aatec Medical GmbH. Дата публикации: 2023-06-29.

Agent for use in the treatment and prophylaxis of postischemic tissue injury

Номер патента: US20230036161A1. Автор: Bernhard Nieswandt,Peter Rosenberger. Владелец: Julius Maximilians Universitaet Wuerzburg. Дата публикации: 2023-02-02.

Fasl immunomodulatory gene therapy compositions and methods for use

Номер патента: EP3841116A1. Автор: David A. Nelles. Владелец: Locanabio Inc. Дата публикации: 2021-06-30.

Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies

Номер патента: US20110052640A1. Автор: Alberto Martinez Garate,Juan Andres Asturias Ortega,Inaki Ibarrola Lopez De Davalillo,Maria Carmen Arilla Rodriguez. Владелец: Bial Industrial Farmaceutica SA. Дата публикации: 2011-03-03.

Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies

Номер патента: WO2009118642A3. Автор: Alberto Martinez Garate,Juan Andres Asturias Ortega,Inaki Ibarrola Lopez De Davalillo,Maria Carmen Arilla Rodriguez. Владелец: Bial Industrial Farmaceutica S.A.. Дата публикации: 2009-12-03.

Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies

Номер патента: US20150152148A1. Автор: Alberto Martinez Garate,Juan Andres Asturias Ortega,Inaki Ibarrola Lopez De Davalillo,Maria Carmen Arilla Rodriguez. Владелец: Bial Industrial Farmaceutica SA. Дата публикации: 2015-06-04.

Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions

Номер патента: US20180325997A1. Автор: Stefan Franz Thomas Weiss,Tyrone Chad Otgaar,Boitelo Theresiah Letsolo,Kerrilyn Naidoo. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2018-11-15.

Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions

Номер патента: US11896645B2. Автор: Stefan Franz Thomas Weiss,Tyrone Chad Otgaar,Boitelo Theresiah Letsolo,Kerrilyn Naidoo. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2024-02-13.

Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions

Номер патента: US20210169974A1. Автор: Stefan Franz Thomas Weiss,Tyrone Chad Otgaar,Boitelo Theresiah Letsolo,Kerrilyn Naidoo. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2021-06-10.

Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma

Номер патента: US12084498B2. Автор: Cecile Bonnafous,Hélène Sicard,Renaud Buffet. Владелец: Innate Pharma SA. Дата публикации: 2024-09-10.

Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis

Номер патента: US09844580B2. Автор: Aprile L. Pilon-Clayton. Владелец: Therabron Therapeutics Inc. Дата публикации: 2017-12-19.

Modified bont/a for use in the treatment of a disorder affecting an eyelid muscle of a subject

Номер патента: EP4404955A1. Автор: Nicolae GRIGORE,Laurent PONS. Владелец: Ipsen Biopharm Ltd. Дата публикации: 2024-07-31.

Periostin compounds for the treatment of haematological complications

Номер патента: WO2020016346A1. Автор: Daniela KRAUSE,Divij Verma. Владелец: Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus. Дата публикации: 2020-01-23.

Anti-ck8 antibodies for use in the treatment of cancers

Номер патента: CA2959671C. Автор: Claudine Vermot-Desroches,Boris VUILLERMOZ,Jean-Jacques Diaz,Marie Alexandra ALBARET,Hichem Claude MERTANI,Jean-Christophe Saurin. Владелец: International Drug Development Biotech SAS. Дата публикации: 2023-10-03.

Peptide for use in the prevention and/or treatment of a disease caused by a virus affecting the respiratory tract

Номер патента: US20230173022A1. Автор: Alejandro Mira Obrador,Maria de los Desamparados FERRER GARCÍA,Paula CORELL ESCUIN,Francisco Javier LÓPEZ LABRADOR. Владелец: Fundacion Para El Fomento de la Investitacion Sanitaria Y Biomedica de la Comunitat Valenciana. Дата публикации: 2023-06-08.

Fasl immunomodulatory gene therapy compositions and methods for use

Номер патента: CA3110282A1. Автор: David A. Nelles. Владелец: Locanabio Inc. Дата публикации: 2020-02-27.

Il-18 binding protein (il-18bp) in the treatment of vexas

Номер патента: WO2023166206A1. Автор: Eduardo Schiffrin,Michael Soldan,Laurence Goffin,Djordje Filipovic,Cyril PORTMANN. Владелец: AB2 BIO SA. Дата публикации: 2023-09-07.

Periostin compounds for the treatment of haematological complications

Номер патента: EP3823660A1. Автор: Daniela KRAUSE,Divij Verma. Владелец: Chemotherapeutisches Forschungsinstitut Georg Speyer Haus. Дата публикации: 2021-05-26.

Compounds and pharmaceutical use thereof in the treatment of cancer

Номер патента: US11759496B2. Автор: Santos A. Susin,Hélène MERLE-BERAL,Philippe KAROYAN. Владелец: Individual. Дата публикации: 2023-09-19.

A mycobacterium for use in cancer therapy

Номер патента: EP4243842A1. Автор: Jakob KAMPINGA,Thomas KLEEN. Владелец: Immodulon Therapeutics Ltd. Дата публикации: 2023-09-20.

Bispecific antibodies for use in the treatment of hematological malignancies

Номер патента: US12077586B2. Автор: Tanja Denise DE GRUIJL,Johannes Jelle VAN DER VLIET,Roeland Lameris,Paul Willem Henri Ida PARREN,Arnon Philip KATER,Iris DE WEERDT. Владелец: Lava Therapeutics NV. Дата публикации: 2024-09-03.

Synthetic retinoids for use in rar activation

Номер патента: EP4414355A2. Автор: Andrew Whiting,Iain Greig,David Chisholm,Thabat KHATIB,Peter MCCAFFERY. Владелец: University of Durham. Дата публикации: 2024-08-14.

Combination of a fcyrllb- and a tumor antibody for use in the treatment of an fcyriib-negative cancer

Номер патента: AU2023232303A1. Автор: Ingrid Teige,Robert Oldham,Björn FRENDÉUS,Linda Mårtensson,Stephen Beers,Mark Cragg,Ali Roghanian. Владелец: BIOINVENT INTERNATIONAL AB. Дата публикации: 2024-09-12.

Anti-claudin 1 antibodies for use in the treatment of colorectal cancer

Номер патента: US09931416B2. Автор: Marguerite Del Rio,Nadia VEZZIO-VIE. Владелец: Institut Regional du Cancer de Montpellier. Дата публикации: 2018-04-03.

Mutant selectivity and combinations of a phosphoinositide-3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer

Номер патента: RU2665949C2. Автор: Марсия БЕЛВИН,Лори ФРИДМАН,Дипак САМПАТ,Джеффри ВАЛЛИН. Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2018-09-05.

Introduction of constructed t cells for the treatment of central nervous system cancer

Номер патента: RU2757308C2. Автор: Стивен Дж. ФОРМЭН,Кристин Е. БРАУН,Сол Дж. ПРАЙСМЕН,Бенхэм БАДИ. Владелец: Сити Оф Хоуп. Дата публикации: 2021-10-13.

Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders

Номер патента: US20190091294A1. Автор: Nigel Irwin,Victor Gault. Владелец: Ulster University. Дата публикации: 2019-03-28.

Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders

Номер патента: US20210379157A1. Автор: Nigel Irwin,Victor Gault. Владелец: Ulster University. Дата публикации: 2021-12-09.

Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders

Номер патента: US11738065B2. Автор: Nigel Irwin,Victor Gault. Владелец: Ulster University. Дата публикации: 2023-08-29.

Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders

Номер патента: US10888604B2. Автор: Nigel Irwin,Victor Gault. Владелец: Ulster University. Дата публикации: 2021-01-12.

Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders

Номер патента: WO2017093562A1. Автор: Nigel Irwin,Victor Gault. Владелец: UNIVERSITY OF ULSTER. Дата публикации: 2017-06-08.

Sipa-1 gene and sipa-1 inhibitor for the treatment, prevention, and diagnosis of cancer

Номер патента: WO2006084027A3. Автор: Kent Hunter,Douglas R Lowy,Xiaolan Qian. Владелец: Xiaolan Qian. Дата публикации: 2007-08-02.

Trimeric peptides for use in treating obesity

Номер патента: WO2006108818A3. Автор: Kilian Waldemar Conde FRIEBOES. Владелец: Kilian Waldemar Conde FRIEBOES. Дата публикации: 2007-01-11.

Trimeric peptides for use in treating obesity

Номер патента: WO2006108818A2. Автор: Kilian Waldemar Conde FRIEBOES. Владелец: Novo Nordisk A/S. Дата публикации: 2006-10-19.

Trimeric peptides for use in treating obesity

Номер патента: EP1874813A2. Автор: Kilian Waldemar Conde FRIEBOES. Владелец: Novo Nordisk AS. Дата публикации: 2008-01-09.

Nucleoside analogues for the treatment of parasitic infections

Номер патента: EP4408854A1. Автор: Serge Van Calenbergh,Fabian HULPIA,Guy CALJON,Jakob BOUTON. Владелец: UNIVERSITEIT ANTWERPEN. Дата публикации: 2024-08-07.

Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity

Номер патента: WO2001012176A3. Автор: Pierre Rosenzweig. Владелец: Pierre Rosenzweig. Дата публикации: 2002-03-21.

Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity

Номер патента: EP1210080A2. Автор: Pierre Rosenzweig. Владелец: Sanofi Synthelabo SA. Дата публикации: 2002-06-05.

BARETTIN AND DERIVATIVES THEREOF FOR MEDICAL USE, IN PARTICULAR FOR THE TREATMENT OF DISEASES RELATED TO OXIDATIVE STRESS OR INFLAMMATION, AND FOR PRESERVING OR WASHING ORGANS

Номер патента: US20160039796A1. Автор: Andersen Jeanette Hammer,Hansen Espen,Eilertsen Karl- Erik,Lind Karianne Fredenfeldt,Østerud Bjarne,Hofer Tim. Владелец: . Дата публикации: 2016-02-11.

New medicament based on an ether which can be used, in particular for the treatment of various solid tumors.

Номер патента: FR1903M. Автор: . Владелец: Ciba AG. Дата публикации: 1989-03-11.

MONOCARBOXYLATE TRANSPORTER 4 (MCT4) ANTISENSE OLIGONUCLEOTIDE (ASO) INHIBITORS FOR USE AS THERAPEUTICS IN THE TREATMENT OF CANCER

Номер патента: US20190010492A1. Автор: Wang Yuzhuo,Choi Stephen Yiu Chuen. Владелец: . Дата публикации: 2019-01-10.

METHODS FOR USING SYNTHETIC TRITERPENOIDS IN THE TREATMENT OF BONE OR CARTILAGE DISEASES OR CONDITIONS

Номер патента: US20140377235A1. Автор: Gribble Gordon W.,SPORN Michael B.,LIBY Karen T.,Suh Nanjoo,Medici Damian,Robey Pamela Gehron. Владелец: . Дата публикации: 2014-12-25.

Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions

Номер патента: US8921340B2. Автор: Michael B. Sporn,Karen T. Liby,Gordon W. Gribble,Nanjoo Suh,Damian Medici,Pamela Gehron Robey. Владелец: US Department of Health and Human Services. Дата публикации: 2014-12-30.

Farnesyl transferase inhibitor for use in methods for the treatment of hrd cancer

Номер патента: WO2024194402A1. Автор: Marton Kovacs,Raphael CECCALDI,Marie VALLETTE. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2024-09-26.

Vps4b inhibitor for use in methods for the treatment of hrd cancer

Номер патента: WO2024194401A1. Автор: Marton Kovacs,Raphael CECCALDI,Marie VALLETTE. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2024-09-26.

Combination of dasatinib and lovastatin for use in methods for the treatment of cardiac fibrosis

Номер патента: WO2023175136A1. Автор: Angelo Parini,Hélène TRONCHERE,Oxana KOUNDOUZOVA,Frédéric BOAL,Jérôme RONCALLI,Ruslan SHARIPOV,Fedor KOLPAKOV,Sergei PINTUS,Alexander KEL. Владелец: Centre Hospitalier Universitaire De Toulouse. Дата публикации: 2023-09-21.

Remedy for the treatment of escherichiosis and citrobacteriosis of young cattle in early postnatal ontogenesis

Номер патента: RU2758066C1. Автор: Валентин Сергеевич Скрипкин,Александр Николаевич Симонов,Надежда Аркадьевна Ожередова,Виктор Сергеевич Самойленко,Елена Валентиновна Светлакова. Владелец: федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет". Дата публикации: 2021-10-26.

Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease

Номер патента: CA2758189C. Автор: Thomas Voit,Luis Garcia,Denis Furling,Christian Leumann,Daniel Schuemperli. Владелец: ASSOCIATION INSTITUT DE MYOLOGIE. Дата публикации: 2020-12-29.

Compositions for the treatment of ischemic tissue damage

Номер патента: WO2010060928A3. Автор: Juan Carlos RODRÍGUEZ CIMADEVILLA,Patricia Salama Cohen. Владелец: Projech Science To Technology, S.L.. Дата публикации: 2010-10-14.

Methods for Using Synthetic Triterpenoids in the Treatment of Bone or Cartilage Diseases or Conditions

Номер патента: US20130089526A1. Автор: Gribble Gordon W.,SPORN Michael B.,Suh Nanjoo,Medici Damian,Robey Pamela Gehron,Lyby Karen T.. Владелец: . Дата публикации: 2013-04-11.

Dosage regimen for the treatment of nash

Номер патента: WO2024079071A1. Автор: Bernhard Schmid,Bob Dale Brown,Kevin Craig,Marc Abrams,Ingo Uphues,Florian Sommer,Henryk T. Dudek,Stephan TENBAUM,JiHye PARK,Boris Ferger,Utsav SAXENA,Martin Lee KOSER,Jens Markus BORGHARDT,Andre Broermann,Saskia ERBEL,Felix JOST. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2024-04-18.

Methods for the treatment of nash with advanced fibrosis and/or cirrhosis

Номер патента: WO2024079076A1. Автор: Bob Dale Brown,Kevin Craig,Marc Abrams,Ingo Uphues,Henryk T. Dudek,JiHye PARK,Boris Ferger,Utsav SAXENA,Martin Lee KOSER,Andre Broermann. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2024-04-18.

Dosage regimen for the treatment of nash

Номер патента: US20240139230A1. Автор: Bernhard Schmid,Bob Dale Brown,Kevin Craig,Marc Abrams,Ingo Uphues,Florian Sommer,Henryk T. Dudek,Stephan TENBAUM,JiHye PARK,Boris Ferger,Utsav SAXENA,Martin Lee KOSER,Jens Markus BORGHARDT,Andre Broermann,Saskia ERBEL,Felix JOST. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2024-05-02.

Fluorescent dyes comprising new 2-aminophenylvinyl-1-sulfanylalkyl-pyridinium salts, used in compositions for the treatment of keratin fibres, especially for lightening dark hair

Номер патента: FR2912137A1. Автор: Andrew Greaves,Nicolas Daubresse. Владелец: LOreal SA. Дата публикации: 2008-08-08.

Fluorescent dyes comprising new 4-dimethylaminophenylvinyl-1-sulfanylalkyl-pyridinium salts, used in compositions for the treatment of keratin fibres, especially for lightening dark hair

Номер патента: FR2912139A1. Автор: Andrew Greaves,Nicolas Daubresse. Владелец: LOreal SA. Дата публикации: 2008-08-08.

Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions and their use in medicaments for the treatment of tumors and/or cancers

Номер патента: CN109576231B. Автор: 秦云,陈霖,赵荣华,胡放,绳纪坡,康三毛,傅瑾. Владелец: Beijing Kangwanda Pharmaceutical Technology Co ltd. Дата публикации: 2022-03-25.

Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions and their use in medicaments for the treatment of tumors and/or cancers

Номер патента: CN111344398B. Автор: 秦云,陈霖,赵荣华,胡放,绳纪坡,康三毛,傅瑾. Владелец: Beijing Kangwanda Pharmaceutical Technology Co ltd. Дата публикации: 2022-03-22.

Mouveau medicament useful in particular for the treatment of hyperchlorhydria, peptic ulcers and colitis caused by fermentation and putrefaction.

Номер патента: FR1511M. Автор: Lucien Harnist. Владелец: Individual. Дата публикации: 2020-10-15.

Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer

Номер патента: US20100298281A1. Автор: Nadia Dahmane,Jeffrey D. Winkler. Владелец: Wistar Institute of Anatomy and Biology. Дата публикации: 2010-11-25.

A food supplement for use as coadjuvant in the prevention and treatment of cognitive decline associated with alzheimer disease

Номер патента: CA3217534A1. Автор: Francesco Bonomo,Maria Cristina DEL BONO. Владелец: Cristalfarma SRL. Дата публикации: 2022-11-17.

A food supplement for use as coadjuvant in the prevention and treatment of cognitive decline associated with alzheimer disease

Номер патента: EP4337029A1. Автор: Francesco Bonomo,Maria Cristina DEL BONO. Владелец: Cristalfarma SRL. Дата публикации: 2024-03-20.

A food supplement for use as coadjuvant in the prevention and treatment of cognitive decline associated with alzheimer disease

Номер патента: WO2022238793A1. Автор: Francesco Bonomo,Maria Cristina DEL BONO. Владелец: CRISTALFARMA S.R.L.. Дата публикации: 2022-11-17.

A food supplement for use as coadjuvant in the prevention and treatment of cognitive decline associated with alzheimer disease

Номер патента: US20240285713A1. Автор: Francesco Bonomo,Maria Cristina DEL BONO. Владелец: Cristalfarma SRL. Дата публикации: 2024-08-29.

Composition for use as a medicament for the treatment of sudden attacks of covid-19 and other pathogenic epidemics, sera set and method for identifying viral antigens and effective antibodies

Номер патента: WO2021176257A1. Автор: Peter K. Law. Владелец: Law Peter K. Дата публикации: 2021-09-10.

Compositions and methods for use in combination for the treatment and diagnosis of autoimmune diseases

Номер патента: US20200080152A1. Автор: Hakon Hakonarson,Brendan KEATING,Yun Rose Li. Владелец: Childrens Hospital of Philadelphia CHOP. Дата публикации: 2020-03-12.

Compositions and methods for use in combination for the treatment and diagnosis of autoimmune diseases

Номер патента: EP3730188B1. Автор: Hakon Hakonarson,Brendan KEATING,Yun Rose Li. Владелец: Childrens Hospital of Philadelphia CHOP. Дата публикации: 2024-07-31.

Pkc inhibitors for the treatment of septic cholestasis with polymethine dye targeting

Номер патента: US20210315996A1. Автор: Marc Lehmann,Christoph Enzensperger. Владелец: Smartdyelivery GmbH. Дата публикации: 2021-10-14.

Pkc inhibitors for the treatment of septic cholestasis with polymethine dye targeting

Номер патента: EP3843786A1. Автор: Marc Lehmann,Christoph Enzensperger. Владелец: Smartdyelivery GmbH. Дата публикации: 2021-07-07.

Pkc inhibitors for the treatment of septic cholestasis with polymethine dye targeting

Номер патента: CA3106436A1. Автор: Marc Lehmann,Christoph Enzensperger. Владелец: Smartdyelivery GmbH. Дата публикации: 2020-03-05.

IMIDAZOLE DERIVATIVES USED IN PARTICULAR FOR THE TREATMENT OF HYPERTENSION

Номер патента: FR2424912A1. Автор: Masaki Hayashi,Masanori Kawamura,Tadao Tanouchi,Yoichi Iguchi,Ikuo Kajiwara. Владелец: Ono Pharmaceutical Co Ltd. Дата публикации: 1979-11-30.

New drug which can be used in particular for the treatment of degenerative cardiovascular diseases.

Номер патента: FR3115M. Автор: . Владелец: RICHARD LAB M. Дата публикации: 1965-02-08.

New compound of the hydantoin series which can be used in particular for the treatment of salmonellosis.

Номер патента: FR1920M. Автор: . Владелец: Norwich Pharmacal Co. Дата публикации: 1962-08-06.

Use of a birnavirus for the treatment of a disease caused by varicella zoster virus (vzv)

Номер патента: US20230277650A1. Автор: Tibor Bakács. Владелец: HEPC TERAPIA KERESKEDELMI ES SZOLGALTATO ZRT. Дата публикации: 2023-09-07.

3-HALOGEN-6-HYDROXY-2H-PYRANE-3 (6H) -ON COMPOUNDS FOR USING SOME INTERMEDIATES IN THE PRODUCTION OF GAMMA PYRONS AND PROCEDURES FOR THE PRODUCTION OF INTERMEDIATE PRODUCTS

Номер патента: DK326086D0. Автор: Thomas Mott Brennan,Daniel Patrick Brannegan,Paul Douglas Weeks,Donald Ernest Kuhla. Владелец: Pfizer. Дата публикации: 1986-07-09.

4-halogen-6-hydroxy-2H-pyran-3(6H)-one compounds for use as intermediates in the preparation of gamma-pyrones and method for preparation of the intermediate compounds

Номер патента: DK153401B. Автор: Thomas Mott Brennan,Daniel Patrick Brannegan,Paul Douglas Weeks,Donald Ernest Kuhla. Владелец: Pfizer. Дата публикации: 1988-07-11.

QUINOLINE DERIVATIVES FOR USE AS INTERMEDIATES IN THE PREPARATION OF 6,7-DIALCOXY-4-OXY-QUINOLIN-3-CARBOXYL ACID ESTERS

Номер патента: NO145788B. Автор: Eva Somfai,Zoltan Meszaros,Andras Kelemen,Judit Frank,Ivan Dozsa. Владелец: Chinoin Gyogyszer Es Vegyeszet. Дата публикации: 1982-02-22.

2- (2-OXOAZETIDIN-1-YL) -CROTONIC ACID COMPOUNDS FOR USE AS INTERMEDIATES IN THE PREPARATION OF 7BETA-AMINO-3-CEPHEM COMPOUNDS

Номер патента: DK167278B1. Автор: Robert Burns Woodward,Hans Bickel. Владелец: Ciba Geigy AG. Дата публикации: 1993-10-04.

TIOFENDER DERIVATIVES FOR USE AS INTERMEDIATE IN THE PREPARATION OF THERAPEUTIC ACTIVE AMINOAL COOLESTERS OF ALFA-SUBSTITUTED (3-TIENYL) ACETIC ACID

Номер патента: NO142399C. Автор: Claude Grain,Charles Pigerol,Paul De Cointet De Fillain,Jacques Le Blay. Владелец: Labaz. Дата публикации: 1980-08-13.

Micropatterning technique for creating morphologically specific free-floating structures for use as standards in the pharmaceutical industry

Номер патента: EP3426220A1. Автор: Robert James SCHULTHEIS,Frederick Talley GERTZ. Владелец: Zebrasci Inc. Дата публикации: 2019-01-16.

Elastic bandage that can be used, in particular, for the treatment and prevention of vein diseases

Номер патента: US09913755B2. Автор: Serge Lecomte,Jean-Marc Henri Maurice Pernot. Владелец: URGO RECHERCHE INNOVATION ET DEVELOPPEMENT. Дата публикации: 2018-03-13.

Self-adhesive elastic bandage that can be used, in particular, for the treatment and prevention of diseases of the veins

Номер патента: US09913754B2. Автор: Serge Lecomte,Jean-Marc Henri Maurice Pernot. Владелец: URGO RECHERCHE INNOVATION ET DEVELOPPEMENT. Дата публикации: 2018-03-13.

Tlr3 inhibitors for use in the treatment of diseases associated with cardiovascular calcification

Номер патента: EP4419098A2. Автор: Johannes HOLFELD,Can GOLLMANN-TEPEKÖYLÜ,Ivan TANCEVSKI. Владелец: Individual. Дата публикации: 2024-08-28.

Gata-3 inhibitors for use in the treatment of th2-driven asthma

Номер патента: NZ736807A. Автор: Joachim BILLE,Jonas Renz. Владелец: Sterna Biologicals GmbH. Дата публикации: 2024-08-30.

Use of fubp1 inhibitors for treating hepatitis b virus infection

Номер патента: US20240150758A1. Автор: Søren OTTOSEN,Lykke PEDERSEN,Souphalone LUANGSAY,Barbara TESTONI,Fabien Zoulim. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2024-05-09.

A method for increasing the replication of oncolytic hsvs in highly resistant tumor cells using mtor pathway and pi3k inhibitors

Номер патента: WO2012056327A2. Автор: Xinping Fu,Xiaoliu Zhang. Владелец: Xiaoliu Zhang. Дата публикации: 2012-05-03.

Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy

Номер патента: EP1490051A1. Автор: John Univ. of Liverpool Dep. Phys.& Med. JENKINS. Владелец: University of Liverpool. Дата публикации: 2004-12-29.

Cyp11a1 inhibitor for use in the treatment of prostate cancer

Номер патента: CA3232600A1. Автор: Tarja IKONEN,Annamari VUORELA. Владелец: Orion Oyj. Дата публикации: 2023-04-06.

Cyp11a1 inhibitor for use in the treatment of prostate cancer

Номер патента: EP4408426A1. Автор: Tarja IKONEN,Annamari VUORELA. Владелец: Orion Oyj. Дата публикации: 2024-08-07.

Composition for use in the treatment and/or prevention of mycotoxic disease

Номер патента: NZ805733A. Автор: David Wilde. Владелец: ANPARIO PLC. Дата публикации: 2024-03-22.

Inhibitor of cellular purine nucleotide salvage pathway enzyme for use in the treatment and/or prevention of helicobacter pylori infection and/or disease associated with such infection and pharmaceutical composition comprising the same

Номер патента: WO2023177312A2. Автор: Biserka Zinic,Maria Agnieszka BZOWSKA,Marta WOJTYŚ,Katarzyna JAGUSZTYN-KRYNICKA,Marta NARCZYK,Ivana LEŠČIĆ AŠLER,Zoran ŠTEFANIĆ,Marija LUIĊ,Weronika MAKSYMIUK. Владелец: RUDER BOSKOVIC INSTITUTE. Дата публикации: 2023-09-21.

Inhibitor of cellular purine nucleotide salvage pathway enzyme for use in the treatment and/or prevention of helicobacter pylori infection and/or disease associated with such infection and pharmaceutical composition comprising the same

Номер патента: WO2023177312A3. Автор: Biserka Zinic,Maria Agnieszka BZOWSKA,Marta WOJTYŚ,Katarzyna JAGUSZTYN-KRYNICKA,Marta NARCZYK,Ivana LEŠČIĆ AŠLER,Zoran ŠTEFANIĆ,Marija LUIĊ,Weronika MAKSYMIUK. Владелец: RUDER BOSKOVIC INSTITUTE. Дата публикации: 2023-10-26.

Composition for use in the treatment and/or prevention of mycotoxic disease

Номер патента: AU2022277989A1. Автор: David Wilde. Владелец: ANPARIO PLC. Дата публикации: 2023-12-07.

Antisense oligonucleotide for use in the treatment of psoriasis-induced itching and phospholipid vesicle comprising said oligonucleotide

Номер патента: CA3239517A1. Автор: Pierangelo Geppetti,Romina NASSINI,Francesco DE LOGU. Владелец: Flonext Srl. Дата публикации: 2023-06-01.

Antisense oligonucleotide for use in the treatment of psoriasis-induced itching and phospholipid vesicle comprising said oligonucleotide

Номер патента: AU2022396114A1. Автор: Pierangelo Geppetti,Romina NASSINI,Francesco DE LOGU. Владелец: Flonext Srl. Дата публикации: 2024-06-27.

Antisense oligonucleotide for use in the treatment of psoriasis-induced itching and phospholipid vesicle comprising said oligonucleotide

Номер патента: WO2023095030A1. Автор: Pierangelo Geppetti,Romina NASSINI,Francesco DE LOGU. Владелец: Flonext S.R.L.. Дата публикации: 2023-06-01.

Antisense oligonucleotide for use in the treatment of psoriasis-induced itching and phospholipid vesicle comprising said oligonucleotide

Номер патента: EP4437105A1. Автор: Pierangelo Geppetti,Romina NASSINI,Francesco DE LOGU. Владелец: Flonext Srl. Дата публикации: 2024-10-02.

Screening method, diagnostic method and small nucleic acid for the treatment of cns disorders

Номер патента: WO2010010000A3. Автор: Magnus Ingelman-Sundberg,Sarah Sim. Владелец: Karolinska Innovations Ab. Дата публикации: 2010-05-06.

Nicotinamide for use in the treatment and prevention of ocular neurodegenerative disorder (e.g. glaucoma)

Номер патента: AU2022209298B2. Автор: Peter Alexander Williams,Simon W. M. John. Владелец: Jackson Laboratory. Дата публикации: 2024-06-13.

Molecules targeting ribosomal protein rpl40 for use in cosmetics and the treatment of diseases of the skin

Номер патента: WO2024099952A1. Автор: Joerg Von Hagen,Hannelore Breitenbach Koller. Владелец: Merck Patent GmBH. Дата публикации: 2024-05-16.

Molecules targeting ribosomal protein rpl40 for use in cosmetics and the treatment of diseases of the skin

Номер патента: EP4368729A1. Автор: Joerg Von Hagen,Hannelore Breitenbach Koller. Владелец: Merck Patent GmBH. Дата публикации: 2024-05-15.

Apparatus for using Exhaust Steam in the Manufacture of Water-gas.

Номер патента: GB191423052A. Автор: Herbert Edmund Smith. Владелец: Individual. Дата публикации: 1915-11-04.

A glun2d inhibitor for use in the treatment or relapse prevention of a depressive episode

Номер патента: AU2023210727A1. Автор: Claus NORMANN,Stefan VESTRING. Владелец: Albert Ludwigs Universitaet Freiburg. Дата публикации: 2024-07-11.

Faecalibacterium prausnitzii and desulfovibrio piger for use in treatment or prevention of diabetes and intestinal diseases

Номер патента: RU2754367C2. Автор: Мухаммад-Танвир КХАН,Фредрик БЕКХЕД. Владелец: Метабоген Аб. Дата публикации: 2021-09-01.

Mixture of probiotic bacteria strains for use in the treatment of allergic asthma and with recurrent wheezing, preferably in paediatric subjects

Номер патента: EP4368252A3. Автор: Marco Pane,Angela AMORUSO,Vera Mogna. Владелец: Probiotical SpA. Дата публикации: 2024-05-22.

Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne

Номер патента: US20230226128A1. Автор: Giovanni Mogna. Владелец: Probiotical SpA. Дата публикации: 2023-07-20.

Inhibition of the liver enriched protein foxa2 for the treatment of colorectal liver metastases

Номер патента: WO2010118832A3. Автор: Frank Lehner,Jϋrgen BORLAK,Jϋrgen KLEMPNAUER. Владелец: Fraunhofer Gesellschaft Zur Förderung Der Angewandten Forschung E. V.. Дата публикации: 2010-12-16.

Inhibition of the liver enriched protein foxa2 for the treatment of colorectal liver metastases

Номер патента: WO2010118832A2. Автор: Frank Lehner,Jϋrgen BORLAK,Jϋrgen KLEMPNAUER. Владелец: Fraunhofer Gesellschaft Zur Förderung Der Angewandten Forschung E. V.. Дата публикации: 2010-10-21.

Influenza virus defective interfering particles for use in the prophylactic or therapeutic treatment of coronaviridae infection

Номер патента: US20240131094A1. Автор: Udo Reichl,Sascha KUPKE,Ulfert RAND,Marc Dominique HEIN,Dunja BRUDER. Владелец: Otto Von Guericke Universitaet Magdeburg. Дата публикации: 2024-04-25.

Influenza virus defective interfering particles for use in the prophylactic or therapeutic treatment of coronaviridae infection

Номер патента: EP4294524A1. Автор: Udo Reichl,Sascha KUPKE,Ulfert RAND,Marc Dominique HEIN,Dunja BRUDER. Владелец: Helmholtz Zentrum fuer Infektionsforschung HZI GmbH. Дата публикации: 2023-12-27.

Influenza virus defective interfering particles for use in the prophylactic or therapeutic treatment of coronaviridae infection

Номер патента: US20240226204A9. Автор: Udo Reichl,Sascha KUPKE,Ulfert RAND,Marc Dominique HEIN,Dunja BRUDER. Владелец: Helmholtz Zentrum fuer Infektionsforschung HZI GmbH. Дата публикации: 2024-07-11.

Use of a birnavirus alone or in combination therapy for the treatment of a disease caused by a nidovirus

Номер патента: EP4263810A1. Автор: Shimon Slavin,Imre Kovesdi,Volker Sandig,Tibor Bakács,Alexander Karlas,Sven KRÜGENER,Deborah Horn. Владелец: PROBIOGEN AG. Дата публикации: 2023-10-25.

Use of a birnavirus alone or in combination therapy for the treatment of cancer

Номер патента: US20240299476A1. Автор: Shimon Slavin,Imre Kovesdi,Volker Sandig,Tibor Bakács,Alexander Karlas,Sven KRÜGENER,Deborah Horn,Wolfgang W. RENZ. Владелец: PROBIOGEN AG. Дата публикации: 2024-09-12.

METHOD OF PRODUCING AND CONCENTRATING microRNA-CONTAINING EXOSOMES OF MULTIPOTENT MESENCHYMAL STROMAL CELLS FOR USE IN COSMETIC AND MEDICINAL AGENTS FOR STIMULATING REGENERATIVE PROCESSES AND SLOWING DOWN AGING PROCESSES

Номер патента: RU2710368C2. Автор: Станислав Евгеньевич Волчков,Ольга Владимировна Тюмина. Владелец: Ольга Владимировна Тюмина. Дата публикации: 2019-12-26.

Lsd1 inhibitor and prmt6 inhibitor for use in the treatment of a disease associated with gain-of-function of androgen receptor (ar) and/or with overexpression of an ar coactivator

Номер патента: WO2024134525A1. Автор: Andrea Contestabile,Giuseppe Ronzitti,Maria PENNUTO,Manuela BASSO. Владелец: Université D'Évry-Val D'essonne. Дата публикации: 2024-06-27.

Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases

Номер патента: EP2162747A2. Автор: Reginald Christophe Xavier Brys,NickErnest René VANDEGHINSTE. Владелец: GALAPAGOS NV. Дата публикации: 2010-03-17.

Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases

Номер патента: US20140155461A1. Автор: Reginald Christophe Xavier Brys,Nick Ernest René Vandeghinste. Владелец: GALAPAGOS NV. Дата публикации: 2014-06-05.

Hyaluronidase polypeptide for use in the treatment or prophylaxis of a neurodegenerative disease

Номер патента: EP4419125A1. Автор: Gunther Burgard,Sven BENSON,Lenz LORENZ,Philipp SCHELLENBERGER,Rainer BÖHNKE. Владелец: Pharmact Holding Ag. Дата публикации: 2024-08-28.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: EP3793567A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc. Дата публикации: 2021-03-24.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: US20190382761A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc. Дата публикации: 2019-12-19.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: WO2019241624A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc.. Дата публикации: 2019-12-19.

Methods and pharmaceutical composition for the treatment of sanfilippo syndrome type iiib

Номер патента: WO2024175604A1. Автор: Françoise PIGUET,Nissrine BALLOUT,Jérôme AUSSEIL,Kumaran DEIVA. Владелец: Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives (Cea). Дата публикации: 2024-08-29.

Pharmaceutical combination for the treatment of multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma

Номер патента: WO2024102361A1. Автор: Kathleen E. Clarence-Smith. Владелец: Clarence Smith Kathleen E. Дата публикации: 2024-05-16.

Alkaline phosphatase for use in the treatment of a neurodegenerative disorder

Номер патента: NL2028418B1. Автор: Brands Rudi,Gerrit Keizer Hiskias,Sake Oosting Ronald. Владелец: Amrif Bv. Дата публикации: 2022-12-19.

Alkaline phosphatase for use in the treatment of a neurodegenerative disorder

Номер патента: WO2022258712A1. Автор: Herman Feil,Rudi Brands,Ronald Sake OOSTING,Willem SEINEN,Hiskias Gerrit KEIZER. Владелец: Amrif Bv. Дата публикации: 2022-12-15.

Probiotic bacterial strains producing antimicrobial proteins and compositions comprising these for use in the treatment of diarrheal and other microbial diseases

Номер патента: US20240197794A1. Автор: Federico Graf. Владелец: Crigasseni Ag. Дата публикации: 2024-06-20.

Isolated or artificial nucleotide sequences for use in neurodegenerative diseases

Номер патента: US20240238385A1. Автор: Clévio David RODRIGUES NÓBREGA,Adriana Isabel DO VALE MARCELO,André Filipe VIEIRA DA CONCEIÇÃO,Rebekah COVACO KOPPENOL. Владелец: UNIVERSIDADE DO ALGARVE. Дата публикации: 2024-07-18.

Probiotic bacterial strains producing antimicrobial proteins and compositions comprising these for use in the treatment of diarrheal and other microbial diseases

Номер патента: US11918611B2. Автор: Federico Graf. Владелец: Crigasseni Ag. Дата публикации: 2024-03-05.

Compositions for the treatment of gluten intolerance and uses thereof

Номер патента: US20190010477A1. Автор: Teodor Stelmasiak,Hugh James Beatty Cornell. Владелец: Glutagen Pty Ltd. Дата публикации: 2019-01-10.

Alkaline phosphatase for use in the treatment of a neurodegenerative disorder

Номер патента: EP4351632A1. Автор: Herman Feil,Rudi Brands,Ronald Sake OOSTING,Willem SEINEN,Hiskias Gerrit KEIZER. Владелец: Amrif Bv. Дата публикации: 2024-04-17.

Alkaline phosphatase for use in the treatment of a neurodegenerative disorder

Номер патента: CA3221370A1. Автор: Herman Feil,Rudi Brands,Ronald Sake OOSTING,Willem SEINEN,Hiskias Gerrit KEIZER. Владелец: Amrif Bv. Дата публикации: 2022-12-15.

Compositions for the treatment of skin conditions

Номер патента: EP3813872A1. Автор: Gerald Thomas PROEHL,Christopher Joseph Nardo. Владелец: Dermata Therapeutics Inc. Дата публикации: 2021-05-05.

Compositions for the treatment of gluten intolerance and uses thereof

Номер патента: EP4400163A1. Автор: Teodor Stelmasiak,Hugh James Beatty Cornell. Владелец: Glutagen Pty Ltd. Дата публикации: 2024-07-17.

Alkaline phosphatase for use in the treatment of a neurodegenerative disorder

Номер патента: US20240269243A1. Автор: Herman Feil,Rudi Brands,Ronald Sake OOSTING,Willem SEINEN,Hiskias Gerrit KEIZER. Владелец: Amrif Bv. Дата публикации: 2024-08-15.

Compounds for the treatment of ischemic injury

Номер патента: US09457046B2. Автор: Zoltan Varga,Péter FERDINANDY,Tamás CSONT,Anikó GÖRBE. Владелец: Pharmalhungary 2000 Kft. Дата публикации: 2016-10-04.

Novel glucocorticoid receptor ligands for the treatment of metabolic disorders

Номер патента: US20070027117A1. Автор: Chunqiu Lai,Noah Tu,Philip Kym,Lars Hagberg,Steven Richards,James Link,Richard Bishop,Tom Von Geldern,Russell Cink,Bradley Gates,Peer Jacobsen,Marvin Leanna. Владелец: Individual. Дата публикации: 2007-02-01.

CHEMICAL ASSOCIATION CONTAINING SULPHONIC ACID GROUPS FOR USE AS AND IN THE PREPARATION OF SURFACTIVE SUBSTANCES AND FOR USE IN THE PREPARATION OF POLYMERS

Номер патента: SE406909B. Автор: G Swift,W D Emmons. Владелец: Rohm & Haas. Дата публикации: 1979-03-05.

Self-assembled monolayers and methods for using the same in biosensing applications

Номер патента: US9829487B2. Автор: Thomas Fisher,Rebecca Y. Lai,Patrick H. Dussault,Anita J. Zaitouna. Владелец: NuTech Ventures Inc. Дата публикации: 2017-11-28.

Self-assembled monolayers and methods for using the same in biosensing applications

Номер патента: US20160047803A1. Автор: Thomas Fisher,Rebecca Y. Lai,Patrick H. Dussault,Anita J. Zaitouna. Владелец: NuTech Ventures Inc. Дата публикации: 2016-02-18.

Ammonia recovery in the preparation of silazanes and polysilazanes

Номер патента: CA2502518C. Автор: Gary J. Knasiak. Владелец: CLARIANT INTERNATIONAL LTD. Дата публикации: 2008-08-12.

Self-assembled monolayers and methods for using the same in biosensing applications

Номер патента: US20120315625A1. Автор: Thomas Fisher,Rebecca Y. Lai,Patrick H. Dussault,Anita J. Zaitouna. Владелец: University of Nebraska. Дата публикации: 2012-12-13.

Self-assembled monolayers and methods for using the same in biosensing applications

Номер патента: US9079835B2. Автор: Thomas Fisher,Rebecca Y. Lai,Patrick H. Dussault,Anita J. Zaitouna. Владелец: NuTech Ventures Inc. Дата публикации: 2015-07-14.

NITROGEN COMPOUNDS FOR USE AS CATALYSTS IN THE SYNTHESIS OF POLYURETHANNES

Номер патента: FR2332975A1. Автор: . Владелец: Bayer AG. Дата публикации: 1977-06-24.

NITROGEN URETHAN COMPOUNDS FOR USE AS CATALYSTS IN THE SYNTHESIS OF POLYURETHANNES

Номер патента: FR2332978A1. Автор: . Владелец: Bayer AG. Дата публикации: 1977-06-24.

Ketals of 3,5,17-trioxo-13beta-alkyl-4,5-secogonanes for use as intermediates in the preparation of 19-nor-steroids.

Номер патента: DK136115B. Автор: Julien Warnant,Robert Joly,Jean Jolly. Владелец: Roussel Uclaf. Дата публикации: 1977-08-15.

Ethers for use as intermediates in the preparation of 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives

Номер патента: NZ213749A. Автор: G F Cooper. Владелец: Syntex Inc. Дата публикации: 1989-01-06.

Use of PI3K inhibitors for the preparation of a medicament for the treatment of resistance to FLT3 inhibitors

Номер патента: CN114053416A. Автор: 黄阿敏. Владелец: First Affiliated Hospital of Sun Yat Sen University. Дата публикации: 2022-02-18.

Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity

Номер патента: SK2162002A3. Автор: Pierre Rosenzweig. Владелец: Sanofi Synthelabo. Дата публикации: 2002-07-02.

Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity

Номер патента: PL364865A1. Автор: Pierre Rosenzweig. Владелец: Sanofi-Synthelabo. Дата публикации: 2004-12-27.

Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity

Номер патента: IL147790A0. Автор: . Владелец: Sanofi Synthelabo. Дата публикации: 2002-08-14.

Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity

Номер патента: AU6441900A. Автор: Pierre Rosenzweig. Владелец: Sanofi Synthelabo SA. Дата публикации: 2001-03-13.

Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity.

Номер патента: ZA200200738B. Автор: Pierre Rosenzweig. Владелец: Sanofi Synthelabo. Дата публикации: 2003-03-26.

Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with oladaterol

Номер патента: US20200069679A1. Автор: Stefan WOLLIN,Eva WEX,Franziska HERRMANN. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2020-03-05.

Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol

Номер патента: WO2018108669A1. Автор: Stefan WOLLIN,Eva WEX,Franziska HERRMANN. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2018-06-21.

USE OF MONOAMINE OXIDASE INHIBITORS FOR THE PREPARATION OF PHARMACES INTENDED FOR THE TREATMENT OF OBESITY

Номер патента: AR025244A1. Автор: . Владелец: Giraldo Osorio Oscar Hernan. Дата публикации: 2002-11-13.

Substituted quinoline derivatives as pi3k inhibitors

Номер патента: WO2024026423A1. Автор: Iwona WRONA,Matthew C. Lucas,Fernando Padilla,Ivan JEWETT,Istvan J. Enyedy,Yelena ARNAUTOVA,Etienne DARDENNE. Владелец: Black Diamond Therapeutics, Inc.. Дата публикации: 2024-02-01.

A hydrogel, a method of preparation thereof, and its use in the treatment of wounds

Номер патента: WO2024105620A1. Автор: Linn BERGLUND,Kristiina Oksman Niska. Владелец: S2MEDICAL AB. Дата публикации: 2024-05-23.

Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption

Номер патента: WO2000031289A1. Автор: Goran Andersson,Barbro Ek-Rylander,Cornelia Oellig. Владелец: Pharmacia AB. Дата публикации: 2000-06-02.

Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption

Номер патента: EP1131463A1. Автор: Goran Andersson,Barbro Ek-Rylander,Cornelia Oellig. Владелец: Pharmacia AB. Дата публикации: 2001-09-12.

Antisense oligonucleotides for the treatment of neurological disorders

Номер патента: WO2024206175A1. Автор: Lenka VAN SINT FIET,Lisanne Alieda VAN WISSEN,Aron KOS,Marieke HOGERVORST,Ryan Matthew Smith. Владелец: ProQR Therapeutics II B.V.. Дата публикации: 2024-10-03.

Oleofuransulfonate surfactants for use in wellbore applications

Номер патента: US20200308475A1. Автор: HONG SUN,Antonio RECIO, III,Janette CORTEZ. Владелец: Halliburton Energy Services Inc. Дата публикации: 2020-10-01.

Poly(ester urea) adhesion barriers for use in the treatment of hernia-mesh repair

Номер патента: US11771543B2. Автор: Michael Hiles,Matthew Becker,Trenton PARSELL,Zachary K. ZANDER,Nathan Z. DREGER. Владелец: UNIVERSITY OF AKRON. Дата публикации: 2023-10-03.

Use of micrornas in the treatment of lung diseases

Номер патента: EP4421173A1. Автор: Luca BRAGA,Maria Concetta VOLPE. Владелец: INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY. Дата публикации: 2024-08-28.

Use of micrornas in the treatment of lung diseases

Номер патента: WO2024175775A1. Автор: Luca BRAGA,Maria Concetta VOLPE. Владелец: International Centre For Genetic Engineering And Biotechnology - Icgeb. Дата публикации: 2024-08-29.

Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status

Номер патента: CA2685302A1. Автор: Waleed Hassanein,Tamer Khayal,Paul Lezberg,Ahmed Elbetanony,Giovanni Cecere,Dennis Sousa,Elizabeth Hansen. Владелец: Individual. Дата публикации: 2008-12-11.

Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status

Номер патента: CA2937022C. Автор: Waleed Hassanein,Tamer Khayal,Paul Lezberg,Ahmed Elbetanony,Giovanni Cecere,Dennis Sousa,Elizabeth Hansen. Владелец: TransMedics Inc. Дата публикации: 2018-11-20.

Method for using antimicrobial polymers for the protection of building and monuments

Номер патента: US20040024082A1. Автор: Peter Ottersbach,Beate Kossmann. Владелец: Creavis Gesellschaft fuer Technologie und Innovation mbH. Дата публикации: 2004-02-05.

METHODS AND COMPOSITIONS FOR USING HAPLOID PLANTS IN THE GENETIC MAPPING OF CHARACTERISTICS, AS A RESISTANCE TO DISEASES

Номер патента: AR071243A1. Автор: Donald Bockelman,T Carlson,M Kerns,J Peters Jeffrey,K Grote,Samuel Eathington,G Holland,K Cook,R Weyhrich,S Walker,G Pozar,D Butruille,Travis J Frey,Laron Peters,T Frey D Bockelman,H Jia. Владелец: MONSANTO TECHNOLOGY LLC. Дата публикации: 2010-06-09.

Chlorine dioxide generation from chlorate and sulphamic acid for use as disinfectant in the presence of copper surfaces

Номер патента: GB2332148A. Автор: Maqsood Fazel,Noel Stuart James Christopher,John David Squire,Jim Scott Robinson. Владелец: Houseman Ltd. Дата публикации: 1999-06-16.

PDE4 inhibitors for the treatment of inflammatory skin diseases

Номер патента: NZ503551A. Автор: Siegfried Benjamin Christensen,Don E Griswold. Владелец: SmithKline Beecham Corp. Дата публикации: 2002-05-31.

4-(3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)piperazine for use in the the treatment of cov-229e or cov-oc43 coronaviruses infections

Номер патента: EP4138844A1. Автор: Praveen Tyle,Suma GOPINATHAN,Qi Melissa YANG. Владелец: Lexicon Pharmaceuticals Inc. Дата публикации: 2023-03-01.

4-(3-(pyridin-3-yl)pyrazolo(1,5-a)pyrimidin-5-yl)piperazine for use in the the treatment of COV-229E or COV-OC43 coronaviruses infections

Номер патента: AU2021258128A1. Автор: Praveen Tyle,Suma GOPINATHAN,Qi Melissa YANG. Владелец: Lexicon Pharmaceuticals Inc. Дата публикации: 2022-11-03.

Combination of a mapk/erk pathway inhibitor and a glycosaminoglycan for the treatment of cancer

Номер патента: US20210128603A1. Автор: Hans-Ake Fabricius. Владелец: Cell Receptor AG. Дата публикации: 2021-05-06.

Combination of a mapk/erk pathway inhibitor and a glycosaminoglycan for the treatment of cancer

Номер патента: CA3072856A1. Автор: Hans-Ake Fabricius. Владелец: Cell Receptor AG. Дата публикации: 2019-02-28.

Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Номер патента: US20230255951A1. Автор: John D. Minna,Amit Das,Maithili P. DALVI,Elisabeth D. MARTINEZ,Juan BAYO-FINA. Владелец: University of Texas System. Дата публикации: 2023-08-17.

Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Номер патента: US20190151296A1. Автор: Amit Das,John D Minna,Juan BAYO-FINA,Maithili P DALVI,Elisabeth D MARTINEZ. Владелец: University of Texas System. Дата публикации: 2019-05-23.

Use of pkc inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection

Номер патента: WO1999044605A1. Автор: Douglas Kirk Ways. Владелец: ELI LILLY AND COMPANY. Дата публикации: 1999-09-10.

Combination of a MAPK/ERK pathway inhibitor and a glycosaminoglycan for the treatment of cancer

Номер патента: AU2018319344B2. Автор: Hans-Ake Fabricius. Владелец: Cell Receptor AG. Дата публикации: 2024-04-04.

Type v pde-inhibitors for the treatment of cystic fibrosis

Номер патента: EP1194148B1. Автор: Robert Leslie Uni. of Wales Coll.of Med. DORMER,Margaret Ann Uni. of Wales Coll.of Med MCPHERSON. Владелец: Cardiff University. Дата публикации: 2005-03-02.

Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Номер патента: KR100699757B1. Автор: 캐머론노먼유진,카터메어리앤. Владелец: 더 유니버시티 코트 오브 더 유니버시티 오브 애버딘. Дата публикации: 2007-03-27.

Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Номер патента: EP1150678A1. Автор: Norman E. Inst. Med. Sci. Dia. Comp. Lab. CAMERON,Mary A. Inst. Med. Sci. Dia. Comp. Lab. COTTER. Владелец: University of Aberdeen. Дата публикации: 2001-11-07.

Use of cox-2 inhibitors for the preparation of a medicament for the treatment of neoplasia in a subject being treated with radiation therapy

Номер патента: IL143805A. Автор: . Владелец: Searle & Co. Дата публикации: 2007-03-08.

Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Номер патента: JP2014065718A. Автор: Mary Anne Cotter,Norman Euguene Cameron,キャメロン，ノーマン・ユージー,コッター，メリー・アン. Владелец: University of Aberdeen. Дата публикации: 2014-04-17.

Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Номер патента: HU0105138A2. Автор: Norman Eugene Cameron,Mary Anne Cotter. Владелец: Astrazeneca Ab,. Дата публикации: 2002-04-29.

Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis

Номер патента: EP0870502A2. Автор: Yuko Okamura,Junichi Shimada,Akira Karasawa,Toru Noji,Chikako Katagiri. Владелец: Kyowa Hakko Kogyo Co Ltd. Дата публикации: 1998-10-14.

Use of pkc inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection

Номер патента: CA2323158A1. Автор: Douglas Kirk Ways. Владелец: Individual. Дата публикации: 1999-09-10.

Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer

Номер патента: US20050207998A1. Автор: Yaoping Lu,Allan Conney,YouRong Lou. Владелец: Rutgers State University of New Jersey. Дата публикации: 2005-09-22.

Capsaicyns in the treatment of leaky gut

Номер патента: AU2021380874A2. Автор: Erik Lager,Bomi FRAMROZE,Torsten Helsing,Lucas ALTEPOST. Владелец: aXichem AB. Дата публикации: 2023-07-13.

Capsaicyns in the treatment of leaky gut

Номер патента: AU2021380874A1. Автор: Erik Lager,Bomi FRAMROZE,Torsten Helsing,Lucas ALTEPOST. Владелец: aXichem AB. Дата публикации: 2023-06-15.

Capsaicyns in the treatment of leaky gut

Номер патента: EP4247353A1. Автор: Erik Lager,Bomi FRAMROZE,Torsten Helsing,Lucas ALTEPOST. Владелец: aXichem AB. Дата публикации: 2023-09-27.

Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis

Номер патента: US20240277637A1. Автор: Erik Lager,Bomi FRAMROZE,Torsten Helsing,Lucas ALTEPOST. Владелец: aXichem AB. Дата публикации: 2024-08-22.

Capsaicyns in the treatment of leaky gut

Номер патента: US20240009150A1. Автор: Erik Lager,Bomi FRAMROZE,Torsten Helsing,Lucas ALTEPOST. Владелец: Axichem [se]/[se] AB. Дата публикации: 2024-01-11.

Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease

Номер патента: WO1999030695A8. Автор: Roger Aki Fujimoto,Paul James Marshall. Владелец: Paul James Marshall. Дата публикации: 1999-07-29.

Compostions for use in the prophylactic treatment of hypocalcemia in a ruminant animal

Номер патента: WO2024125758A1. Автор: Per THEILGAARD. Владелец: Vilofoss A/S. Дата публикации: 2024-06-20.

Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders

Номер патента: AU2019402087B2. Автор: Kjell Anders Ivan Svensson,Kevin Michael BIGLAN,Christina Marie KILEY. Владелец: Eli Lilly and Co. Дата публикации: 2023-04-06.

Dose regimens for use of ly3154207 in the treatment of dopaminergic cns disorders

Номер патента: EP4417258A2. Автор: Kjell Anders Ivan Svensson,Kevin Michael BIGLAN,Christina Marie KILEY. Владелец: Eli Lilly and Co. Дата публикации: 2024-08-21.

Dose regimens for use of ly3154207 in the treatment of dopaminergic cns disorders

Номер патента: EP4417258A3. Автор: Kjell Anders Ivan Svensson,Kevin Michael BIGLAN,Christina Marie KILEY. Владелец: Eli Lilly and Co. Дата публикации: 2024-10-30.

Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome

Номер патента: US09913818B2. Автор: Christian Darimont-Nicolau,Christophe Moinard,Luc Cynober,Denis Breuille,Gabrielle VENTURA. Владелец: Nestec SA. Дата публикации: 2018-03-13.

Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis

Номер патента: WO2022253884A4. Автор: Erik Lager,Bomi FRAMROZE,Torsten Helsing,Lucas ALTEPOST. Владелец: aXichem AB. Дата публикации: 2023-01-12.

Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis

Номер патента: EP4346789A1. Автор: Erik Lager,Bomi FRAMROZE,Torsten Helsing,Lucas ALTEPOST. Владелец: aXichem AB. Дата публикации: 2024-04-10.

A composition for use in the treatment of rectal and/or intestinal inflammation

Номер патента: AU2021412502A1. Автор: Sari Prutchi SAGIV. Владелец: Cannamore Biotechs Ltd. Дата публикации: 2023-07-13.

A composition for use in the treatment of rectal and/or intestinal inflammation

Номер патента: WO2022144897A1. Автор: Sari Prutchi SAGIV. Владелец: Cannamore Biotechs Ltd.. Дата публикации: 2022-07-07.

A composition for use in the treatment of rectal and/or intestinal inflammation

Номер патента: CA3203192A1. Автор: Sari Prutchi SAGIV. Владелец: Cannamore Biotechs Ltd. Дата публикации: 2022-07-07.

A composition for use in the treatment of rectal and/or intestinal inflammation

Номер патента: EP4271373A1. Автор: Sari Prutchi SAGIV. Владелец: Cannamore Biotechs Ltd. Дата публикации: 2023-11-08.

A composition for use in the treatment of rectal and/or intestinal inflammation

Номер патента: US20240058364A1. Автор: Sari Prutchi SAGIV. Владелец: Cannamore Biotechs Ltd. Дата публикации: 2024-02-22.

Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders

Номер патента: AU2019402087A1. Автор: Kjell Anders Ivan Svensson,Kevin Michael BIGLAN,Christina Marie KILEY. Владелец: Eli Lilly and Co. Дата публикации: 2021-07-15.

Dose regimens for use of ly3154207 in the treatment of dopaminergic cns disorders

Номер патента: EP3897578A1. Автор: Kjell Anders Ivan Svensson,Kevin Michael BIGLAN,Christina Marie KILEY. Владелец: Eli Lilly and Co. Дата публикации: 2021-10-27.

Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease

Номер патента: EP1037617A1. Автор: Roger Aki Fujimoto,Paul James Marshall. Владелец: Novartis Erfindungen Verwaltungs GmbH. Дата публикации: 2000-09-27.

Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease

Номер патента: WO1999030695A1. Автор: Roger Aki Fujimoto,Paul James Marshall. Владелец: Novartis-Erfindungen Verwaltungsgesellschaft Mbh. Дата публикации: 1999-06-24.

Dose regimens for use of ly3154207 in the treatment of dopaminergic cns disorders

Номер патента: EP3897578B1. Автор: Kjell Anders Ivan Svensson,Kevin Michael BIGLAN,Christina Marie KILEY. Владелец: Eli Lilly and Co. Дата публикации: 2024-11-06.

Electrospun fibers containing nanodispersions and their use for the treatment of wounds

Номер патента: US12128080B2. Автор: Rolf Daniels,Francis KARNAU MWIIRI. Владелец: Nsc Pharma & Co KG GmbH. Дата публикации: 2024-10-29.

Electrospun fibers containing nanodispersions and their use for the treatment of wounds

Номер патента: EP3810203A1. Автор: Rolf Daniels,Francis KARNAU MWIIRI. Владелец: Prof4skin GmbH. Дата публикации: 2021-04-28.

Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome

Номер патента: CA2923705A1. Автор: Christian Darimont-Nicolau,Christophe Moinard,Luc Cynober,Denis Breuille,Gabrielle VENTURA. Владелец: Nestec SA. Дата публикации: 2015-04-16.

Tablet formulation of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide for use in the the treatment of cystic fibrosis

Номер патента: HRP20190660T1. Автор: Gregor Zlokarnik,Alfredo Grossi,William Rowe,Patricia Hurter,Kirk Dinehart,Marinus Jacobus Verwijs,Kirk Overhoff,Martyn Botfield,Fredrick F. Van Goor,Christopher R. Young,Peter D. J. Grootenhuis. Владелец: VERTEX PHARMACEUTICALS INCORPORATED. Дата публикации: 2019-05-31.

Pharmaceutical compositions for the treatment of cellulite

Номер патента: NZ555836A. Автор: Alessandro Giolitti,Sandro Giuliani,Massimiliana Landini. Владелец: Menarini Ricerche SpA. Дата публикации: 2009-09-25.

Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome

Номер патента: CA2923705C. Автор: Christian Darimont-Nicolau,Christophe Moinard,Luc Cynober,Denis Breuille,Gabrielle VENTURA. Владелец: SOCIETE DES PRODUITS NESTLE SA. Дата публикации: 2024-05-14.

Oral solid dosage form with mycophenolic acid or its salt for use as an immunosuppressant for the treatment or prevention of organ or tissue transplant rejection and method thereof

Номер патента: RU2016145122A. Автор: Елена Сергеевна Хазанова,Сергей Юрьевич Ногай,Евгения Александровна Филиппова. Владелец: Общество с ограниченной ответственностью "Изварино Фарма". Дата публикации: 2018-05-17.

Trilobine and its natural analogs for use as a drug

Номер патента: EP3355883A1. Автор: Christophe Long,Francois Sautel,Yoann MENON,Paola B. ARIMONDO. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2018-08-08.

Trilobine and its natural analogs for use as a drug

Номер патента: US20180280379A1. Автор: Christophe Long,Francois Sautel,Yoann MENON,Paola B. ARIMONDO. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2018-10-04.

Trilobine and its natural analogs for use as a drug

Номер патента: WO2017055632A1. Автор: Christophe Long,Francois Sautel,Yoann MENON,Paola B. ARIMONDO. Владелец: PIERRE FABRE MEDICAMENT. Дата публикации: 2017-04-06.

Trilobine and its natural analogs for use as a drug

Номер патента: US10517863B2. Автор: Christophe Long,Francois Sautel,Yoann MENON,Paola B. ARIMONDO. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2019-12-31.

DOSE REGIMENS FOR USE OF LY3154207 IN THE TREATMENT OF DOPAMINERGIC CNS DISORDERS

Номер патента: US20220062265A1. Автор: BIGLAN Kevin Michael,KILEY Christina Marie,SVENSSON Kjell Anders Ivan. Владелец: ELI LILLY AND COMPANY. Дата публикации: 2022-03-03.

NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF MUSCULAR DYSTROPHY

Номер патента: US20180280385A1. Автор: WOLLIN Stefan Ludwig Michael,DIAZ MANERA Jorge Alberto. Владелец: . Дата публикации: 2018-10-04.

Bath drug and method for using said drug in the treatment and prophylaxis of discirculatory encephalopathy

Номер патента: WO2011112116A1. Автор: Владимир Израилевич Хейфец,Роман Анатольевич ТРУНИН,Михаил Львович Учитель,Дана КАССЕИНОВА,Евгений Ильич MАЕВСКИЙ. Владелец: Kasseinova Dana. Дата публикации: 2011-09-15.

Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines in the treatment of diabetes

Номер патента: EP2842555B1. Автор: Pablo Vicente Escribá Ruiz,Xavier Busquets Xaubet. Владелец: Universitat De Les Illes Balears. Дата публикации: 2018-04-18.

Dermatological compositions comprising a combination of peroxidized lipids and zinc for use amongst others in the treatment of herpes

Номер патента: EP2343038A1. Автор: Stephane Desjonqueres. Владелец: Laboratoires Carilene. Дата публикации: 2011-07-13.

Dermatological compositions comprising a combination of peroxidized lipids and zinc for use amongst others in the treatment of herpes.

Номер патента: PL2343038T3. Автор: Stephane Desjonqueres. Владелец: Laboratoires Carilene. Дата публикации: 2015-04-30.

Methods of using avermectin compositions for the treatment of neurological disorders and dosing regimens

Номер патента: WO2023180955A1. Автор: Wei Chen,Alexandra Zanin-Zhorov,Samuel D. Waksal,Rui WU,Julien MORETTI,Melanie NYUYDZEFE. Владелец: Equilibre Biopharmaceuticals Bv. Дата публикации: 2023-09-28.

Methods of using avermectin compositions for the treatment of pain and dosing regimens

Номер патента: WO2023180957A1. Автор: Alexandra Zanin-Zhorov,Samuel D. Waksal,Rui WU. Владелец: Equilibre Biopharmaceuticals Bv. Дата публикации: 2023-09-28.

Methods of using avermectin compositions for the treatment of spasticity and dosing regimens

Номер патента: WO2023180956A1. Автор: Alexandra Zanin-Zhorov,Samuel D. Waksal,Rui WU. Владелец: Equilibre Biopharmaceuticals Bv. Дата публикации: 2023-09-28.

Macrolides for the treatment of reversible obstructive airways diseases

Номер патента: US5519049A. Автор: Takeshi Fukuda,Sohei Makino,Ikuo Akutsu,Alan A. Norris,Dale M. Jackson. Владелец: Fisons Ltd. Дата публикации: 1996-05-21.

Use of glepp-1 inhibitor for the manufacture of a medicament for treatment of an autoimmune and/or inflammatory disorder

Номер патента: IL188735A. Автор: Catherine Jorand-Lebrun,Agnès Bombrun,Rob Hooft Van Huijsduijnen,Pierre-Alain Vitte,Patrick Gerber. Владелец: Patrick Gerber. Дата публикации: 2012-07-31.

Liquid formulations of ivermectin compositions and use in gelatin dosage forms

Номер патента: WO2023183831A1. Автор: Samuel D. Waksal,Rui WU,Yafei LYU,Wai Sheung MA. Владелец: Equilibre Biopharmaceuticals Bv. Дата публикации: 2023-09-28.

NANOVECTORS AND USES, IN PARTICULAR FOR THE TREATMENT OF TUMORS

Номер патента: FR3072281B1. Автор: Olivier Tillement,François Lux,Fabien ROSSETTI,Vu-Long Tran,Clelia Mathieu,Myleva Dahan. Владелец: NH Theraguix SA. Дата публикации: 2020-12-04.

NEW COMPOUND MEDICINE USEFUL IN PARTICULAR FOR THE TREATMENT OF INFECTIOUS DISEASES

Номер патента: FR2521006B1. Автор: Leif Tybring. Владелец: Leo Pharmaceutical Products Ltd AS. Дата публикации: 1986-09-12.

Antifoam compositions useful in particular for the treatment of gastric disorders.

Номер патента: FR2705966B1. Автор: Briquet Francois Jean. Владелец: Dow Corning France SAS. Дата публикации: 1995-08-25.

NEW MEDICINES USEFUL IN PARTICULAR FOR THE TREATMENT OF HEART DISORDERS

Номер патента: BE768809A. Автор: A Garzia. Владелец: ISTITUTO CHEMIOTERAPICO. Дата публикации: 1971-11-03.

Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections

Номер патента: KR20000035864A. Автор: 마이클 알. 지로세크,더글라스 케이. 웨이스,로렌스 이. 스트람. Владелец: 피터지.스트링거. Дата публикации: 2000-06-26.

Use of kqt1 channel inhibitors for the preparation of a medicine for the treatment of diseases, which are caused by helminths and ectoparasites

Номер патента: BR9916190A. Автор: Uwe Gerlach,Hans Jochen Lang,Joachim Hofmann,Aguan Wei. Владелец: Aventis Pharma Gmbh. Дата публикации: 2001-09-11.

USE OF ACETYLCHOLINESTERASIS INHIBITORS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF FUNCTIONAL AND / OR ORGANIC PAIN SYNDROME

Номер патента: DE69931640T2. Автор: Maria Nicolodi,Federigo Sicuteri. Владелец: Eisai Co Ltd. Дата публикации: 2007-03-08.

Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv

Номер патента: EP0980249A1. Автор: Brigitte T. Huber,Tracy Schmitz,Robert Underwood. Владелец: TUFTS UNIVERSITY. Дата публикации: 2000-02-23.

Use of 11-(4-piperidilydene)-5H-benzo[5,6]cyclohepta[1,2- b]pyridine compound as a farnesyl protein transferase inhibitor for the manufacture of a medicament for the treatment of proliferative disease

Номер патента: SK285584B6. Автор: Ming Liu,Viyyoor Girijavallabhan,Ronald J. Doll,Ashit Ganguly,Walter R. Bishop,Paul Kirschmeier,David L. Cutler,Joseph J. Catino,Loretta L. Nielsen. Владелец: Schering Corporation. Дата публикации: 2007-04-05.

Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes

Номер патента: EP1112067A2. Автор: Maria Nicolodi,Federigo Sicuteri. Владелец: Eisai Co Ltd. Дата публикации: 2001-07-04.

Use of PKC Inhibitors for the Preparation of a Medication for the Treatment of Sexual Disorders

Номер патента: DK0829262T3. Автор: Douglas Kirk Ways,Michael R Jirousek,Lawrence E Stramm. Владелец: Lilly Co Eli. Дата публикации: 2002-03-18.

Use of PKC inhibitors for the manufacture of a medicament for the treatment f HTLV-1 infections

Номер патента: AU4179397A. Автор: Michael R. Jirousek,Douglas K. Ways,Lawrence E. Stramm. Владелец: Eli Lilly and Co. Дата публикации: 1998-03-19.

USE OF COLINESTERASE INHIBITORS FOR THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF XEROSTOMY

Номер патента: PT866699E. Автор: Herbert Helander,Joergen Ekstrom. Владелец: Biora Ab. Дата публикации: 2002-08-30.

Use of spermidine synthase inhibitors for the preparation of a medicament for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: IL156405A. Автор: . Владелец: Quark Pharmaceuticals Inc. Дата публикации: 2010-06-30.

COMPOSITION INCLUDING AT LEAST ONE GLYCEROL ESTER OF FATTY ACIDS FOR USE FOR INJECTION IN THE VITREUS CAVITY

Номер патента: BR112012011825B1. Автор: Jean-Sebastien Garrigue,Frédéric Lallemand,Jeffrey Heier. Владелец: Arcadophta. Дата публикации: 2021-08-24.

Recombinant il-12 albumin binding domain fusion proteins for use in methods for the treatment of cancer

Номер патента: WO2024097767A1. Автор: John K. Cini,Richard T. KENNEY. Владелец: Sonnet BioTherapeutics, Inc.. Дата публикации: 2024-05-10.

Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes

Номер патента: US09566348B2. Автор: Robert J. Binder,Pramod K. Srivastava. Владелец: University of Connecticut Health Center. Дата публикации: 2017-02-14.

An il-2 fc fusion protein for use in methods for the treatment of plaque psoriasis and atopic dermatitis

Номер патента: WO2024054868A1. Автор: Raphael Clynes,Shelley Belouski,Ralph ZITNIK. Владелец: Xencor, Inc.. Дата публикации: 2024-03-14.

Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes

Номер патента: CA2517274C. Автор: Robert J. Binder,Pramod K. Srivastava. Владелец: University of Connecticut Health Center. Дата публикации: 2012-09-18.

composition for use as supportive therapy for the treatment of tumors, AIDS and leukemia

Номер патента: BR112015015393A2. Автор: Mogna Giovanni. Владелец: Mogna Giovanni. Дата публикации: 2017-07-11.

USE IN COSMETICS, FOR THE TREATMENT OF HAIR OR SKIN AND / OR IN DERMATOLOGY, AN AQUEOUS DISPERSION BASED ON ORGANOPOLYSILOXANES AND A COPOLYMER ACRYLATE AMMONIUM / ACRYLAMIDE CROSSLINKED.

Номер патента: FR2653331B1. Автор: Claude Dubief,Daniele Cauwet. Владелец: LOreal SA. Дата публикации: 1994-05-20.

USE IN COSMETICS, FOR THE TREATMENT OF HAIR OR SKIN AND / OR IN DERMATOLOGY, AN AQUEOUS DISPERSION BASED ON ORGANOPOLYSILOXANES AND A COPOLYMER ACRYLATE AMMONIUM / ACRYLAMIDE CROSSLINKED.

Номер патента: FR2653331A1. Автор: DUBIEF Claude,Cauwet Daniele. Владелец: LOreal SA. Дата публикации: 1991-04-26.

Method for using activated protein c for the treatment of coagulation-associated disorders

Номер патента: WO2002024215A3. Автор: Sau-Chi Betty Yan. Владелец: Sau-Chi Betty Yan. Дата публикации: 2003-05-22.

Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4]triazolo[4,3-a]quinoxaline compounds and pde 10 inhibitors for use in treatment of neurological or metabolic disorders

Номер патента: RU2657540C2. Автор: Андрес Авелино Трабанко-Суарес,Антониус Адрианус Хендрикус Петрус МЕГЕНС,Хосе Игнасио АНДРЕС-ХИЛЬ,Ксавье Жан Мишель Ланглуа,Грета Констанция Петер Ванхоф,Анхелис Мери Де,Петер Якобус Йоханнес Антониус Бейнстерс,Фредерик Ян Рита Ромбаутс. Владелец: Янссен Фармацевтика Нв. Дата публикации: 2018-06-14.

Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neck

Номер патента: US09913846B2. Автор: Samit Hirawat,Cristian Massacesi,Emmanuelle DI TOMASO. Владелец: NOVARTIS AG. Дата публикации: 2018-03-13.

Pde5 inhibitor for use in the treatment of medical conditions associated with mitochondrial complex iv deficiency

Номер патента: WO2024200678A1. Автор: Markus Schülke-Gerstenfeld,Alessandro Prigione,Carmen MENACHO. Владелец: Universitätsklinikum Düsseldorf. Дата публикации: 2024-10-03.

Finafloxacin for use in the treatment of urinary tract infections

Номер патента: EP3242667A1. Автор: Carsten Fischer,Andreas Vente,Sven-Eric Wohlert,Christine Bentley,Mark Lückermann. Владелец: Merlion Pharmaceuticals Pte Ltd. Дата публикации: 2017-11-15.

Synergistic compositions for use in the treatment of cancer

Номер патента: CA3239568A1. Автор: Harri SIHTO,Kirsi TOIVANEN,Tom Bohling. Владелец: Sartar Therapeutics Oy. Дата публикации: 2023-06-15.

Sars-cov-2 main protease inhibitor for use in the treatment of covid 19

Номер патента: WO2024128990A1. Автор: Ugur UZUNER,Selcen CELIK UZUNER,Ebru AKKUS,Abdulkadir KOCAK. Владелец: Karadeniz Teknik Universitesi. Дата публикации: 2024-06-20.

Synergistic compositions for use in the treatment of cancer

Номер патента: EP4444314A1. Автор: Harri SIHTO,Kirsi TOIVANEN,Tom Bohling. Владелец: Sartar Therapeutics Oy. Дата публикации: 2024-10-16.

Novel glucose uptake inhibitors for use in the treatment of cancer

Номер патента: US20240252508A1. Автор: Johan Thevelein,Ward VANTHIENEN. Владелец: Novelyeast BV. Дата публикации: 2024-08-01.

Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of congenital muscular dystrophies

Номер патента: AU2023204891A1. Автор: Wolfgang Brysch,Jörg VON WEGERER,Sara SCHUMANN,Felix Brembeck. Владелец: Metriopharm AG. Дата публикации: 2024-08-08.

Adenosine receptor modulators for the treatment of circadian rhythm disorders

Номер патента: WO2017178820A1. Автор: Prof Russell Foster,Dr. Sridhar VASUDEVAN,Dr. Aarti JAGANNATH. Владелец: OXFORD UNIVERSITY INNOVATION LIMITED. Дата публикации: 2017-10-19.

Azasetron for the treatment of sudden sensorineural hearing loss

Номер патента: AU2023235420A1. Автор: Géraldine HONNET,Judith LAREDO. Владелец: Sensorion SA. Дата публикации: 2024-08-29.

Flt3 receptor inhibitor at low dosage for the treatment of neuropathic pain

Номер патента: US20190298691A1. Автор: Jean Valmier. Владелец: Biodol Therapeutics. Дата публикации: 2019-10-03.

Compound for the treatment and prophylaxis of a lipofuscin-associated disease and/or a disease associated with aged oxidized melanin

Номер патента: US20230285399A1. Автор: Ulrich Schraermeyer. Владелец: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet. Дата публикации: 2023-09-14.

6-Hydroxy-2,5,7,8-Tetramethylchroman-Compounds for the Treatment of Chronic Obstructive Airway Diseases

Номер патента: US20170151234A1. Автор: Hermanus Meurs,Robert Henk Henning,Martina Schmidt,Adrianus Cornelis Van Der Graaf,Gerrit Jan Willem Euverink. Владелец: Sulfateq Bv. Дата публикации: 2017-06-01.

6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

Номер патента: EP3157518A1. Автор: Hermanus Meurs,Robert Henk Henning,Martina Schmidt,Adrianus Cornelis Van Der Graaf,Gerrit Jan Willem Euverink. Владелец: Sulfateq Bv. Дата публикации: 2017-04-26.

Nlrp3 activators for use in the treatment of infectious diseases or cancer by activating nlrp3 inflammasome

Номер патента: WO2022079246A1. Автор: Manfred Jung,Olaf Gross,Emilia Neuwirt. Владелец: ALBERT-LUDWIGS-UNIVERSITAT FREIBURG. Дата публикации: 2022-04-21.

Nlrp3 activators for use in the treatment of infectious diseases or cancer by activating nlrp3 inflammasome

Номер патента: US20240277658A1. Автор: Manfred Jung,Olaf Gross,Emilia Neuwirt. Владелец: Albert Ludwigs Universitaet Freiburg. Дата публикации: 2024-08-22.

Pharmaceutical composition for use in the treatment or prevention of calcium release-activated calcium channel or discoidin domain receptor 2 related disorders or conditions

Номер патента: WO2024153190A1. Автор: Yi-Chun Yeh,Yu-Fen Chang. Владелец: Lumistar Biotechnology, Inc.. Дата публикации: 2024-07-25.

Compound for the treatment and prophylaxis of a lipofuscin-associated disease and/or a disease associated with aged oxidized melanin

Номер патента: EP4192445A1. Автор: Ulrich Schraermeyer. Владелец: Individual. Дата публикации: 2023-06-14.

Compound for the treatment and prophylaxis of a lipofuscin-associated disease and/or a disease associated with aged oxidized melanin

Номер патента: CA3190961A1. Автор: Ulrich Schraermeyer. Владелец: Individual. Дата публикации: 2022-02-10.

Nlrp3 activators for use in the treatment of infectious diseases or cancer by activating nlrp3 inflammasome

Номер патента: EP4228630A1. Автор: Manfred Jung,Olaf Gross,Emilia Neuwirt. Владелец: Albert Ludwigs Universitaet Freiburg. Дата публикации: 2023-08-23.

Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer

Номер патента: US09993482B2. Автор: Thomas Jorg MEHRLING. Владелец: Purdue Pharma LP. Дата публикации: 2018-06-12.

6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

Номер патента: US09913841B2. Автор: Hermanus Meurs,Robert Henk Henning,Martina Schmidt,Adrianus Cornelis Van Der Graaf,Gerrit Jan Willem Euverink. Владелец: Sulfateq Bv. Дата публикации: 2018-03-13.

Combination of a pi3 kinase inhibitor with paclitaxel for use in the treatment or prevention of a cancer of the head and neck

Номер патента: EP2994126A1. Автор: Samit Hirawat,Cristian Massacesi,Emmanuelle DI TOMASO. Владелец: NOVARTIS AG. Дата публикации: 2016-03-16.

Combination of a pi3 kinase inhibitor with paclitaxel for use in the treatment or prevention of a cancer of the head and neck

Номер патента: CA2909448C. Автор: Samit Hirawat,Cristian Massacesi,Emmanuelle DI TOMASO. Владелец: NOVARTIS AG. Дата публикации: 2021-10-26.

Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and Neck

Номер патента: US20160082012A1. Автор: Samit Hirawat,Cristian Massacesi,Emmanuelle DI TOMASO. Владелец: Individual. Дата публикации: 2016-03-24.

Combination of a pi3 kinase inhibitor with paclitaxel for use in the treatment or prevention of a cancer of the head and neck

Номер патента: WO2014181252A1. Автор: Samit Hirawat,Cristian Massacesi,Emmanuelle DI TOMASO. Владелец: NOVARTIS AG. Дата публикации: 2014-11-13.

Triple kinase inhibition for the treatment of type i interferon response associated disorders

Номер патента: WO2024170776A1. Автор: Manolis PASPARAKIS,Remzi Onur EREN,Simone WOLF. Владелец: Universität zu Köln. Дата публикации: 2024-08-22.

Azaquinazoline derivatives for use in treating or preventing dirofilaria infection in a mammal

Номер патента: US20240108629A1. Автор: Mark J. Taylor,Joseph D. Turner,Stephen A. Ward,Paul M. O'NEILL,Weiquan David Hong. Владелец: Liverpool Foundation Building, University of. Дата публикации: 2024-04-04.

Azaquinazoline derivatives for use in treating or preventing dirofilaria infection in a mammal

Номер патента: EP4277631A1. Автор: Mark J. Taylor,Joseph D. Turner,Stephen A. Ward,Weiqian David HONG,Paul M. O'NEILL. Владелец: University of Liverpool. Дата публикации: 2023-11-22.

Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity

Номер патента: EP2131854A1. Автор: Jurgen Engel,Oliver Bauer. Владелец: Aeterna Zentaris GmbH. Дата публикации: 2009-12-16.

Reduced toxicity methotrexate formulations and methods for using the same

Номер патента: WO2006031614A3. Автор: Patrick Fogarty. Владелец: Patrick Fogarty. Дата публикации: 2006-07-06.

Accessory device for a dental articulator and method for use in fabricating dental prosthetics

Номер патента: US5795152A. Автор: Marc J. Glatt. Владелец: Individual. Дата публикации: 1998-08-18.

Nanostructured titanium alloys for use as biomaterials in the manufacture of medical devices

Номер патента: EP1967218A3. Автор: Marina Ziche,Alessandro Facchini. Владелец: Lima LTO SpA. Дата публикации: 2008-12-03.

Device Having a Structured Coating for Use as an Implant, for the Treatment of Eardrum Perforations, and for Cell Cultivation

Номер патента: US20210346142A1. Автор: Bernhard Schick,Eduard Arzt,Sarah FISCHER,Klaus KRUTTWIG,René HENSEL,Gentiana WENZEL. Владелец: Leibniz Institut fuer Neue Materialien Gemeinnuetzige GmbH. Дата публикации: 2021-11-11.

Device Having a Structured Coating for Use as an Implant, for the Treatment of Eardrum Perforations, and for Cell Cultivation

Номер патента: US20190282353A1. Автор: Arzt Eduard,Hensel René,Fischer Sarah,Wenzel Gentiana,Kruttwig Klaus,Schick Bernhard. Владелец: . Дата публикации: 2019-09-19.

Device having a structured coating for use as an implant, for the treatment of eardrum perforations, and for cell cultivation

Номер патента: WO2018019879A1. Автор: Bernhard Schick,Eduard Arzt,Sarah FISCHER,Klaus KRUTTWIG,René HENSEL,Gentiana WENZEL. Владелец: Leibniz-Institut für Neue Materialien gemeinnützige GmbH. Дата публикации: 2018-02-01.

NOVEL SELF-ADHESIVE ELASTIC BANDAGE THAT CAN BE USED, IN PARTICULAR, FOR THE TREATMENT AND PREVENTION OF DISEASES OF THE VEINS

Номер патента: US20150250653A1. Автор: Lecomte Serge,PERNOT Jean-Marc Henri Maurice. Владелец: . Дата публикации: 2015-09-10.

NOVEL ELASTIC BANDAGE THAT CAN BE USED, IN PARTICULAR, FOR THE TREATMENT AND PREVENTION OF VEIN DISEASES

Номер патента: US20150250654A1. Автор: Lecomte Serge,PERNOT Jean-Marc Henri Maurice. Владелец: . Дата публикации: 2015-09-10.

Novel self-adhesive elastic bandage that can be used, in particular, for the treatment and prevention of diseases of the veins

Номер патента: EP2892482B1. Автор: Serge Lecomte,Jean-Marc Henri Maurice Pernot. Владелец: URGO RECHERCHE INNOVATION ET DEVELOPPEMENT. Дата публикации: 2017-11-08.

Novel self-adhesive elastic bandage that can be used, in particular, for the treatment and prevention of diseases of the veins

Номер патента: WO2014033417A1. Автор: Serge Lecomte,Jean-Marc Henri Maurice Pernot. Владелец: LABORATOIRES URGO. Дата публикации: 2014-03-06.

Micropatterning technique for creating morphologically specific free-floating structures for use as Standards in the pharmaceutical industry

Номер патента: US20170254759A1. Автор: Gertz Frederick Talley,Schultheis Robert James. Владелец: . Дата публикации: 2017-09-07.

TEMPORARY IMPLANT FOR USE AS ANCHOR IN THE MOUTH

Номер патента: FR2735013A1. Автор: Chaman Lal Sachdeva Rohit,Farzin Nia Farrokh. Владелец: Ormco Corp. Дата публикации: 1996-12-13.

Inflatable thermal blanket with surgical access for use with patients in the lithotomy position

Номер патента: US6176870B1. Автор: Scott D. Augustine. Владелец: Augustine Medical Inc. Дата публикации: 2001-01-23.

TEMPORARY IMPLANT FOR USE AS ANCHOR IN THE MOUTH

Номер патента: FR2735013B1. Автор: Chaman Lal Sachdeva Rohit,Farzin Nia Farrokh. Владелец: Ormco Corp. Дата публикации: 2000-04-21.

Methods for using kukharev regions in the atmosphere, in space, and at the level of the earth's surface to obtain antimatter

Номер патента: US20220139589A1. Автор: Vadim Kukharev. Владелец: Individual. Дата публикации: 2022-05-05.

Illumination device and method for using the same in the projection lithography machine

Номер патента: US09804502B2. Автор: YING Wang,Yunbo Zhang,Huijie Huang,Aijun ZENG,Mingxing Chen. Владелец: Shanghai Institute of Optics and Fine Mechanics of CAS. Дата публикации: 2017-10-31.

Slide rule for use inter alia in the interpretation of gas- chromatograms

Номер патента: GB1402412A. Автор: . Владелец: Magyar Asvanyolaj es Foldgaz Kiserleti Intezet. Дата публикации: 1975-08-06.

Bet inhibitors for treating pab1 deficient cancer

Номер патента: EP4401715A1. Автор: Raphaël MARGUERON,Ming-Kang Lee. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2024-07-24.

Methods for the treatment of hrd cancer and brca-associated cancer

Номер патента: EP4433089A1. Автор: Raphael CECCALDI,Yucel HATICE,Daniele MUSIANI. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2024-09-25.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: US20220387368A1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: UNIVERSITE DU LUXEMBOURG. Дата публикации: 2022-12-08.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: LU101477B1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: Univ Luxembourg. Дата публикации: 2021-05-14.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: CA3157474A1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: Individual. Дата публикации: 2021-05-20.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: EP4058008A1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: UNIVERSITE DU LUXEMBOURG. Дата публикации: 2022-09-21.

An inhibitor of an iron-containing hydrogenase of a methanogenic archaeon for use in the treatment or prevention of a parkinsonian condition

Номер патента: WO2021094424A1. Автор: Paul WILMES,Jean-Pierre Trezzi. Владелец: UNIVERSITE DU LUXEMBOURG. Дата публикации: 2021-05-20.

Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer

Номер патента: EP1534338A1. Автор: Stephen Robert AstraZeneca R & D Alderley WEDGE. Владелец: AstraZeneca AB. Дата публикации: 2005-06-01.

Composition for the treatment of veisalgia

Номер патента: RU2757379C2. Автор: Педро ШМИДТ. Владелец: Пх. Аг. Дата публикации: 2021-10-14.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: US20210228580A1. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma BV. Дата публикации: 2021-07-29.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: NZ723645A. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma B V. Дата публикации: 2020-09-25.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: EP3102212A1. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: Dezima Pharma BV. Дата публикации: 2016-12-14.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: US20240024315A1. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: NewAmsterdam Pharma NV. Дата публикации: 2024-01-25.

Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: US11642344B2. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: NewAmsterdam Pharma NV. Дата публикации: 2023-05-09.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: IL247037A. Автор: . Владелец: Dezima Pharma B V. Дата публикации: 2017-01-31.

Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: CA2938718C. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: NewAmsterdam Pharma NV. Дата публикации: 2022-10-18.

Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases

Номер патента: AU2014381733B2. Автор: Kozo Oka,John Ford,Patrick ROUND,John Kastelein,Atsuhiro Kawaguchi,Koichi Tomiyasu. Владелец: NewAmsterdam Pharma NV. Дата публикации: 2020-09-03.

New auxiliary therapy for use in the treatment of prostate cancer

Номер патента: RU2758386C2. Автор: Ф.М.Й. Дебрюйне. Владелец: Фанд Са. Дата публикации: 2021-10-28.

Vcp inhibitors for use in treating amyotrophic lateral sclerosis

Номер патента: EP4366738A2. Автор: Rickie PATANI,Jasmine HARLEY. Владелец: Francis Crick Institute Ltd. Дата публикации: 2024-05-15.

Rock inhibitors for use in treating or preventing pulmonary edema

Номер патента: EP4138846A1. Автор: Stephan Pleschka,John Ziebuhr,Susanne HEROLD,Christin PETERANDERL,Irina Kuznetsova. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2023-03-01.

Rock inhibitors for use in treating or preventing pulmonary edema

Номер патента: WO2021214200A1. Автор: Stephan Pleschka,John Ziebuhr,Susanne HEROLD,Christin PETERANDERL,Irina Kuznetsova. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2021-10-28.

Prmt5 inhibitor for use in cancer therapy

Номер патента: WO2024170488A1. Автор: James Thomas Lynch. Владелец: AstraZeneca AB. Дата публикации: 2024-08-22.

Liposomal drug for use in the treatment of malignant neoplasm

Номер патента: RU2756755C2. Автор: Хенрикус ТИМЕССЕН,Петер ВЕССЕЛЬС,МАРКО Паоло ДЕ,Малика ЛАРАБИ,Кристиана ШИДЕЛЬ,Марина ГУРИНА. Владелец: Ле Лаборатуар Сервье. Дата публикации: 2021-10-05.

Non-saponifiable compounds from natural lipids for use in the treatment and the readjustment of the steroidal balance suffering from permanent chronic modification

Номер патента: EP3365019A1. Автор: Chiara De Gregorio. Владелец: Codex V Srl. Дата публикации: 2018-08-29.

Mek-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: EP4153159A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2023-03-29.

Mek-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: CA3178137A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2021-11-25.

MEK-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine storm

Номер патента: AU2021277517A1. Автор: Michael Schindler,Oliver Planz,Stephan Ludwig,Helen Elisa HOFFMANN,Julia KOCH-HEIER. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2022-12-08.

Using braf inhibitors for treating skin reactions

Номер патента: RU2722667C2. Автор: Ноа ШЕЛАЧ. Владелец: Лутрис Фарма Лтд.. Дата публикации: 2020-06-02.

Purine nucleoside phosphorylase inhibitors for the treatment of metabolic syndrome and associated conditions

Номер патента: WO2024126630A1. Автор: Thomas Mehrling,Shanta Bantia. Владелец: Metashape Pharma Ag. Дата публикации: 2024-06-20.

Compound (8ar,12as,13as)-5,8,8a,9,10,11,12,12a,13,13a-decaidro-3-methoxy-12-(ethylsulphonyl)-6h-isochino [2,1-g] [1,6] naftiridine for use in the treatment of psychoses

Номер патента: CA3114867A1. Автор: Gian Luigi Gessa,Paola DEVOTO,Roberto FRAU. Владелец: Universita Degli Studi Di Cagliari. Дата публикации: 2020-04-09.

Treprostinil for the treatment of pulmonary hypertension

Номер патента: AU2023208357A1. Автор: Jürgen Rawert,Isabel D'OREY MARCHAND SEQUEIRA LOPES BEIRÃO BELO. Владелец: Invox Belgium Nv. Дата публикации: 2024-07-25.

4-PYRROLIDIN-1-Yl-5-P-TOLYL-THIENO[2,3-D] PYRIMIDINE FOR USE IN THE TREATMENT OF AGING-ASSOCIATED AND PREMATURE AGING DISEASES THROUGH RESTORED CHROMOSOMAL STABILITY AND INHIBITION OF CELLULAR SENESCENCE

Номер патента: US20230346785A1. Автор: Elsa Clara CARVALHO LOGARINHO SANTOS. Владелец: IBMC Instituto de Biologia Molecular e Celular. Дата публикации: 2023-11-02.

Pde5 inhibitor for use in the treatment of anterior ischemic optic neuropathy

Номер патента: EP4233867A1. Автор: Elena Bastia,Francesco Impagnatiello,Gael Ronsin. Владелец: Nicox Sa. Дата публикации: 2023-08-30.

Cd93 inhibitors for use in the treatment of cancer

Номер патента: WO2021089845A1. Автор: Carsten Riether,Adrian Ochsenbein. Владелец: UNIVERSITÄT BERN. Дата публикации: 2021-05-14.

Pde5 inhibitor for use in the treatment of anterior ischemic optic neuropathy

Номер патента: WO2023161314A1. Автор: Elena Bastia,Francesco Impagnatiello,Gael Ronsin. Владелец: Nicox Sa. Дата публикации: 2023-08-31.

4-pyrrolidin-1-yl-5-p-tolyl-thieno[2,3-d] pyrimidine for use in the treatment of aging-associated and premature aging diseases through restored chromosomal stability and inhibition of cellular senescence

Номер патента: EP4110343A1. Автор: Elsa Clara CARVALHO LOGARINHO SANTOS. Владелец: IBMC Instituto de Biologia Molecular e Celular. Дата публикации: 2023-01-04.

4-pyrrolidin-1-yl-5-p-tolyl-thieno[2,3-d] pyrimidine for use in the treatment of aging-associated and premature aging diseases through restored chromosomal stability and inhibition of cellular senescence

Номер патента: WO2021167478A1. Автор: Elsa Clara CARVALHO LOGARINHO SANTOS. Владелец: IBMC - INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR. Дата публикации: 2021-08-26.

Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient

Номер патента: US09901579B2. Автор: Heikki Joensuu,Olli Kallioniemi,Harri SIHTO,Olli-Pekka PULKKA. Владелец: Sartar Therapeutics Ltd. Дата публикации: 2018-02-27.

Vcp inhibitors for use in treating amyotrophic lateral sclerosis

Номер патента: AU2022309123A1. Автор: Rickie PATANI,Jasmine HARLEY. Владелец: Francis Crick Institute Ltd. Дата публикации: 2024-01-25.

Vcp inhibitors for use in treating amyotrophic lateral sclerosis

Номер патента: WO2023281030A3. Автор: Rickie PATANI,Jasmine HARLEY. Владелец: The Francis Crick Institute Limited. Дата публикации: 2023-03-09.

Atr inhibitors for use in the treatment of viral infections

Номер патента: EP4232037A1. Автор: Ulrich Betz,Thomas Fuchss. Владелец: Merck Patent GmBH. Дата публикации: 2023-08-30.

Bromodomain inhibitors for treating autoimmune and inflammatory diseases

Номер патента: EP2496235A1. Автор: Chun-Wa Chung,Edwige Nicodeme. Владелец: GlaxoSmithKline LLC. Дата публикации: 2012-09-12.

3beta-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of cannabinoids-related disorders

Номер патента: EP3755339A1. Автор: Jean-Michel REVEST,Monique VALLEE,Pier Vincenzo PIAZZA,Sandy FABRE,Mathilde Metna,Stéphanie Monlezun,Arnau Busquet-Garcia,Daniela Cota,Giovanni Marsicano. Владелец: Aelis Farma SA. Дата публикации: 2020-12-30.

Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcoma

Номер патента: US20160151344A1. Автор: Xizhong Huang. Владелец: NOVARTIS AG. Дата публикации: 2016-06-02.

Melflufen for use in the treatment of multiple myeloma

Номер патента: US20240307480A1. Автор: Jakob LINDBERG. Владелец: ONCOPEPTIDES AB. Дата публикации: 2024-09-19.

Cholecalciferol for use in the treatment of celiac disease

Номер патента: EP4009983A1. Автор: Silvia Trasciatti. Владелец: Abiogen Pharma SRL. Дата публикации: 2022-06-15.

Cholecalciferol for use in the treatment of celiac disease

Номер патента: US20220273676A1. Автор: Silvia Trasciatti. Владелец: Abiogen Pharma SRL. Дата публикации: 2022-09-01.

Cholecalciferol for use in the treatment of celiac disease

Номер патента: WO2021028772A1. Автор: Silvia Trasciatti. Владелец: Abiogen Pharma Spa. Дата публикации: 2021-02-18.

Drug combination and its use in the treatment of cancer

Номер патента: EP4188359A1. Автор: Christos Panotopoulos. Владелец: Inderes Ltd. Дата публикации: 2023-06-07.

Drug combination and its use in the treatment of cancer

Номер патента: WO2022029555A1. Автор: Christos Panotopoulos. Владелец: Inderes Ltd. Дата публикации: 2022-02-10.

Rock2 inhibitor for the treatment of viral infection

Номер патента: WO2022178420A1. Автор: Samuel D. Waksal,Rui WU. Владелец: Graviton Bioscience Bv. Дата публикации: 2022-08-25.

Masitinib for the treatment of alzheimer's disease

Номер патента: AU2021399925A9. Автор: Alain Moussy,Colin Mansfield. Владелец: AB Science SA. Дата публикации: 2024-10-10.

Trmt2a inhibitors for use in the treatment of polyglutamine diseases

Номер патента: WO2020109233A2. Автор: Nadim Joni Shah,Jorg Schulz,Elena Davydova,Aaron Voigt,Giulia ROSSETTI,Michael Alois MARGREITER,Dierk NIESSING,Monika WITZENBERGER. Владелец: Forschungszentrum Jülich Gmbh Fachbereich Patente (R-P). Дата публикации: 2020-06-04.

Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin d deficiency, and disorders associated therewith

Номер патента: CA3175078A1. Автор: Andrea BIFFI,Walter FIORE. Владелец: SOFAR SPA. Дата публикации: 2021-09-30.

Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin D deficiency, and disorders associated therewith

Номер патента: AU2021243859A1. Автор: Andrea BIFFI,Walter FIORE. Владелец: SOFAR SPA. Дата публикации: 2022-09-08.

Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin d deficiency, and disorders associated therewith

Номер патента: EP4125971A1. Автор: Andrea BIFFI,Walter FIORE. Владелец: SOFAR SPA. Дата публикации: 2023-02-08.

Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin d deficiency, and disorders associated therewith

Номер патента: US20230190833A1. Автор: Andrea BIFFI,Walter FIORE. Владелец: SOFAR SPA. Дата публикации: 2023-06-22.

A formulation, e.g. for use in the treatment of flu and colds

Номер патента: WO2014118735A1. Автор: Christopher Francis Bennett. Владелец: Bennett Christopher Francis. Дата публикации: 2014-08-07.

Formulations for use in the treatment or in the prevention of urological diseases

Номер патента: EP3448372A1. Автор: Simone Castelli,Giuseppe SAMARITANI,Vincenzo COSENTINO. Владелец: Inpha Duemila Srl. Дата публикации: 2019-03-06.

Imatinib for use in the treatment of stroke

Номер патента: EP3423060A1. Автор: Ulf Eriksson,Nils Gunnar Wahlgren. Владелец: Brain Consultant Nils Gunnar Wahlgren Ab. Дата публикации: 2019-01-09.

Imatinib for use in the treatment of stroke

Номер патента: WO2017151043A1. Автор: Ulf Eriksson,Nils Gunnar Wahlgren. Владелец: Brain Consultant Nils Gunnar Wahlgren Ab. Дата публикации: 2017-09-08.

Myosin inhibitors for use in the treatment of hypertrophic cardiomyopathy

Номер патента: WO2024182469A1. Автор: Jay Edelberg,Carlos DEL RIO,Angelos OIKONOMOPOULOS,Matthew MEALIFFE. Владелец: MyoKardia, Inc.. Дата публикации: 2024-09-06.

Formulations for use in the treatment or in the prevention of urological diseases

Номер патента: WO2017187302A1. Автор: Simone Castelli,Giuseppe SAMARITANI,Vincenzo COSENTINO. Владелец: Inpha Duemila S.R.L.. Дата публикации: 2017-11-02.

Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of l-dopa-induced dyskinesia

Номер патента: CA3145360A1. Автор: Ana M. MUÑOZ PATIÑO,Jose Luis LABANDEIRA GARCIA,Andrea LOPEZ LOPEZ. Владелец: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA. Дата публикации: 2021-02-04.

Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors in combination with an akt inhibitor for the treatment of cancer

Номер патента: AU2023246862A1. Автор: Paul David Smith,Nicolas FLOCH,Matthew Joseph Martin,Ursula GRAZINI. Владелец: AstraZeneca AB. Дата публикации: 2024-10-31.

Asbt inhibitors in the treatment of renal diseases

Номер патента: WO2024121434A1. Автор: Erik LINDSTRÖM,Jan Hengstler,Ellen STRÄNGBERG,Ahmed GHALLAB. Владелец: ALBIREO AB. Дата публикации: 2024-06-13.

Cxcl8 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Номер патента: EP4397305A1. Автор: Ralf Ludwig,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Enno Schmidt,Pasquale COCCHIARO,Nicola DETTA,Sabrina Patzelt. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2024-07-10.

3beta-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of cannabinoids-related disorders

Номер патента: AU2019223049B2. Автор: Jean-Michel REVEST,Monique VALLEE,Pier Vincenzo PIAZZA,Sandy FABRE,Mathilde Metna,Stéphanie Monlezun,Arnau Busquet-Garcia,Daniela Cota,Giovanni Marsicano. Владелец: Aelis Farma SA. Дата публикации: 2024-07-04.

Cxcl8 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Номер патента: WO2024146918A1. Автор: Ralf Ludwig,Andrea Aramini,Gianluca Bianchini,Laura Brandolini,Enno Schmidt,Pasquale COCCHIARO,Nicola DETTA,Sabrina Patzelt. Владелец: Dompe' Farmaceutici Spa. Дата публикации: 2024-07-11.

5beta, 6beta-epoxycholesterol for use in the treatment of cancer

Номер патента: WO2022129569A1. Автор: Khouloud SASSI,Gérard LIZARD. Владелец: Université Bourgogne. Дата публикации: 2022-06-23.

Biodegradeable multi-cavity microparticles and their use in treatment

Номер патента: US20230248652A1. Автор: James KWAN,Ipshita GUPTA,Umesh Sai JONNALAGADDA,Xiaoqian SU. Владелец: Oxford University Innovation Ltd. Дата публикации: 2023-08-10.

Imatinib for use in the treatment of stroke

Номер патента: US20190030030A1. Автор: Ulf Eriksson,Nils Gunnar Wahlgren. Владелец: Brain Consultant Nils Gunnar Wahlgren Ab. Дата публикации: 2019-01-31.

Imatinib for use in the treatment of stroke

Номер патента: US20210236488A1. Автор: Ulf Eriksson,Nils Gunnar Wahlgren. Владелец: Brain Consultant Nils Gunnar Wahlgren Ab. Дата публикации: 2021-08-05.

Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto

Номер патента: WO2017179012A1. Автор: Bernard Fioretti,Lucio Leonardi. Владелец: S&R Farmaceutici S.P.A.. Дата публикации: 2017-10-19.

5beta, 6beta-epoxycholesterol for use in the treatment of cancer

Номер патента: EP4262810A1. Автор: Khouloud SASSI,Gérard LIZARD. Владелец: Universite Bourgogne Franche Comte. Дата публикации: 2023-10-25.

Use of aromatase inhibitors for the treatment of growth failure

Номер патента: WO2003105901A3. Автор: Barbara Lippe. Владелец: Barbara Lippe. Дата публикации: 2004-03-04.

Osimertinib for use in the treatment of non-small cell lung cancer

Номер патента: AU2022203007B2. Автор: Anthony Francis Patrick NASH. Владелец: AstraZeneca AB. Дата публикации: 2024-07-04.

Fasting mimicking diet and vitamin c for the treatment of cancer

Номер патента: EP3917512A1. Автор: Valter Longo,Maira DI TANO. Владелец: Individual. Дата публикации: 2021-12-08.

Use of a compound or composition comprising an inhibitor of nlrp1 inflammasome activation for the treatment of human airway inflammation

Номер патента: US20230172933A1. Автор: Lei Zhong,Bruno Reversade,Kim Samirah ROBINSON. Владелец: Agency for Science Technology and Research Singapore. Дата публикации: 2023-06-08.

Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy

Номер патента: CA2981757C. Автор: Paolo Luca Maria Giorgetti. Владелец: Professional Dietetics SpA. Дата публикации: 2023-06-27.

Imatinib for use in the treatment of stroke

Номер патента: SE1650260A1. Автор: Eriksson Ulf,Gunnar Wahlgren Nils. Владелец: . Дата публикации: 2017-08-30.

Compositions for use in the prevention and/ or treatment of intellectual disability and neurodegenerative diseases in a subject with down syndrome

Номер патента: US20240238286A1. Автор: Eugenio BARONE,Antonella TRAMUTOLA,Marzia PERLUIGI. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2024-07-18.

Osimertinib for use in the treatment of non-small cell lung cancer

Номер патента: US20230226059A1. Автор: Anthony Francis Patrick NASH. Владелец: AstraZeneca AB. Дата публикации: 2023-07-20.

Osimertinib for use in the treatment of non-small cell lung cancer

Номер патента: US20220184076A1. Автор: Anthony Francis Patrick NASH. Владелец: AstraZeneca AB. Дата публикации: 2022-06-16.

Osimertinib for use in the treatment of non-small cell lung cancer

Номер патента: EP4431154A2. Автор: Anthony Francis Patrick NASH. Владелец: AstraZeneca AB. Дата публикации: 2024-09-18.

Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia

Номер патента: US09707198B2. Автор: Paolo Luca Maria Giorgetti. Владелец: Professional Deitetics SpA. Дата публикации: 2017-07-18.

Cytotoxic substance for use in combination with radiotherapy in cancer treatment

Номер патента: US09649298B2. Автор: Valentin DJONOV,Beat STEGER. Владелец: Fumedica AG. Дата публикации: 2017-05-16.

Use of buspirone for the treatment of functional dizziness

Номер патента: RU2660583C1. Автор: Максим Валерьевич Замерград. Владелец: Общество С Ограниченной Ответственностью "Валента - Интеллект". Дата публикации: 2018-07-06.

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections

Номер патента: AU8106794A. Автор: Malcolm Richard Boyd,Richard Anthony Vere Hodge. Владелец: SmithKline Beecham Ltd. Дата публикации: 1995-05-29.

Methylene blue for use in therapy of hepatitis b and/or hepatitis d infection

Номер патента: WO2024115630A1. Автор: Andreas Cerny,Francesco Negro,Thomas Cerny,Sophie CLÉMENT-LEBOUBE. Владелец: CERNY, Erich. Дата публикации: 2024-06-06.

Medicament for the treatment of liver fibrosis and cirrhosis of liver

Номер патента: WO2019121764A1. Автор: Jochen Hampe,Clemens Schafmeyer,Raghavan THANGAPANDI,Mario BROSCH. Владелец: Christian-Albrechts-Universität zu Kiel. Дата публикации: 2019-06-27.

Golexanolone for use in the treatment of fatigue or cognitive impairment in liver disease patients

Номер патента: EP4326278A1. Автор: David Jones,Magnus DOVERSKOG,Maja Johansson,Lars ÖHMAN. Владелец: Umecrine Cognition AB. Дата публикации: 2024-02-28.

Golexanolone for use in the treatment of fatigue or cognitive impairment in liver disease patients

Номер патента: CA3216680A1. Автор: David Jones,Magnus DOVERSKOG,Maja Johansson,Lars ÖHMAN. Владелец: Umecrine Cognition AB. Дата публикации: 2022-10-27.

Golexanolone for use in the treatment of fatigue or cognitive impairment in liver disease patients

Номер патента: AU2022260105A1. Автор: David Jones,Magnus DOVERSKOG,Maja Johansson,Lars ÖHMAN. Владелец: Umecrine Cognition AB. Дата публикации: 2023-11-30.

Golexanolone for use in the treatment of fatigue or cognitive impairment in liver disease patients

Номер патента: US20240216394A1. Автор: David Jones,Magnus DOVERSKOG,Maja Johansson,Lars ÖHMAN. Владелец: Umecrine Cognition AB. Дата публикации: 2024-07-04.

Golexanolone for use in the treatment of fatigue or cognitive impairment in liver disease patients

Номер патента: WO2022223526A1. Автор: David Jones,Magnus DOVERSKOG,Maja Johansson,Lars ÖHMAN. Владелец: Umecrine Cognition AB. Дата публикации: 2022-10-27.

Cell line for use in producing recombinant adenoviruses

Номер патента: US20230313228A1. Автор: Ryan Cawood. Владелец: Oxford Genetics Ltd. Дата публикации: 2023-10-05.

Compositions and Methods for Use in Combination for the Treatment and Diagnosis of Autoimmune Diseases

Номер патента: US20170051351A1. Автор: Hakonarson Hakon,Li Yun Rose,Keating Brendan. Владелец: . Дата публикации: 2017-02-23.

COMPOSITIONS AND METHODS FOR USE IN COMBINATION FOR THE TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASES

Номер патента: US20200080152A1. Автор: Hakonarson Hakon,Li Yun Rose,Keating Brendan. Владелец: . Дата публикации: 2020-03-12.

Accelerator circulation temperature exchanger, used in particular for the treatment of wines

Номер патента: FR1094781A. Автор: PIERRE Vincent. Владелец: . Дата публикации: 1955-05-24.

Medicament useful in particular for the treatment of tuberculosis.

Номер патента: FR3881M. Автор: . Владелец: Parke Davis and Co LLC. Дата публикации: 1966-01-31.

Production of binder liquor from tannin-containing bark, for use e.g. in the production of fiberboard, involves pulping bark in hot aqueous medium with ground, used fiberboard containing amino-resin binder

Номер патента: DE10017524A1. Автор: Edmone Roffael,Esther Roffael. Владелец: Individual. Дата публикации: 2001-10-18.

Process for using protective layers in the fabrication of electronic devices

Номер патента: AU2003287660A8. Автор: Young H Kim. Владелец: EI Du Pont de Nemours and Co. Дата публикации: 2004-06-15.

METHOD AND DEVICE FOR USING ALTERNATIVE FUELS IN THE PRODUCTION OF CLINKER AND CEMENT

Номер патента: RU2008109004A. Автор: Урс ГАССЕР,Эдилберто Л. ТАДУЛАН,Урс ГАССЕР (CH),Эдилберто Л. ТАДУЛАН (PH). Владелец: Хольцим Текнолоджи Лтд. (Ch). Дата публикации: 2009-09-20.

Process for using protective layers in the fabrication of electronic devices

Номер патента: WO2004047166A2. Автор: Young H. Kim. Владелец: E.I. Du Pont De Nemours and Company. Дата публикации: 2004-06-03.

Agents enhancing HuR/ELAV protein levels for use in the treatment of BRAF-mutated cancers

Номер патента: US10772875B2. Автор: Rastine Mérat. Владелец: HOPITAUX UNIVERSITAIRES DE GENEVE. Дата публикации: 2020-09-15.

AGENTS ENHANCING HuR/ELAV PROTEIN LEVELS FOR USE IN THE TREATMENT OF BRAF-MUTATED CANCERS

Номер патента: EP3595724A1. Автор: Rastine Mérat. Владелец: HOPITAUX UNIVERSITAIRES DE GENEVE. Дата публикации: 2020-01-22.

AGENTS ENHANCING HuR/ELAV PROTEIN LEVELS FOR USE IN THE TREATMENT OF BRAF-MUTATED CANCERS

Номер патента: WO2018167107A1. Автор: Rastine Mérat. Владелец: Les Hopitaux Universitaires De Geneve. Дата публикации: 2018-09-20.

AGENTS ENHANCING HuR/ELAV PROTEIN LEVELS FOR USE IN THE TREATMENT OF BRAF-MUTATED CANCERS

Номер патента: US20200085799A1. Автор: Rastine Mérat. Владелец: HOPITAUX UNIVERSITAIRES DE GENEVE. Дата публикации: 2020-03-19.

Methods for the treatment of dedifferentiated liposarcoma

Номер патента: WO2024194673A1. Автор: Sarah Watson. Владелец: INSTITUT CURIE. Дата публикации: 2024-09-26.

GlyT1 inhibitors for use in the treatment of hematological disorders

Номер патента: US09877963B2. Автор: Emmanuel Pinard,Michael Winter,Daniela Alberati,Annette KOERNER. Владелец: Hoffmann La Roche Inc. Дата публикации: 2018-01-30.

Tgf-beta inhibitor for use in the treatment of dedifferentiated liposarcoma

Номер патента: WO2024194692A1. Автор: Sarah Watson,Nadège GRUEL,Chloé QUIGNOT. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2024-09-26.

Inhibitors for treating diseases characterized by atrial enlargement or remodeling

Номер патента: US09937143B2. Автор: Thomas Holbro,Christoph Schumacher. Владелец: NOVARTIS AG. Дата публикации: 2018-04-10.

Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia

Номер патента: NL2022616A. Автор: Johannes Glas Ronald. Владелец: Patrick Alexander Unger. Дата публикации: 2020-09-11.

Dosing regimen of a csf-1r inhibitor for use in the treatment of amyotrophic lateral sclerosis

Номер патента: WO2024095118A1. Автор: Olivier David,Javier ESTRADA DIEZ,Marie-Emmanuelle Riviere,Huixin YU,Anne GARDIN,Elisa GARCIA GARAYOA,Ram Ron MILLER. Владелец: NOVARTIS AG. Дата публикации: 2024-05-10.

Foxo inhibitors for use in the treatment of diseases caused by abnormal processing of tdp-43 and/or fus proteins

Номер патента: US20240277695A1. Автор: Jesus Maria Aizpurua Iparraguirre,José Ignacio MIRANDA MURUA,Adolfo LÓPEZ DE MUNAIN ARREGUI,Mónica Zufiría García,Gorka Gereñu Lopetegi,Patxi Gil Bea,Sonia Alonso Martin,Jaione Lasa Elgarresta. Владелец: Universidad Del Pais Vasco/Euskal Herriko Unibersitatea. Дата публикации: 2024-08-22.

Gamma-secretase inhibitors for use in the treatment of inherited epidermolysis bullosa

Номер патента: EP4422622A1. Автор: Angelo Giuseppe CONDORELLI,Giovanna Zambruno,May EL HACHEM,Daniele CASTIGLIA,Teresa ODORISIO. Владелец: Fondazione Luigi Maria Monti. Дата публикации: 2024-09-04.

Novel MEK-inhibitor for the treatment of viral and bacterial infections

Номер патента: AU2020258002A1. Автор: Oliver Planz. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2021-11-18.

Novel mek-inhibitor for the treatment of viral and bacterial infections

Номер патента: EP3955908A1. Автор: Oliver Planz. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2022-02-23.

Mek-inhibitor for the treatment of viral and bacterial infections

Номер патента: CA3136171A1. Автор: Oliver Planz. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2020-10-22.

The use of the thymoquinone, thymoquinone analogs and derivatives as topoisomerase ii inhibitor for the treatment of virus infection

Номер патента: WO2020130961A1. Автор: Fikret SAHIN. Владелец: ŞAHİN FiKRET. Дата публикации: 2020-06-25.

Hydrogen sulphide (h2s) generating compounds for use in the treatment of preeclampsia and related disorders in obese pregnant women

Номер патента: WO2024126977A1. Автор: Asif AHMED. Владелец: Mirzyme Therapeutics Limited. Дата публикации: 2024-06-20.

Mek-inhibitor for the treatment of viral and bacterial infections

Номер патента: US20240245637A1. Автор: Oliver Planz,Stephan Ludwig. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2024-07-25.

Mek inhibitors for the prevention and treatment of long covid syndrome

Номер патента: EP4186500A1. Автор: Oliver Planz,Yvonne FÜLL. Владелец: Atriva Therapeutics GmbH. Дата публикации: 2023-05-31.

Composition for use in the treatment of intervertebral disc-related pain

Номер патента: RU2682675C2. Автор: Челль ОЛЬМАРКЕР. Владелец: Стайбле Терапеутикс Аб. Дата публикации: 2019-03-20.

Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia

Номер патента: WO2020171713A1. Автор: Ronald Johannes Glas. Владелец: UNGER, Patrick Alexander. Дата публикации: 2020-08-27.

Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject

Номер патента: US20230285373A1. Автор: Michael Strupp. Владелец: INTRABIO LTD. Дата публикации: 2023-09-14.

Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins

Номер патента: US20130281408A1. Автор: Nicolas Levy,Pierre Cau,Carlos Lopez-Otin. Владелец: UNIVERSITE D?AIX-MARSEILLE. Дата публикации: 2013-10-24.

Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins

Номер патента: US20150105352A1. Автор: Nicolas Levy,Pierre Cau,Carlos Lopez-Otin. Владелец: Assistance Publique Hopitaux de Marseille APHM. Дата публикации: 2015-04-16.

Combination of an HMG-CoA reductase inhibitor and a farnesyl-pyrophosphate synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins

Номер патента: US9072757B2. Автор: Nicolas Levy,Pierre Cau,Carlos Lopez-Otin. Владелец: Assistance Publique Hopitaux de Marseille APHM. Дата публикации: 2015-07-07.

HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cells

Номер патента: US8518914B2. Автор: Nicolas Levy,Pierre Cau,Carlos Lopez-Otin. Владелец: Assistance Publique Hopitaux de Marseille APHM. Дата публикации: 2013-08-27.

Novel mixtures as ras inhibitors for use in the treatment of proliferative and genetic diseases

Номер патента: WO2024156704A1. Автор: Krishnaraj Rajalingam. Владелец: KHR Biotec GmbH. Дата публикации: 2024-08-02.

Compositions for use in the treatment of diabetes

Номер патента: US20180228742A1. Автор: Peter Raymond Flatt,Aine Maire McKillop. Владелец: Ulster University. Дата публикации: 2018-08-16.

Compositions for use in the treatment of diabetes

Номер патента: US11541019B2. Автор: Peter Raymond Flatt,Aine Maire McKillop. Владелец: Ulster University. Дата публикации: 2023-01-03.

Compositions for use in the treatment of diabetes

Номер патента: US20210052515A1. Автор: Peter Raymond Flatt,Aine Marie McKillop. Владелец: Ulster University. Дата публикации: 2021-02-25.

Compositions for use in the treatment of diabetes

Номер патента: WO2017021310A9. Автор: Peter Raymond Flatt,Aine Maire McKillop. Владелец: UNIVERSITY OF ULSTER. Дата публикации: 2017-03-30.

Compositions for use in the treatment of diabetes

Номер патента: EP3328391A1. Автор: Peter Raymond Flatt,Aine Maire McKillop. Владелец: Ulster University. Дата публикации: 2018-06-06.

Compositions for use in the treatment of diabetes

Номер патента: WO2017021310A1. Автор: Peter Raymond Flatt,Aine Maire McKillop. Владелец: UNIVERSITY OF ULSTER. Дата публикации: 2017-02-09.

Synergistic composition for use in the treatment of cancer

Номер патента: WO1999059600A1. Автор: Anne Frippiat,Jan Van Loo,Marcel Roberfroid,Henryk Taper. Владелец: TIENSE SUIKERRAFFINADERIJ N.V.. Дата публикации: 1999-11-25.

Synergistic composition of inulin and an anti-cancer drug for use in the treatment of cancer

Номер патента: EP1079840A1. Автор: Anne Frippiat,Jan Van Loo,Marcel Roberfroid,Henryk Taper. Владелец: Tiense Suikerraffinaderij Nv. Дата публикации: 2001-03-07.

Cyclopenta[4,5]furo[3,2-c]pyridine derivatives as ras inhibitors for use in the treatment of hyperproliferative diseases or genetic disorders

Номер патента: EP4395775A1. Автор: Krishnaraj Rajalingam. Владелец: KHR Biotec GmbH. Дата публикации: 2024-07-10.

Modulators of intracellular chloride concentration for use in the treatment of cognitive decline

Номер патента: WO2023203529A1. Автор: Laura Cancedda,Marco De Vivo,Marco Borgogno,Annalisa Savardi. Владелец: Fondazione Telethon Ets. Дата публикации: 2023-10-26.

Modulators of intracellular chloride concentration for use in the treatment of cognitive decline

Номер патента: WO2023203527A1. Автор: Laura Cancedda,Marco De Vivo,Marco Borgogno,Annalisa Savardi. Владелец: Fondazione Telethon Ets. Дата публикации: 2023-10-26.

Kv1.3 antagonists for use in the treatment of chronic and acute pain

Номер патента: US20220280474A1. Автор: Pedro Afonso DOS SANTOS BALTAZAR DE LIMA,Beatriz SZWARC DOS SANTOS,Ana Rosa MAÇO ABREU,André Emanuel PINHEIRO BASTOS,Marisa Isabel LOPES DE SOUSA,Joana Maria MONTEIRO SERRÃO,Patrícia Isabel DA SILVEIRA MÁXIMO,Ana Maria FERREIRA DA COSTA LOURENÇO,Miguel Angelo SEGÃO MONDRAGÃO,Rui GOMES,Sílvia Patrícia PENA LINO,Luísa Maria PINTO FERREIRA,Paula Cristina DE SÉRIO BRANCO,Henrique SOVELA MOURÃO,Vanessa Alexandra ROSADO SABINO,Ming HIM TONG,Laurent Alain CLAUDETREMBLEAU. Владелец: Sea4us Biotecnologia e Recursos Marinhos Ltda. Дата публикации: 2022-09-08.

Etoposide and prodrugs thereof for use in targeting cancer stem cells

Номер патента: US20160022721A1. Автор: Nalan Utku,Steven R. Gullans. Владелец: Cellact Pharma GMBH. Дата публикации: 2016-01-28.

Dosage form for intra-articular injection comprising colchicine for use in the treatment of a joint disease such as osteoarthritis

Номер патента: WO2024156699A1. Автор: Daniel Hayoz,Gauthier Pouliquen,Charles Sanson,Farah Marzouki. Владелец: Pk Med. Дата публикации: 2024-08-02.

Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy

Номер патента: NZ743344A. Автор: Laura Brandolini,Marcello Allegretti,Pier Ruffini. Владелец: Dompe’ Farm S P A. Дата публикации: 2024-05-31.

Etoposide and prodrugs thereof for use in targeting cancer stem cells

Номер патента: US09827261B2. Автор: Nalan Utku,Steven R. Gullans. Владелец: Cellact Pharma GMBH. Дата публикации: 2017-11-28.

Oral compositions comprising ketamine combined with subcutaneal or intravenous ketamine for use in the treatment, control or prevention of depressive disorders

Номер патента: EP4262769A1. Автор: Carmel REILLY,Mario Francisco Pereira JURUENA. Владелец: Neurocentrx Pharma Ltd. Дата публикации: 2023-10-25.

Selective pacl inhibitors for use in the treatment of migraine and headaches

Номер патента: WO2009033489A3. Автор: Jes Olesen,Steffen Birk. Владелец: Steffen Birk. Дата публикации: 2009-05-07.

Oral compositions comprising ketamine combined with subcutaneal or intravenous ketamine for use in the treatment, control or prevention of depressive disorders

Номер патента: AU2021404187A1. Автор: Carmel REILLY,Mario Francisco Pereira JURUENA. Владелец: Neurocentrx Pharma Ltd. Дата публикации: 2023-07-20.

Oral compositions comprising ketamine combined with subcutaneal or intravenous ketamine for use in the treatment, control or prevention of depressive disorders

Номер патента: US20240315987A1. Автор: Carmel REILLY,Mario Francisco Pereira JURUENA. Владелец: Neurocentrx Pharna Ltd. Дата публикации: 2024-09-26.

Use of sugar cane extracts in the treatment or prevention of microbial infections and dysbiosis

Номер патента: AU2024204161B2. Автор: Shane Mitchell,Barry Kitchen,Gregor Macnab,Matthew Flavel. Владелец: Poly Gain Pte Ltd. Дата публикации: 2024-09-26.

BYL719 (Alpelisib) for use in the treatment of PIK3CA-Related Overgrowth Spectrum (PROS - CLOVES syndrome)

Номер патента: AU2022235569B2. Автор: Guillaume CANAUD. Владелец: Université Paris Cite. Дата публикации: 2024-10-10.

Bacteroides faecichinchillae and its use in the treatment of metabolic disorders

Номер патента: WO2024115631A1. Автор: Hubert Vidal,Annick BERNALIER DONADILLE,Murielle GODET,Eve DELMAS. Владелец: Institut National De Recherche Pour L’Agriculture, L’Alimentation Et L’Environnement (Inrae). Дата публикации: 2024-06-06.

Artemisinin and its derivatives for use in the treatment of kidney disease

Номер патента: US09603831B2. Автор: Christoph Thiemermann. Владелец: QUEEN MARY AND WESTFILED COLLEGE UNIVERSITY OF LONDON. Дата публикации: 2017-03-28.

A method of use for cannabidiol in the prevention and treatment of interferon-responsive conditions

Номер патента: WO2023195029A3. Автор: Manit PATEL,Robin Elaine DUNCAN,Maria Fernanda de Andrade FERNANDES,Shreema DR. MERCHANT. Владелец: MERCHANT, Sheela Harish. Дата публикации: 2024-03-07.

A screening method, a kit, a method of treatment and a compound for use in a method of treatment

Номер патента: US20170016881A1. Автор: Tore Bengtsson. Владелец: ATROGI AB. Дата публикации: 2017-01-19.

Use of chelating agents in the treatment of atherosclerotic conditions

Номер патента: WO1999033521A3. Автор: Anders Olsson,Robertson Towart,Per Jynge,Jan Olof Gustav Karlsson,Rolf Goeran Gustav Andersson,Bo Zieden,Tudor Griffith,Derek Grant,Helge Refsum. Владелец: Helge Refsum. Дата публикации: 1999-09-02.

Compounds for use in the treatment of bacterial infections

Номер патента: EP3833338A1. Автор: Thomas Böttcher,Michaela PROTHIWA,Felix ENGLMAIER. Владелец: Universitaet Konstanz. Дата публикации: 2021-06-16.

Inhalable protease inhibitors for use in the prevention and/or treatment of fibrotic autoimmune or inflammatory lung diseases

Номер патента: WO2023062219A1. Автор: Christoph Peters,Gernot Zissel,Sebastian FÄHNDRICH,Martin J. HUG. Владелец: ALBERT-LUDWIGS-UNIVERSITAT FREIBURG. Дата публикации: 2023-04-20.

Compounds for use in the treatment of bacterial infections

Номер патента: WO2020079001A1. Автор: Thomas Böttcher,Michaela PROTHIWA,Felix ENGLMAIER. Владелец: UNIVERSITÄT KONSTANZ. Дата публикации: 2020-04-23.

Compounds for use in the treatment of schizophrenia

Номер патента: WO2024170895A1. Автор: Thomas Pfeiffer,Alleyn Thomas Plowright,Man-Ling HO. Владелец: Ontrack Therapeutics Limited. Дата публикации: 2024-08-22.

Use of sugar cane extracts in the treatment or prevention of microbial infections and dysbiosis

Номер патента: AU2021384768B2. Автор: Shane Mitchell,Barry Kitchen,Gregor Macnab,Matthew Flavel. Владелец: Poly Gain Pte Ltd. Дата публикации: 2024-08-15.

Use of sugar cane extracts in the treatment or prevention of microbial infections and dysbiosis

Номер патента: AU2021384768A1. Автор: Shane Mitchell,Barry Kitchen,Gregor Macnab,Matthew Flavel. Владелец: Poly Gain Pte Ltd. Дата публикации: 2023-07-13.

Use of cannabidiol in the treatment of dravet syndrome

Номер патента: EP4003315A1. Автор: Geoffrey Guy,Benjamin Whalley,Pabitra PATRA. Владелец: GW Research Ltd. Дата публикации: 2022-06-01.

Use of cannabidiol in the treatment of dravet syndrome

Номер патента: US20220184000A1. Автор: Geoffrey Guy,Benjamin Whalley,Pabitra PATRA. Владелец: GW Research Ltd. Дата публикации: 2022-06-16.

Use of cannabidiol in the treatment of dravet syndrome

Номер патента: WO2021019231A1. Автор: Geoffrey Guy,Benjamin Whalley,Pabitra PATRA. Владелец: GW Research Limited. Дата публикации: 2021-02-04.

Use of cannabidiol in the treatment of dravet syndrome

Номер патента: CA3145369A1. Автор: Geoffrey Guy,Benjamin Whalley,Pabitra PATRA. Владелец: Individual. Дата публикации: 2021-02-04.

Inhalable protease inhibitors for use in the prevention and/or treatment of fibrotic autoimmune or inflammatory lung diseases

Номер патента: EP4415705A1. Автор: Christoph Peters,Gernot Zissel,Sebastian FÄHNDRICH,Martin J. HUG. Владелец: Albert Ludwigs Universitaet Freiburg. Дата публикации: 2024-08-21.

Hydroxynorketamine for the use in the treatment of depression

Номер патента: US20230330043A1. Автор: Hélène Rey. Владелец: Ketabon GmbH. Дата публикации: 2023-10-19.

Emulsion for use in the treatment of rosacea

Номер патента: US20240299378A1. Автор: Frédéric Lallemand,Mathieu SCHMITT. Владелец: Exinov. Дата публикации: 2024-09-12.

Compounds for use in the treatment of schizophrenia

Номер патента: GB2627332A. Автор: Pfeiffer Thomas,Thomas Plowright Alleyn,Ho Man-Ling. Владелец: Ontrack Therapeutics Ltd. Дата публикации: 2024-08-21.

Use of sugar cane extracts in the treatment or prevention of microbial infections and dysbiosis

Номер патента: AU2024204161A1. Автор: Shane Mitchell,Barry Kitchen,Gregor Macnab,Matthew Flavel. Владелец: Poly Gain Pte Ltd. Дата публикации: 2024-07-11.

Tri-substituted glycerol compounds for use in the treatment of clinically isolated syndrome and/or multiple sclerosis

Номер патента: WO2013171345A1. Автор: Roland Martin,Pierre ABRAMOWSKI. Владелец: Alphaptose GmbH. Дата публикации: 2013-11-21.

Screening method, a kit, a method of treatment and a compound for use in a method of treatment

Номер патента: US09891212B2. Автор: Tore Bengtsson. Владелец: ATROGI AB. Дата публикации: 2018-02-13.

Carolacton and derivatives thereof for use in the treatment of cell proliferation disorders

Номер патента: EP3630094A1. Автор: Rolf Müller,Irene WAGNER-DÖBLER,Andreas Kirschning,Michael Reck,Chengzhang FU,Jannik DONNER,Jonas AMMERRMANN. Владелец: Helmholtz Zentrum fuer Infektionsforschung HZI GmbH. Дата публикации: 2020-04-08.

Formulations comprising hyaluronic acid and cetyl myristoleate and the use of these formulations in the treatment of osteoarthritis

Номер патента: WO2024030103A3. Автор: Mustafa ŞAHİN,Hatice Yesim KARASULU,Neslihan ÜSTÜNDAĞ OKUR,İlknur KESKIN,Bahtiyar DEMIRALP,Yüksel ANTEPÜZÜMÜ BOLAT,Vildan YOZGATLI. Владелец: Istanbul Medipol Universitesi. Дата публикации: 2024-03-14.

Composition or association of compounds preferably for use in the treatment of nervous diseases in particular neurodegenerative diseases, method for the preparation of such composition or association of compounds and uses thereof.

Номер патента: WO2023169713A1. Автор: Matteo Bevilacqua. Владелец: Pharmaceutica San Marco S.R.L.. Дата публикации: 2023-09-14.

Use of chelating agents in the treatment of atherosclerotic conditions

Номер патента: EP1054670A2. Автор: Anders Olsson,Robertson Towart,Per Jynge,Jan Olof Gustav Karlsson,Bo Zieden,Tudor Griffith,Derek Grant,Helge Refsum,Rolf Göran Gustav ANDERSSON. Владелец: Amersham Health As. Дата публикации: 2000-11-29.

A therapeutic agent for use in the treatment of infections

Номер патента: US20170079930A1. Автор: Adrian Neville Fellows. Владелец: AGA NANOTECH LTD. Дата публикации: 2017-03-23.

Cannabinoids for use in supressing cancer stem cells

Номер патента: US20230097024A1. Автор: Eduardo Munoz Blanco,Juan Diego UNCITI BROCETA,Jon PEÑARANDO SÁEZ. Владелец: Vivacell Biotechnology Espana SL. Дата публикации: 2023-03-30.

Adenosine derivatives for use in the treatment of neurodegenerative disorders and cancer

Номер патента: WO2024126991A1. Автор: Youcef MEHELLOU. Владелец: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED. Дата публикации: 2024-06-20.

Cannabinoids for use in the treatment of neurodegenerative diseases or disorders

Номер патента: GB2492487A8. Автор: Vincenzo Di Marzo,Geoffrey Guy,Stephen Wright,Colin Stott,Teresa Iuvone. Владелец: GW Pharma Ltd. Дата публикации: 2013-01-09.

Cannabinoids for use in the treatment of neurodegenative diseases or disorders

Номер патента: GB201211639D0. Автор: . Владелец: GW Pharma Ltd. Дата публикации: 2012-08-15.

Use of chelating agents in the treatment of atherosclerotic conditions

Номер патента: WO1999033521A2. Автор: Anders Olsson,Robertson Towart,Per Jynge,Jan Olof Gustav Karlsson,Bo Zieden,Tudor Griffith,Derek Grant,Helge Refsum,Rolf Göran Gustav ANDERSSON. Владелец: Nycomed Imaging AS. Дата публикации: 1999-07-08.

Composition for the treatment of osteoarthritis

Номер патента: EP2301554A8. Автор: Josep Escaich Ferrer,Ramon Ruhi Roura,Ana Maria Torrent Gibert,Pere Dalmau Castañares. Владелец: Bioiberica SA. Дата публикации: 2011-10-26.

Cyclic lipopeptide antibiotic compounds for use in the treatment of protein aggregation disease

Номер патента: EP4374869A1. Автор: Markus Zweckstetter,Lisa-Marie RAMIREZ,Alain IBANEZ DE OPAKUA LOPEZ DE ABETXUKO,Ina VORBERG,Alina HEBESTREIT,Gajula Balija MADHUBABU. Владелец: Deutsches Zentrum fuer Neurodegenerative Erkrankungen eV. Дата публикации: 2024-05-29.

Derivatives of nifuroxazide for use in the treatment of mitochondrial disorders and neurodegenerative diseases

Номер патента: EP4440569A1. Автор: Stéphane Azoulay,Véronique PAQUIS-FLUCKLINGER,Marc-Alexandre D'ELIA,Baptiste ROPERT. Владелец: Centre Hospitalier Regional. Дата публикации: 2024-10-09.

Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour

Номер патента: US09795628B2. Автор: Robert Johan Joseph Hageman. Владелец: Nutricia NV. Дата публикации: 2017-10-24.

Methods and compositions for the treatment of disorders characterized by a kidins220 dysfunction in a subject

Номер патента: US20240226062A1. Автор: Teresa IGLESIAS VACAS,Miguel R CAMPANERO GARCÍA,Julia POSE UTRILLA,Ana SIMÓN GARCÍA,Celia LÓPEZ MENÉNDEZ,Luis SÁNCHEZ-MIRANDA PAJUELO,Ana María DEL PUERTO DEL PINO. Владелец: Consorcio Centro de Investigacion Biomedica en Red MP. Дата публикации: 2024-07-11.

Lonafarnib for use in the treatment of viral infections

Номер патента: EP4281074A1. Автор: Thomas Schulz,Thomas Pietschmann,Sibylle Haid,Svenja SAKE,Jessica RÜCKERT. Владелец: Twincore Zentrum fur Experimentelle und Klinische Infektionsforschung GmbH. Дата публикации: 2023-11-29.

Coloured solution in particular for use in surgical methods for the treatment of the bodies of humans or animals

Номер патента: EP2827911A1. Автор: Mauro Beccaro. Владелец: BBS Srl. Дата публикации: 2015-01-28.

Nitisinone dosing regimens for the treatment of alkaptonuria

Номер патента: WO2015165972A1. Автор: Birgitta Olsson. Владелец: Swedish Orphan Biovitrum International AB. Дата публикации: 2015-11-05.

Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease

Номер патента: EP3585382A1. Автор: Jacqueline PARKIN,Alastair MACKINNON. Владелец: Mereo Biopharma 1 Ltd. Дата публикации: 2020-01-01.

Controlled long acting release pharmaceutical preparation for use in the oral cavity

Номер патента: CA2593094A1. Автор: Yoram Sela. Владелец: Individual. Дата публикации: 2006-07-13.

PDE3 inhibitors for treating viral infections

Номер патента: US20230270724A1. Автор: Jan Beute,Henricus Bartholomeus Benraad. Владелец: Breakthrough Medical Research BV. Дата публикации: 2023-08-31.

Carolacton and derivatives thereof for use in the treatment of cell proliferation disorders

Номер патента: US20210186926A1. Автор: Rolf Müller,Irene WAGNER-DÖBLER,Andreas Kirschning,Michael Reck,Chengzhang FU,Jannik DONNER,Jonas AMMERRMANN. Владелец: HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GmbH. Дата публикации: 2021-06-24.

Coloured solution in particular for use in surgical methods for the treatment of the bodies of humans or animals.

Номер патента: WO2013140300A1. Автор: Mauro Beccaro. Владелец: BBS S.R.L.. Дата публикации: 2013-09-26.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: WO2023051925A1. Автор: Ulrich Mrowietz,Günther SCHERR. Владелец: Christian-Albrechts-Universität zu Kiel. Дата публикации: 2023-04-06.

Fosfestrol for use in curative or palliative treatment of prostate cancer

Номер патента: US20170258817A1. Автор: Johannes Jan Platteeuw,Martijn DE BREE. Владелец: CHAMAELEO PHARMA BVBA. Дата публикации: 2017-09-14.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: WO2023052520A1. Автор: Günter Scherr,Ulrich Mrowietz. Владелец: Christian-Albrechts-Universität zu Kiel. Дата публикации: 2023-04-06.

Nhe-1 inhibitors for the treatment of coronavirus infections

Номер патента: US20240041804A1. Автор: Caroline KANT MAREDA,Florence Porte Thomé,Caroline Durand Avallone,Jiri Mareda,Sameera Allie. Владелец: Fondation Esperare. Дата публикации: 2024-02-08.

Composition comprising hydroxytyrosol and punicalagin for use in the treatment of dyslipidemia

Номер патента: US20230033106A1. Автор: Agustin Villar Gonzalez,Rebeca QUIROS FERNANDEZ,Laura Maria BERMEJO LOPEZ,Bricia LOPEZ PLAZA,Andrea ZANGARA. Владелец: Euromed SA. Дата публикации: 2023-02-02.

Polymers obtained by the reaction of a phenolic compound and a carbonyl compound for use in the treatment or prevention of a condition associated with one or more protease(s)

Номер патента: EP4408440A1. Автор: Günter Scherr,Ulrich Mrowietz. Владелец: Christian Albrechts Universitaet Kiel. Дата публикации: 2024-08-07.

Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders

Номер патента: AU2020361741B2. Автор: Fotios M. Plakogiannis,Nisarg Modi,Tamanna LATHER,Marina BOROVINSKAYA. Владелец: Pike Therapeutics Inc. Дата публикации: 2024-09-05.

Cyclic lipopeptide antibiotic compounds for use in the treatment of protein aggregation disease

Номер патента: WO2024115486A1. Автор: Markus Zweckstetter,Lisa-Marie RAMIREZ,Alain IBANEZ DE OPAKUA LOPEZ DE ABETXUKO,Ina VORBERG,Alina HEBESTREIT,Gajula Balija MADHUBABU. Владелец: Deutsches Zentrum Für Neurodegenerative Erkrankungen E. V. (Dzne). Дата публикации: 2024-06-06.

Nhe-1 inhibitors for the treatment of coronavirus infections

Номер патента: EP4203930A1. Автор: Caroline KANT MAREDA,Florence Porte Thomé,Caroline Durand Avallone,Jiri Mareda,Sameera Allie. Владелец: Fondation Esperare. Дата публикации: 2023-07-05.

Nhe-1 inhibitors for the treatment of coronavirus infections

Номер патента: CA3187903A1. Автор: Caroline KANT MAREDA,Florence Porte Thomé,Caroline Durand Avallone,Jiri Mareda,Sameera Allie. Владелец: Fondation Esperare. Дата публикации: 2022-03-03.

Lta4h inhibitor for the treatment or prevention of hidradenitis suppurativa

Номер патента: EP4442315A2. Автор: Till Roehn,Christian Loesche,Grazyna Wieczorek,Carlos Penno. Владелец: NOVARTIS AG. Дата публикации: 2024-10-09.

Therapeutic agent for use in the treatment of infections

Номер патента: US09913805B2. Автор: Adrian Neville Fellows. Владелец: AGA NANOTECH LTD. Дата публикации: 2018-03-13.

Combinations of opioid/TLR4 antagonist and acetyl-para-aminophenol (APAP) for use in the treatment of pain

Номер патента: US09707225B2. Автор: Annette Channa Toledano. Владелец: Allodynic Therapeutics LLC. Дата публикации: 2017-07-18.

Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseases

Номер патента: US09399031B2. Автор: Francesco Della Valle,Maria Federica Della Valle,Gabriele Marcolongo,Salvatore Cuzzocrea. Владелец: Epitech Group SpA. Дата публикации: 2016-07-26.

Method for the treatment of unresectable hylus cholangiocarcinoma

Номер патента: RU2755329C2. Автор: Алексей Александрович Поликарпов,Дмитрий Анатольевич Гранов,Владимир Николаевич Жуйков,Инхат Ибрагимович Тилеубергенов,Артур Чарыкулыевич Гапбаров,Аслан Рахимджонович Шералиев. Владелец: ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ ИМЕНИ АКАДЕМИКА А.М. ГРАНОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ /ФГБУ "РНЦРХТ им. академика А.М. Гранова" Минздрава России. Дата публикации: 2021-09-15.

Dalcetrapib in the treatment of sickle cell trait

Номер патента: WO2020182803A1. Автор: Joseph Eric NIESOR,Renée BENGHOZI,François LAMOUR. Владелец: Hartis-Pharma Sa. Дата публикации: 2020-09-17.

Modified adenosine nucleoside for use in the treatment of viral infections

Номер патента: US20230330126A1. Автор: Giampietro IACHETTINI. Владелец: Individual. Дата публикации: 2023-10-19.

Dalcetrapib in the treatment of sickle cell trait

Номер патента: US20220142952A1. Автор: Joseph Eric NIESOR,Renée BENGHOZI,François LAMOUR. Владелец: Hartis-Pharma Sa. Дата публикации: 2022-05-12.

Adelmidrol in association with hyaluronic acid for use in the treatment of articular chondropathies

Номер патента: EP4233853A1. Автор: Francesco Della Valle,Maria Federica Della Valle,Salvatore Cuzzocrea. Владелец: Epitech Group SpA. Дата публикации: 2023-08-30.

Adelmidrol for use in diseases characterized by insufficient agonism of ppar-gamma receptor

Номер патента: CA3205778A1. Автор: Francesco Della Valle,Maria Federica Della Valle,Salvatore Cuzzocrea. Владелец: Epitech Group SpA. Дата публикации: 2017-04-30.

Adelmidrol for use in diseases characterized by insufficient agonism of ppar-gamma receptor

Номер патента: AU2022201087B2. Автор: Francesco Della Valle,Maria Federica Della Valle,Salvatore Cuzzocrea. Владелец: Epitech Group SpA. Дата публикации: 2023-09-07.

Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer

Номер патента: WO2009151910A3. Автор: Renate Wagner,Thomas Grunt. Владелец: WYETH LLC. Дата публикации: 2010-05-06.

Compositions comprising amino acids for use in the prevention and treatment of chemotherapy side effects

Номер патента: US20230067642A1. Автор: Paolo Luca Maria Giorgetti. Владелец: Professional Dietetics SpA. Дата публикации: 2023-03-02.

Compositions comprising cetylated fatty acids for use in the treatment of gastric mucosa, diabetes and high blood glucose levels

Номер патента: EP3976023A1. Автор: Andrea Lacorte,Germano Tarantino,Elisa BRILLI. Владелец: Alesco SRL. Дата публикации: 2022-04-06.

Compositions comprising cetylated fatty acids for use in the treatment of gastric mucosa, diabetes and high blood glucose levels

Номер патента: WO2020240441A1. Автор: Andrea Lacorte,Germano Tarantino,Elisa BRILLI. Владелец: Alesco S.R.L.. Дата публикации: 2020-12-03.

Hexahydronaphthalen-2-one derivatives for use against a coronavirus infection

Номер патента: EP4384154A1. Автор: Gabor Kovacs,Zoltan Kis,Imre Boldizsár,Kata Horváti,Bernadett Pályi,Szilvia Erika BÖSZE. Владелец: Eotvos Lorand University. Дата публикации: 2024-06-19.

Adelmidrol for use in diseases characterized by insufficient agonism of ppar-gamma receptor

Номер патента: AU2022201087C1. Автор: Francesco Della Valle,Maria Federica Della Valle,Salvatore Cuzzocrea. Владелец: Epitech Group SpA. Дата публикации: 2024-01-11.

Silicic acids for use in the treatment of periodontitis

Номер патента: AU2019354855B2. Автор: Mario Remi Yvonne CALOMME,Kathleen Jozef Ingrid Suzanne Van Hoof. Владелец: Bio Minerals NV. Дата публикации: 2024-08-29.

Dosage form for intra-articular injection comprising colchicine for use in the treatment of a joint disease such as osteoarthritis

Номер патента: EP4406530A1. Автор: designation of the inventor has not yet been filed The. Владелец: Pk Med Sas. Дата публикации: 2024-07-31.

R-fadrozole for use in the treatment of aldostonerism

Номер патента: US20240269119A1. Автор: Christoph Schumacher,Ronald Edward Steele. Владелец: DAMIAN PHARMA AG. Дата публикации: 2024-08-15.

Oral solution based on citicoline and nicotinamide for use in the treatment of glaucoma

Номер патента: US20240261315A1. Автор: Marco Malizia,Cristiano Virno. Владелец: Omikron Italia Srl. Дата публикации: 2024-08-08.

Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA Receptor

Номер патента: US20240315990A1. Автор: Francesco Della Valle,Maria Federica Della Valle,Salvatore Cuzzocrea. Владелец: Epitech Group SpA. Дата публикации: 2024-09-26.

Novel formulation for using in the treatment of wounds

Номер патента: WO2024136781A1. Автор: Ahmet Meli̇koğlu,Emine Tuğba GÖRSEV,Ali BARUTÇU. Владелец: IŞIK, Firat. Дата публикации: 2024-06-27.

Pharmaceutical combinations for the treatment of pain

Номер патента: WO2020091712A3. Автор: Mehmet Nevzat PISAK. Владелец: Pisak Mehmet Nevzat. Дата публикации: 2020-06-04.

Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies

Номер патента: US09962355B2. Автор: Raffaele Migliaccio,Antonella SARDEI,Carmela MIGLIACCIO. Владелец: Individual. Дата публикации: 2018-05-08.

Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions

Номер патента: US09907846B2. Автор: Bror Morein,Kefei Hu,Saideh Berenjian. Владелец: MX Adjuvac AB. Дата публикации: 2018-03-06.

Composition for use in the promotion of healthy bone growth and/or in the treatment of bone disease

Номер патента: US09662358B2. Автор: Clara Garcia-Rodenas,Elizabeth Offord Cavin,Gabriela Bergonzelli Degonda,Euridice CASTANEDA GUTIERREZ,Stéphanie VIGUET-CARRIN. Владелец: Nestec SA. Дата публикации: 2017-05-30.

Compositions comprising thymol and amino acids for use in the treatment of inflammatory or functional intestinal disorders

Номер патента: CA3189566A1. Автор: Andrea Piva,Ester GRILLI. Владелец: Vetagro International SRL. Дата публикации: 2022-02-03.

Agents for use in the treatment of tissue damage 2

Номер патента: AU2021225046A1. Автор: Mark Brian Pepys,Melanie Susanne Glossop,Christopher Swain,Charlotte Alice Louise Lane,Graham Walter Taylor,Stephen Paul Wood. Владелец: UCL BUSINESS LTD. Дата публикации: 2022-10-06.

Agents for use in the treatment of tissue damage 2

Номер патента: EP4106753A1. Автор: Mark Brian Pepys,Melanie Susanne Glossop,Christopher Swain,Charlotte Alice Louise Lane,Graham Walter Taylor,Stephen Paul Wood. Владелец: UCL BUSINESS LTD. Дата публикации: 2022-12-28.

Agents for use in the treatment of tissue damage 2

Номер патента: WO2021165424A1. Автор: Mark Brian Pepys,Melanie Susanne Glossop,Christopher Swain,Charlotte Alice Louise Lane,Graham Walter Taylor,Stephen Paul Wood. Владелец: UCL Business PLC. Дата публикации: 2021-08-26.

Composition for the treatment of urinary tract infections

Номер патента: GB2591598A8. Автор: Mann Kevehazi Laura. Владелец: Individual. Дата публикации: 2021-08-25.

Composition for the treatment of urinary tract infections

Номер патента: GB2591598A. Автор: Mann Kevehazi Laura. Владелец: Individual. Дата публикации: 2021-08-04.

Composition for use in the treatment of intestinal alterations

Номер патента: US20200061141A1. Автор: Andrea BIFFI,Walter FIORE,Ruggero ROSSI,Silvia SALAMINA. Владелец: SOFAR SPA. Дата публикации: 2020-02-27.

Composition for use in the treatment of intestinal alterations

Номер патента: US20210077558A1. Автор: Andrea BIFFI,Walter FIORE,Ruggero ROSSI,Silvia SALAMINA. Владелец: SOFAR SPA. Дата публикации: 2021-03-18.

Composition for use in the treatment of intestinal alterations

Номер патента: US11690889B2. Автор: Andrea BIFFI,Walter FIORE,Ruggero ROSSI,Silvia SALAMINA. Владелец: SOFAR SPA. Дата публикации: 2023-07-04.

Composition for use in the treatment of intestinal alterations

Номер патента: US10881703B2. Автор: Andrea BIFFI,Walter FIORE,Ruggero ROSSI,Silvia SALAMINA. Владелец: SOFAR SPA. Дата публикации: 2021-01-05.

Composition for use in the treatment of intestinal alterations

Номер патента: WO2018100551A1. Автор: Andrea BIFFI,Walter FIORE,Ruggero ROSSI,Silvia SALAMINA. Владелец: SoFar S.p.A.. Дата публикации: 2018-06-07.

Composition for use in the treatment of intestinal alterations

Номер патента: EP3548006A1. Автор: Andrea BIFFI,Walter FIORE,Ruggero ROSSI,Silvia SALAMINA. Владелец: SOFAR SPA. Дата публикации: 2019-10-09.

Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events

Номер патента: EP2672976A1. Автор: Gerard Pillion,Marie Hospitel,Pascal Minini,Isabelle Paty. Владелец: SANOFI SA. Дата публикации: 2013-12-18.

Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events

Номер патента: WO2012107402A1. Автор: Gerard Pillion,Marie Hospitel,Pascal Minini,Isabelle Paty. Владелец: SANOFI. Дата публикации: 2012-08-16.

Use of C1-inhibitor for the treatment of secondary edema of the central nervous system

Номер патента: US09452203B2. Автор: Christoph Kleinschnitz,Marc Nolte,Stefan Schulte,Gerhard Dickneite,Ingo Pragst,Bernhard Nieswandt,Guido Stoll. Владелец: CSL Behring GmbH Deutschland. Дата публикации: 2016-09-27.

Combination of valerian root extract and lavender oil for use in treatment of sleep disorders

Номер патента: RU2672876C2. Автор: Вильфред ДИМПФЕЛЬ,Михаэль НЁЛДНЕР. Владелец: Др. Виллмар Швабе Гмбх Унд Ко. Кг. Дата публикации: 2018-11-20.

Self-assembling peptides in the prevention and treatment of cavitated carious lesions

Номер патента: EP3996654A1. Автор: Michael Hug,Dominikus Amadeus Lysek,Brian B. NOVY. Владелец: Credentis Ag. Дата публикации: 2022-05-18.

Self-assembling peptides in the prevention and treatment of cavitated carious lesions

Номер патента: CA3140921A1. Автор: Michael Hug,Dominikus Amadeus Lysek,Brian B. NOVY. Владелец: Credentis Ag. Дата публикации: 2021-01-14.

Self-assembling peptides in the prevention and treatment of cavitated carious lesions

Номер патента: AU2020309166A1. Автор: Michael Hug,Dominikus Amadeus Lysek. Владелец: Credentis Ag. Дата публикации: 2021-12-16.

Anti-infective conjugate for use in the treatment of zika virus infection

Номер патента: WO2023161311A1. Автор: Miguel Augusto RICO BOTAS CASTANHO,David ANDREU MARTÍNEZ,Andrea Thompson DA POIAN,Toni TODOROVSKI,Christine CRUZ OLIVEIRA,Lorena DE OLIVEIRA FERNANDES SIQUEIRA,Diogo Alexandre DE MENDONÇA. Владелец: Instituto De Bioquimica Medica Leopoldo De Meis. Дата публикации: 2023-08-31.

A topical, oral, pharmaceutical composition for use in the treatment of inflammation-based diseases of the oral cavity

Номер патента: EP3796974A1. Автор: Roberto Stefani. Владелец: Individual. Дата публикации: 2021-03-31.

A topical, oral, pharmaceutical composition for use in the treatment of inflammation-based diseases of the oral cavity

Номер патента: WO2019224683A1. Автор: Roberto Stefani. Владелец: Roberto Stefani. Дата публикации: 2019-11-28.

Iron bis-glycinate chelate used in oral therapy of anaemia in patients with celiacia

Номер патента: RU2541092C2. Автор: Массимо БАЛЬДАЧЧИ,Клаудио Альдо АМЕ`. Владелец: Лаборатори Бальдаччи Спа. Дата публикации: 2015-02-10.

Probiotics for use in the treatment of tumor

Номер патента: WO2024094763A1. Автор: Sandra Johanna Maria TEN BRUGGENCATE,Anita FRAUWALLNER,Jacoline GERRITSEN. Владелец: Institut Allergosan Pharmazeutische Produkte Forschungs- U. Дата публикации: 2024-05-10.

Protein or its compositions for use in treatment of the microbiota

Номер патента: EP4380684A1. Автор: Fabrizio Michetti,Vincenzo ROMANO SPICA. Владелец: Genes Srl. Дата публикации: 2024-06-12.

Maqui berry extracts for use in the treatment or prevention of bone disorders

Номер патента: EP3930739A1. Автор: Keiko Suzuki,Bernd BONNLÄNDER,Stefanie LANG. Владелец: Anklam Extrakt Gmbh. Дата публикации: 2022-01-05.

Maqui berry extracts for use in the treatment or prevention of bone disorders

Номер патента: US20220143117A1. Автор: Keiko Suzuki,Bernd BONNLÄNDER,Stefanie LANG. Владелец: Anklam Extrakt Gmbh. Дата публикации: 2022-05-12.

Maqui berry extracts for use in the treatment or prevention of bone disorders

Номер патента: WO2020173968A1. Автор: Keiko Suzuki,Bernd BONNLÄNDER,Stefanie LANG. Владелец: Anklam Extrakt Gmbh. Дата публикации: 2020-09-03.

Autologous fecal sample for use in the treatment of microbial dysbiosis

Номер патента: AU2018209227B2. Автор: Hans Peter Torsten Ekre,Lars Georg Engstrand,Ola Gösta Flink,Otto Sten Gunnar Skolling. Владелец: Bactaviva AB. Дата публикации: 2024-10-10.

Casein peptide for use in the treatment of uterine infections

Номер патента: US09861678B2. Автор: Jose Mario Iscovich. Владелец: Mileutis Ltd. Дата публикации: 2018-01-09.

A composition of gold nanoparticles having antimicrobial peptides bound on their surface for use the treatment of wound healing or in the treatment of ischemic or vascular diseases or in the treatment of skin disorders

Номер патента: WO2017064687A1. Автор: Lino Da Silva Ferreira,Michela COMUNE. Владелец: Centro De Neurociências E Biologia Celular. Дата публикации: 2017-04-20.

Compositions for the treatment of a disease of the urinary tract and treatment of a disease involving the intracellular delivery of the particle or a medicament contained therein

Номер патента: US20240165043A1. Автор: Mohan Edirisinghe,Eleanor Phoebe Jane Stride,Ann SAVELL,Jennifer Rohn,Wai Keith LAU. Владелец: UCL BUSINESS LTD. Дата публикации: 2024-05-23.

Algoriphagus sp, bosea sp, brevundimonas sp, desulfovibrio sp, microbacterium sp, sphingomonas sp, and variovorax sp for use in disease prevention and treatment

Номер патента: AU2022209715A9. Автор: Andrew A. Dahl,Amy E. STEFFEK,William P. PFUND. Владелец: Zivo Bioscience Inc. Дата публикации: 2024-09-19.

Composition comprising a eukaryotic microalgae or an extract thereof for use in the treatment of a viral disease

Номер патента: EP4322978A1. Автор: Julia HOENG,Marco VAN DER TOORN,Letizia ASTROLOGO,Kasper RENGGLI. Владелец: PHILIP MORRIS PRODUCTS SA. Дата публикации: 2024-02-21.

Use of a vegetal extract from salvia haenkei as an active agent in the treatment of a musculoskeletal disorder

Номер патента: CA3222572A1. Автор: Andrea Alimonti,Andrea Maria Giori. Владелец: Altergon SA. Дата публикации: 2023-01-12.

Use of a vegetal extract from salvia haenkei as an active agent in the treatment of a musculoskeletal disorder

Номер патента: EP4366754A1. Автор: Andrea Alimonti,Andrea Maria Giori. Владелец: Altergon SA. Дата публикации: 2024-05-15.

Composition comprising a eukaryotic microalgae or an extract thereof for use in the treatment of a viral disease

Номер патента: CA3213908A1. Автор: Julia HOENG,Marco VAN DER TOORN,Letizia ASTROLOGO,Kasper RENGGLI. Владелец: Individual. Дата публикации: 2022-10-20.

Use of a vegetable extract from salvia haenkei as an active agent in the treatment of heart diseases

Номер патента: US20240261357A1. Автор: Andrea Alimonti,Andrea Maria Giori. Владелец: Altergon SA. Дата публикации: 2024-08-08.

2-hydroxypropyl-beta-cyclodextrin (hpbetacd) for use in the treatment of breast cancer

Номер патента: EP3917628A1. Автор: Mandeep KAUR,Sourav Taru SAHA. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2021-12-08.

2-hydroxypropyl-beta-cyclodextrin (hpbetacd) for use in the treatment of breast cancer

Номер патента: US20220096529A1. Автор: Mandeep KAUR,Sourav Taru SAHA. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2022-03-31.

Fermentation product for use in the treatment of diseases associated with metabolic syndrome and hepatic steatosis

Номер патента: WO2024160988A1. Автор: Giuseppe Giannini,Loredana Vesci,Fabrizio Giorgi. Владелец: ALFASIGMA S.P.A.. Дата публикации: 2024-08-08.

Use of a vegetal extract from salvia haenkei as an active agent in the treatment of a musculoskeletal disorder

Номер патента: US20240285711A1. Автор: Andrea Alimonti,Andrea Maria Giori. Владелец: Altergon SA. Дата публикации: 2024-08-29.

Compounds, compositions and methods for the treatment or prevention of hair loss

Номер патента: GB2595502A. Автор: Chopra Sunil. Владелец: Individual. Дата публикации: 2021-12-01.

Use of a vegetal extract from salvia haenkei as an active agent in the treatment of a musculoskeletal disorder

Номер патента: WO2023280717A1. Автор: Andrea Alimonti,Andrea Maria Giori. Владелец: Altergon SA. Дата публикации: 2023-01-12.

Artificial nail for use in the treatment of a nail disease

Номер патента: CA3227104A1. Автор: Ronald Van Der Geest,Oscar VAN LOOSBROEK. Владелец: Onicor BV. Дата публикации: 2023-02-09.

Composition in solid form for use in the treatment of extraoesophageal symptoms of gastric reflux

Номер патента: US12036235B2. Автор: Luigi Mercuri. Владелец: Drugs Minerals And Generics Italia Srl In Forma Abbreviata DMG Italia Srl. Дата публикации: 2024-07-16.

Medium molecular weight heparin for use in the treatment of endotheliopathy

Номер патента: US20240245718A1. Автор: Pervinder Singh Bhogal. Владелец: Glycos Biomedical Ltd. Дата публикации: 2024-07-25.

Interleukin 12 (il12) or derivative thereof for use in the treatment of secondary disease

Номер патента: WO2019016109A1. Автор: Karim Asehnoune,Antoine Roquilly,Jose VILLADANGOS. Владелец: Chu De Nantes - Centre Hospitalier Unversitaire De Nantes. Дата публикации: 2019-01-24.

2-HYDROXYPROPYL-β-CYCLODEXTRIN (HPβCD) FOR USE IN THE TREATMENT OF BREAST CANCER

Номер патента: WO2020157651A1. Автор: Mandeep KAUR,Sourav Taru SAHA. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2020-08-06.

Pharmaceutical compositions comprising amide derivatives of hyaluronic acid, for use in the treatment of bone traumas, in particular of patients with problems of osteopenia or osteoporosis

Номер патента: US20220211747A1. Автор: Carlo PIZZOCARO,Gina Lisignoli. Владелец: Fidia Farmaceutici SpA. Дата публикации: 2022-07-07.

Pharmaceutical compositions comprising amide derivatives of hyaluronic acid, for use in the treatment of bone traumas, in particular of patients with problems of osteopenia or osteoporosis

Номер патента: EP3986421A1. Автор: Carlo PIZZOCARO,Gina Lisignoli. Владелец: Fidia Farmaceutici SpA. Дата публикации: 2022-04-27.

Allergy-specific immunotherapy compositions for use in the treatment of house-dust mite allergy

Номер патента: EP3302546A1. Автор: Adrianus Cornelis Van Der Graaf,Gerrit Jan Willem Euverink,Laura HESSE,Martijn Christiaan NAWIJN. Владелец: CITEQ BV. Дата публикации: 2018-04-11.

Use of a vegetal extract as an active agent in the treatment of dermatological diseases

Номер патента: CA3084112A1. Автор: Andrea Alimonti,Andrea Maria Giori,Monica MONTOPOLI,Jessica CADAU. Владелец: Altergon SA. Дата публикации: 2019-06-27.

Mesenchymal stem cells for use in a method of treatment of radiation-induced brain injury

Номер патента: WO2019053224A1. Автор: Bernat SORIA ESCOMS,Abdelkrim HMADCHA,Vivian CAPILLA GONZALEZ,Yolanda AGUILERA GARCIA,Emilio Javier LÓPEZ BEAS. Владелец: Fundacion Publica Andaluza Progreso y Salud. Дата публикации: 2019-03-21.

Conjugate compounds and their use in cancer treatment and diagnosis

Номер патента: EP4389150A1. Автор: designation of the inventor has not yet been filed The. Владелец: University of Texas System. Дата публикации: 2024-06-26.

GA binding protein and neurite derived growth factors for use in the treatment of muscular dystrophy

Номер патента: US20020086017A1. Автор: Tejvir Khurana. Владелец: Individual. Дата публикации: 2002-07-04.

Use of angiotensin I derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders

Номер патента: US20030017989A1. Автор: Meng Sim. Владелец: NATIONAL UNIVERSITY OF SINGAPORE. Дата публикации: 2003-01-23.

Conjugate compounds and their use in cancer treatment and diagnosis

Номер патента: WO2024133780A1. Автор: Ali Azhdarinia,Wolfgang Weber,Susanne KOSSATZ,Sukhen C. Ghosh,Beatrice Stefanie LUDWIG,Lena KOLLER. Владелец: The Board of Regents of the University of Texas System. Дата публикации: 2024-06-27.

The use of angiotensin i derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders

Номер патента: EP1406648A1. Автор: Meng Kwoon Sim. Владелец: NATIONAL UNIVERSITY OF SINGAPORE. Дата публикации: 2004-04-14.

A mycobacterium for use in cancer therapy

Номер патента: US20240216443A1. Автор: Glen Martyn,Andrew GAYA,Casper Henricus Johannes VAN EIJCK. Владелец: Immodulon Therapeutics Ltd. Дата публикации: 2024-07-04.

Probiotic for the treatment of infertility and recurrent pregnancy loss

Номер патента: CA3179833A1. Автор: Rebeca Arroyo Rodriguez,Leonides Fernandez Alvarez,Juan Miguel Rodriguez Gomez,Irma CASTRO NAVARRO,Claudio ALBA RUBIO. Владелец: Individual. Дата публикации: 2021-12-16.

Probiotic for the treatment of infertility and recurrent pregnancy loss

Номер патента: EP4166151A1. Автор: Rebeca Arroyo Rodriguez,Leonides Fernandez Alvarez,Juan Miguel Rodriguez Gomez,Irma CASTRO NAVARRO,Claudio ALBA RUBIO. Владелец: Biosearch SA. Дата публикации: 2023-04-19.

Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos)

Номер патента: EP4400119A2. Автор: Gerhard Börner,Oliver Denk,Aldo Iacono. Владелец: BREATH THERAPEUTICS GMBH. Дата публикации: 2024-07-17.

Compositions comprising lactobacillus paracasei and hyaluronic acid and use thereof for the treatment of the skin

Номер патента: CA3142566A1. Автор: Andrea BIFFI. Владелец: Lac2biome Srl. Дата публикации: 2020-12-10.

Ngf isoform for use in the treatment of ocular pathologies

Номер патента: AU2022216840A9. Автор: Andrea Aramini,Marcello Allegretti,Anna SIRICO,Gaetano D'Anniballe,Flavio MANTELLI,Pier GIORGIO AMENDOLA,Franca Cattani. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2024-07-11.

Preparation comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals

Номер патента: US20060121094A1. Автор: Mark Geach. Владелец: Individual. Дата публикации: 2006-06-08.

Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease

Номер патента: US20160243193A1. Автор: Aprile L Clayton-Pilon. Владелец: Therabron Therapeutics Inc. Дата публикации: 2016-08-25.

Peptides containing a pcna interacting motif for use in the treatment of solid cancer

Номер патента: CA3177156A1. Автор: Konstantinos Alevizopoulos,Marit Otterlei. Владелец: Therapim Pty Ltd. Дата публикации: 2021-11-11.

Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos)

Номер патента: CA3094891A1. Автор: Gerhard Börner,Oliver Denk,Aldo Iacono. Владелец: BREATH THERAPEUTICS GMBH. Дата публикации: 2019-10-17.

Probiotics for aggregation with disease-associated species in the oral cavity

Номер патента: AU2018209166B2. Автор: William Wade,Marcus Rudolf Gotz,Kerstin Holmgren,Niklas Larsson,Bernd FIEBICH. Владелец: PROBI AB. Дата публикации: 2024-07-18.

Probiotics for aggregation with disease-associated species in the oral cavity

Номер патента: EP3570858A1. Автор: William Wade,Marcus Rudolf Gotz,Kerstin Holmgren,Niklas Larsson,Bernd FIEBICH. Владелец: PROBI AB. Дата публикации: 2019-11-27.

Probiotics for aggregation with disease-associated species in the oral cavity

Номер патента: US20190365833A1. Автор: William Wade,Marcus Rudolf Gotz,Kerstin Holmgren,Niklas Larsson,Bernd FIEBICH. Владелец: PROBI AB. Дата публикации: 2019-12-05.

Peptides containing a PCNA interacting motif for use in the treatment of solid cancer

Номер патента: AU2021268075A1. Автор: Konstantinos Alevizopoulos,Marit Otterlei. Владелец: Therapim Pty Ltd. Дата публикации: 2022-12-08.

Peptides containing a pcna interacting motif for use in the treatment of solid cancer

Номер патента: EP4146239A1. Автор: Konstantinos Alevizopoulos,Marit Otterlei. Владелец: Therapim Pty Ltd. Дата публикации: 2023-03-15.

Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos)

Номер патента: EP4400119A3. Автор: Gerhard Börner,Oliver Denk,Aldo Iacono. Владелец: BREATH THERAPEUTICS GMBH. Дата публикации: 2024-09-25.

Use of akkermansia in the treatment of oral diseases

Номер патента: US20240293475A1. Автор: Salomon Amar,Willem M. deVOS. Владелец: Individual. Дата публикации: 2024-09-05.

Alpha1-antitrypsin for use in the treatment of diseases or disorders of the nervous system such as chronic inflammatory demyelinating polyneuropathy

Номер патента: AU2023287493A1. Автор: Nikolay ZHUKOVSKY. Владелец: Ageronix SA. Дата публикации: 2024-10-17.

Oral care compositions with phosphopeptides for use against dental hypersensitivity and/or xerostomia

Номер патента: US20240325275A1. Автор: Richard Willson. Владелец: Dentherapy Ltd. Дата публикации: 2024-10-03.

Composition comprising probiotic bacteria for use in the treatment of immune disorders

Номер патента: US09931363B2. Автор: Gian Paolo Strozzi,Luca Mogna,Giovanni Mogna,Lorenzo Drago. Владелец: Probiotical SpA. Дата публикации: 2018-04-03.

Composition comprising at least one alginate for use in treatment and/or prevention of overweight

Номер патента: US09597350B2. Автор: Finn Larsen,Brian Malm,Jens Steen Olsen. Владелец: S-BIOTEK AF 15 MARTS 2006 1 APS. Дата публикации: 2017-03-21.

Composition comprising probiotic bacteria for use in the treatment of immune disorders

Номер патента: US09498503B2. Автор: Gian Paolo Strozzi,Luca Mogna,Giovanni Mogna,Lorenzo Drago. Владелец: Probiotical SpA. Дата публикации: 2016-11-22.

Immunotherapeutic agent for the treatment of prostate cancer comprising 3 prostate cell lines one derived from normal tissue and two from tumor tissue

Номер патента: NZ512004A. Автор: Andrew Derek Sutton,Angus George Dalgleish,Peter Michael Smith,Anthony Ian Walker. Владелец: Onyvax Ltd. Дата публикации: 2003-08-29.

Modified colloidal particles for use in the treatment of haemophilia a

Номер патента: EP4387595A1. Автор: Richard Wolf-Garraway,Edward Tuddenham. Владелец: Cantab Biopharmaceuticals Patents Ltd. Дата публикации: 2024-06-26.

Modified colloidal particles for use in the treatment of Haemophilia A

Номер патента: GB2625007A. Автор: Wolf-Garraway Richard. Владелец: Cantab Biopharmaceuticals Patents Ltd. Дата публикации: 2024-06-05.

Compositions for use in the treatment of insulin deficiency conditions

Номер патента: CA3143388A1. Автор: Roberto COPPARI,Giorgio RAMADORI,Despoina MIKROPOULOU. Владелец: UNIVERSITE DE GENEVE. Дата публикации: 2020-12-30.

Pharmaceutical composition for use in the treatment or prevention of vitamin deficiency and mineral deficiency in patients who have been subjected to gastric sleeve surgery

Номер патента: EP3658159A1. Автор: Sjoerd Arie Pieter VAN BERKEL. Владелец: Ams Advanced Medical Supplements BV. Дата публикации: 2020-06-03.

Bacterial strains of the Lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tract

Номер патента: US12036254B2. Автор: Andrea BIFFI. Владелец: Lac2biome Srl. Дата публикации: 2024-07-16.

Modified colloidal particles for use in the treatment of haemophilia a

Номер патента: CA3227245A1. Автор: Richard Wolf-Garraway. Владелец: Cantab Biopharmaceuticals Patents Ltd. Дата публикации: 2023-02-23.

Modified colloidal particles for use in the treatment of haemophilia a

Номер патента: CA3227154A1. Автор: Richard Wolf-Garraway,Edward Tuddenham. Владелец: Cantab Biopharmaceuticals Patents Ltd. Дата публикации: 2023-02-23.

Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status

Номер патента: US09894894B2. Автор: Waleed Hassanein,Tamer Khayal,Paul Lezberg,Ahmed Elbetanony,Giovanni Cecere,Dennis Sousa,Elizabeth Hansen. Владелец: TransMedics Inc. Дата публикации: 2018-02-20.

Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status

Номер патента: US12010987B2. Автор: Waleed H. Hassanein,Paul Lezberg,Tamer I. Khayal,Ahmed Elbetanony,Giovanni Cecere,Dennis Sousa,Elizabeth Hansen Bulger. Владелец: TransMedics Inc. Дата публикации: 2024-06-18.

Method for the treatment of chronic periodontitis using the technology of transcanal laser non-pigment photoablation

Номер патента: RU2753794C1. Автор: Эрнест Арамович Базикян,Андрей Анатольевич Чунихин,Никита Андреевич Чунихин. Владелец: Никита Андреевич Чунихин. Дата публикации: 2021-08-23.

Method for using guaranteed tidal volume in newborns with severe respiratory pathology, manifested by respiratory failure of ii-iii severity

Номер патента: RU2750841C1. Автор: Айнагуль Жолдошевна Баялиева,Анна Анатольевна Бабинцева,Ильдар Мизахатович Зиганшин. Владелец: Ильдар Мизахатович Зиганшин. Дата публикации: 2021-07-05.

Adjustable locking forceps device for the treatment of anterior epistaxis and method of use

Номер патента: US20160220251A1. Автор: John Gozar. Владелец: Rhinovice LLC. Дата публикации: 2016-08-04.

Methods and systems for engineering power spectral features from biophysical signals for use in characterizing physiological systems

Номер патента: EP4391889A1. Автор: Farhad FATHIEH. Владелец: Analytics 4 Life Inc. Дата публикации: 2024-07-03.

Methods and systems for engineering photoplethysmographic-waveform features from biophysical signals for use in characterizing physiological systems

Номер патента: EP4391892A1. Автор: Farhad FATHIEH,Emmanuel LANGE. Владелец: Analytics 4 Life Inc. Дата публикации: 2024-07-03.

Device for use in the treatment of haemorrhoids

Номер патента: AU2018349792B2. Автор: Johan UNGERSTEDT. Владелец: Dev Ab. Дата публикации: 2023-12-21.

Arrangement comprising medical treatment units and peripheral devices as well as a peripheral device and treatment unit for use in such an arrangement

Номер патента: US09878081B2. Автор: Wei Zhang,Carsten Müller,Elke Schulte,Claus Leiendecker. Владелец: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH. Дата публикации: 2018-01-30.

Mobile interface cart for use in a dialysis system

Номер патента: US20240226398A9. Автор: Kenneth Nelson,Juliet HILDRETH,Steven Michael Schmitt. Владелец: Fresenius Medical Care Holdings Inc. Дата публикации: 2024-07-11.

Methods and systems for engineering respiration rate-related features from biophysical signals for use in characterizing physiological systems

Номер патента: EP4391890A1. Автор: Farhad FATHIEH,Mehdi PAAK,Timothy William Fawcett Burton. Владелец: Analytics 4 Life Inc. Дата публикации: 2024-07-03.

Method and system for engineering cycle variability-related features from biophysical signals for use in characterizing physiological systems

Номер патента: EP4266986A1. Автор: Farhad FATHIEH,Timothy William Fawcett Burton. Владелец: Analytics 4 Life Inc. Дата публикации: 2023-11-01.

Methods and systems for engineering cardiac waveform features from biophysical signals for use in characterizing physiological systems

Номер патента: EP4391893A1. Автор: Farhad FATHIEH,Emmanuel LANGE. Владелец: Analytics 4 Life Inc. Дата публикации: 2024-07-03.

Methods and systems for engineering visual features from biophysical signals for use in characterizing physiological systems

Номер патента: EP4391888A1. Автор: Abhinav DOOMRA. Владелец: Analytics 4 Life Inc. Дата публикации: 2024-07-03.

Auxiliary diagnostic method for use in the treatment of irritable bowel syndrome using corrective diet or fecal microbiota transplantation

Номер патента: RU2762266C1. Автор: Финн Терье ХЕГГЕ,Кристина КАСЕН,Йёрген ВАЛЁР,Арне РЁСЕТ,Милада Чванчарова СМОСТУЭН. Владелец: Дженетик Аналайзис Ас. Дата публикации: 2021-12-17.

Organophosphorus containing composites for use in well treatment operations

Номер патента: RU2676341C2. Автор: Терри Д. МОНРО,Наима БЕСТАОУИ-СПАРР,Сумит БХАДУРИ,Ци ЦУ,Брайан Б. БИЛЛ,Кимберли ЛАНТ,Хоан ЛЭ. Владелец: Бейкер Хьюз Инкорпорейтед. Дата публикации: 2018-12-28.

Oligonucleotides for use in the treatment of dystrophic epidermolysis bullosa

Номер патента: CA3131934A1. Автор: Elisabeth Marlene Haisma,Jim SWILDENS. Владелец: Phoenicis Therapeutics Inc. Дата публикации: 2020-09-03.

Oligonucleotides for use in the treatment of dystrophic epidermolysis bullosa

Номер патента: EP3931327A1. Автор: Elisabeth Marlene Haisma,Jim SWILDENS. Владелец: Phoenicis Therapeutics Inc. Дата публикации: 2022-01-05.

Oligonucleotides for use in the treatment of dystrophic epidermolysis bullosa

Номер патента: WO2020176904A1. Автор: Elisabeth Marlene Haisma,Jim SWILDENS. Владелец: Wings Therapeutics, Inc.. Дата публикации: 2020-09-03.

Crispr-pe system for retinol dehydrogenase 12 (rdh12) gene mutations for use in the treatment of retinitis pigmentosa (rp) disease

Номер патента: WO2023129095A1. Автор: Gorkem AKGUL,Ali Dostcan AKYAR,Batuhan YOLVER,Cihan TASTAN. Владелец: T.C. Uskudar Universitesi. Дата публикации: 2023-07-06.

Method of identifying rna of influenza viruses a and b with simultaneous determination of variants of hemagglutinin and neuraminidase of influenza virus a, identification of genetic markers of pathogenicity and resistance to influenza preparations on biological microchips, biochip, set of oligonucleotide probes, used in method

Номер патента: RU2603000C1. Автор: Олег Иванович Киселев,Александр Сергеевич Заседателев,Евгений Евгеньевич Фесенко,Екатерина Игоревна Дементьева,Владимир Михайлович Михайлович,Борис Леонидович Шаскольский,Рустам Нураддин оглы Гейдаров. Владелец: Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран). Дата публикации: 2016-11-20.

Method for producing polymer scaling inhibitor for water recycling systems

Номер патента: RU2752736C1. Автор: Семен Дмитриевич Камагуров,Максим Сергеевич Ощепков,Константин Иванович Попов,Ольга Владимировна Гусева,Сергей Витальевич Ткаченко. Владелец: Акционерное общество Научный центр "Малотоннажная химия". Дата публикации: 2021-07-30.

Treating agent for use in formation of chromium-free insulating coating film, and oriented electromagnetic steel sheet having insulating coating film attached thereto and method for manufacturing same

Номер патента: EP3808872A1. Автор: Toshito Takamiya,Takashi Terashima,Karin Kokufu. Владелец: JFE Steel Corp. Дата публикации: 2021-04-21.

Treatment fluids containing a relative permeability modifier and a companion polymer interacting synergistically therewith and methods for use thereof

Номер патента: EP2694614A1. Автор: Bairreddy Raghava Reddy,Larry Steven Eoff,Jeff W. LOUCKS. Владелец: Halliburton Energy Services Inc. Дата публикации: 2014-02-12.

Treatment fluids for use in removing acid-soluble materials in subterranean formations

Номер патента: US09745506B2. Автор: Enrique Antonio REYES,Aaron M. BEUTERBAUGH,Alyssa Lynn Lablanc. Владелец: Halliburton Energy Services Inc. Дата публикации: 2017-08-29.

Treatment fluids containing a hydrophobically modified chelating agent and methods for use thereof

Номер патента: US09556377B2. Автор: Enrique Antonio REYES,Aaron Michael BEUTERBAUGH,Alyssa Lynn SMITH. Владелец: Halliburton Energy Services Inc. Дата публикации: 2017-01-31.

Treatment fluids containing a relative permeability modifier and a companion polymer interacting synergistically therewith and methods for use thereof

Номер патента: US09546314B2. Автор: B. Raghava Reddy,Larry S. Eoff,Jeff W. LOUCKS. Владелец: Halliburton Energy Services Inc. Дата публикации: 2017-01-17.

Treatment fluids comprising a silicate complexing agent and methods for use thereof

Номер патента: WO2013154710A1. Автор: Enrique A. Reyes,Alyssa Smith. Владелец: Halliburton Energy Services, Inc.. Дата публикации: 2013-10-17.

Oligonucleotides for use in the treatment of dystrophic epidermolysis bullosa

Номер патента: AU2020227147A1. Автор: Elisabeth Marlene Haisma,Jim SWILDENS. Владелец: Phoenicis Therapeutics Inc. Дата публикации: 2021-09-30.

Precision therapy for the treatment of cancer

Номер патента: WO2023166345A2. Автор: Michele MOSCHETTA. Владелец: NOVARTIS AG. Дата публикации: 2023-09-07.

Invert emulsion treatment fluids comprising polar organic compounds and methods of use in subterranean operations

Номер патента: US20170369760A1. Автор: Dale E. Jamison,William Walter Shumway,Jay Paul Deville,Kenneth William Pober. Владелец: Halliburton Energy Services Inc. Дата публикации: 2017-12-28.

Precision therapy for the treatment of cancer

Номер патента: AU2023227427A1. Автор: Michele MOSCHETTA. Владелец: NOVARTIS AG. Дата публикации: 2024-09-19.

Magnetic proppant particulates for use in subterranean formation operations

Номер патента: US09840902B2. Автор: Philip D. Nguyen. Владелец: Halliburton Energy Services Inc. Дата публикации: 2017-12-12.

Treatment fluids containing a perfluorinated chelating agent and methods for use thereof

Номер патента: US09447314B2. Автор: Enrique Antonio REYES,Aaron Michael BEUTERBAUGH,Alyssa Lynn SMITH. Владелец: Halliburton Energy Services Inc. Дата публикации: 2016-09-20.

Gas distribution plate for use in devices for the treatment of solid particles

Номер патента: DK2475456T3. Автор: Dusan Teslic. Владелец: Brinox D O O. Дата публикации: 2015-07-20.

Tunnelling machine, device for alignment of segments of lining of tunnel relative to each other, used in tunnelling machine, and method of control thereof

Номер патента: RU2716630C2. Автор: Юнлян ЧЭН,Фэйсян ЛЮ,Чжэнян ПЭН,Дацяо Чжэн,Ципин Хэ,Цзяньли Ло,Цзинь ЖУН. Владелец: Чайна Рейлвей Констракшн Хэви Индастри Ко., Лтд.. Дата публикации: 2020-03-13.

Methods and Systems for Coherent Imaging and Feedback Control for Modification of Materials Using Dynamic Optical Path Switch in the Reference Arms

Номер патента: US20240189938A1. Автор: Victor X.D. Yang,James M. Fraser,Paul J.L. Webster. Владелец: IPG Photonics Corp. Дата публикации: 2024-06-13.

In-the-ear hearing aid with directional microphone system

Номер патента: US5757933A. Автор: Mark A. Bren,Timothy S. Peterson,David A. Preves. Владелец: Micro Ear Technology Inc. Дата публикации: 1998-05-26.

Process for preparing catalysts which can be used in particular for the treatment of oils

Номер патента: FR1221410A. Автор: . Владелец: Gulf Research and Development Co. Дата публикации: 1960-06-01.

In-the-ear hearing aid with directional microphone system

Номер патента: CA2223676C. Автор: Mark A. Bren,Timothy S. Peterson,David A. Preves. Владелец: Micro Ear Technology. Дата публикации: 2004-11-23.

METHODS FOR USING KUKHAREV REGIONS IN THE ATMOSPHERE, IN SPACE, AND AT THE LEVEL OF THE EARTH'S SURFACE TO OBTAIN ANTIMATTER

Номер патента: US20220139589A1. Автор: KUKHAREV Vadim. Владелец: . Дата публикации: 2022-05-05.

NEW DEVICE FOR USING THE WHEEL IN THE TRANSPORT OF PEOPLE AND GOODS BY DELETING THE HUBS, AXLES AND AXLES, DIRECT SUPPORT ON THE RIM AND APPLICATIONS THEREFROM

Номер патента: FR2803263B1. Автор: Marcel Felix Codur. Владелец: Marcel Felix Codur. Дата публикации: 2004-02-27.

METHOD FOR USING THE ENERGY IN THE SURFACE WAVES IN A LIQUID BODY, SUCH AS WAVES ON THE SURFACE OF AN OCEAN, AND APPARATUS FOR APPLYING THIS PROCESS

Номер патента: NL8320232A. Автор: . Владелец: Hertz Kristian Dahl. Дата публикации: 1984-07-02.

ILLUMINATION DEVICE AND METHOD FOR USING THE SAME IN THE PROJECTION LITHOGRAPHY MACHINE

Номер патента: US20160109806A1. Автор: Wang Ying,Chen Mingxing,ZENG Aijun,HUANG Huijie,ZHANG Yunbo. Владелец: . Дата публикации: 2016-04-21.

Hydraulic device for using the difference in the levels of a liquid

Номер патента: FR68546E. Автор: . Владелец: Societe des Forges et Ateliers du Creusot. Дата публикации: 1958-05-02.

Reagent and method for using the same in the automatic flow cytometric determination of at least one leukocyte subpopulation from whole blood.

Номер патента: DE69016377T2. Автор: Didier Lefevre Didier Lefevre,Henri Champseix Henr Champseix,Nadine Voltas Nadine Voltas. Владелец: ABX SA. Дата публикации: 1995-05-24.

Hydraulic device for using the difference in the levels of a liquid

Номер патента: FR1125529A. Автор: . Владелец: Societe des Forges et Ateliers du Creusot. Дата публикации: 1956-10-31.

Hydraulic device for using the difference in the levels of a liquid

Номер патента: FR68848E. Автор: . Владелец: Societe des Forges et Ateliers du Creusot. Дата публикации: 1958-06-10.

System and method for using an analogy in the management of personal finances

Номер патента: US20120246045A1. Автор: David Hirsch. Владелец: Fantasy Finance Ventures LLC. Дата публикации: 2012-09-27.

Material comprising ultrafine metals and metal oxide particles and their preparation for use as catalysts in the hydrogenation of olefins or in coupling reactions

Номер патента: FR2784605A1. Автор: Olivier Tillement,Jean Marie Dubois,Yves Fort. Владелец: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS. Дата публикации: 2000-04-21.

REINFORCEMENT FOR USEFUL PROFILES, ESPECIALLY IN THE AUTOMOTIVE INDUSTRY.

Номер патента: FR2661972A1. Автор: Frappier Alain. Владелец: HUTCHINSON SA. Дата публикации: 1991-11-15.

A method and apparatus for using an enzyme in the manufacture and bleaching of pulp

Номер патента: FI108800B. Автор: Brian Foody,Jeffrey Tolan. Владелец: Iogen Corp. Дата публикации: 2002-03-28.

METHOD AND DEVICE FOR USING AUXILIARY DATA IN THE CONTEXT OF A SATELLITE POSITIONING DETERMINATION SYSTEM

Номер патента: DE60142334D1. Автор: Leonid Sheynblat. Владелец: Qualcomm Inc. Дата публикации: 2010-07-22.

Method And Apparatus For Using RFID's In The Investigation Of Motor Vehicle Accidents

Номер патента: US20060006982A1. Автор: Rodney Gunsauley. Владелец: Gunsauley Rodney M. Дата публикации: 2006-01-12.

Device with expandable tubular component and method for using this device in the well

Номер патента: RU2225497C2. Автор: Л. МкД ЩЕТКИ,Крейг Д. ДЖОНСОН,Мэтью Р. ХАКУОРТ,Патрик В. БИКСЕНМАН,Л. МкД ЩЕТКИ (US),Крейг Д. ДЖОНСОН (US),Мэтью Р. ХАКУОРТ (US),Патрик В. БИКСЕНМАН (US). Владелец: Шлюмбергер Текнолоджи Б.В.. Дата публикации: 2004-03-10.

Methods of resistance welding for use, for example, in the manufacture of electronicassemblies

Номер патента: US3231710A. Автор: Barnet Peter Alan,Vickers Victor Eric. Владелец: General Electric Co PLC. Дата публикации: 1966-01-25.

Method for identifying a compound useful in mitigating and/or the treatment of a disease associated with abnormal astrocytic function

Номер патента: US20180284101A1. Автор: Tomaz Mark ZOREC. Владелец: Celica Biomedical. Дата публикации: 2018-10-04.

Method for identifying a compound useful in mitigating and/or the treatment of a disease associated with abnormal astrocytic function

Номер патента: WO2017060367A1. Автор: Tomaz M. ZOREC. Владелец: Celica Biomedical. Дата публикации: 2017-04-13.

Method for identifying a compound useful in mitigating and/or the treatment of a disease associated with abnormal astrocytic function

Номер патента: EP3341731A1. Автор: Toma M. ZOREC. Владелец: Celica Biomedical. Дата публикации: 2018-07-04.

Method for identifying a compound useful in mitigating and/or the treatment of a disease associated with abnormal astrocytic function

Номер патента: US11231410B2. Автор: Toma{hacek over (z)} Mark Zorec. Владелец: Celica Biomedical. Дата публикации: 2022-01-25.

Screening assays for compounds for use in the treatment of stress-related disorders

Номер патента: WO2013083851A1. Автор: Theo Rein,Nicole Zimmermann,Florian Holsboer,Jürgen ZSCHOCKE. Владелец: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.. Дата публикации: 2013-06-13.

Treatment articles and method for using treatment articles

Номер патента: US12054883B1. Автор: Anthony CASCIO,Christopher M. Lonvick,Melissa North,Mack BRINDLE,Christina Maria HOOKER,Dennes Ozuna. Владелец: Aladdin Manufacturing Corp. Дата публикации: 2024-08-06.

An insert for use in an apparatus for the treatment of compressed gas

Номер патента: EP3277400A1. Автор: Pearson John,BILLIET Colin. Владелец: Norgren Ltd. Дата публикации: 2018-02-07.

Baffle for use with a treatment machine

Номер патента: US20220259790A1. Автор: Joseph MATTLEY,Thomas Andrew COBB,Gareth Evan Lyn JONES,Liam ROBERTS. Владелец: Xeros LTD. Дата публикации: 2022-08-18.

Improved Terminal Holders or Connectors for Wires or Rods, for use, for example, in the Brake-operating Mechanism of Cycles and like Vehicles.

Номер патента: GB190722929A. Автор: John Thomas. Владелец: Individual. Дата публикации: 1908-10-15.

Improved Method of, and Apparatus for use in connection with, the Treatment of Sewage.

Номер патента: GB190721566A. Автор: . Владелец: OXYCHLORIDES 1907 Ltd. Дата публикации: 1908-09-24.

Automatic Distributing and Alternating Apparatus for use with Bacteria Beds for the Treatment of Sewage and other Liquids

Номер патента: GB190210571A. Автор: William Lloyd Roach. Владелец: Individual. Дата публикации: 1902-07-31.

ROTOR ASSEMBLY FOR USE IN GAS TURBINE ENGINES AND METHOD FOR ASSEMBLING THE SAME

Номер патента: US20120003091A1. Автор: Segovia Eugenio Yegro. Владелец: . Дата публикации: 2012-01-05.

Improvements in Materials for use as Stuffing in the Manufacture of Bedding, Cushions and the like, including Stuffed Coverlets or Quilts.

Номер патента: GB190225080A. Автор: Francis Thomas Bond. Владелец: Individual. Дата публикации: 1903-09-24.

Radiant heater suitable for use outdoors

Номер патента: AU201611089S. Автор: . Владелец: ALVER Pty Ltd. Дата публикации: 2016-05-04.

Radiant heater suitable for use outdoors

Номер патента: AU201611088S. Автор: . Владелец: ALVER Pty Ltd. Дата публикации: 2016-05-04.

The method of preparation of the inhibitor for hydrochloric acid, used in the treatment of the bottom of a borehole

Номер патента: SU140012A1. Автор: А.Д. Столяров,ров А.Д. Стол,М.А. Гейман. Владелец: М.А. Гейман. Дата публикации: 1961-11-30.

Oral solid dosage form with mycophenolic acid or its salt for use as an immunosuppressant for the treatment or prevention of organ or tissue transplant rejection and method thereof

Номер патента: RU2018106124A. Автор: Елена Сергеевна Хазанова,Сергей Юрьевич Ногай,Евгения Александровна Филиппова. Владелец: Общество с ограниченной ответственностью "Изварино Фарма". Дата публикации: 2019-08-20.

Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Номер патента: AU2007200367A1. Автор: Norman Eugene Cameron,Mary Anne Cotter. Владелец: University of Aberdeen. Дата публикации: 2007-02-22.

Improvements in Apparatus for Use in connection with the Treatment of Sewage and Impure Waters.

Номер патента: GB189414868A. Автор: Frank Pullen Candy. Владелец: Individual. Дата публикации: 1895-07-06.

Improvements in Materials for use as Stuffing in the Manufacture of Bedding, Cushions and the like, including Stuffed Coverlets or Quilts.

Номер патента: GB190203771A. Автор: Francis Thomas Bond. Владелец: Individual. Дата публикации: 1903-01-01.

Improved Preparations for Use as Precipitants in the Treatment of Sewage and other Polluted Water.

Номер патента: GB189614124A. Автор: Frank Candy,Arthur Angell. Владелец: Individual. Дата публикации: 1897-05-15.

Improvements in or relating to the modulation of a beam of light for use for example in the recording of sound or in the reproduciton of recorded sound

Номер патента: AU2822430B. Автор: Arthur Ashton William. Владелец: Nominee Of. Дата публикации: 1931-08-13.

Improvements in or relating to the modulation of a beam of light for use for example in the recording of sound or in the reproduciton of recorded sound

Номер патента: AU2822430A. Автор: Arthur Ashton William. Владелец: Nominee Of. Дата публикации: 1931-08-13.

WORKING PROCESS AND METHOD FOR USING WATER STEAM IN THE WORK OF THE VORONTSOV ENGINE

Номер патента: RU2011114465A. Автор: Олег Ильич Воронцов,Олег Ильич Воронцов (RU). Владелец: Воронцов Сергей Олегович (RU). Дата публикации: 2012-10-20.

Improvements in the Manufacture of Metal Rods and Bars, applicable for Use as or in the Formation of Twist Drills and other like Cutting Tools, Palisading, Railings, and other Articles.

Номер патента: GB189523301A. Автор: William Lockwood. Владелец: Individual. Дата публикации: 1896-12-05.

Improvements in the Production of Armor and like Compound Plates and in Apparatus therefor.

Номер патента: GB189905501A. Автор: Owen Franklin Leibert. Владелец: Individual. Дата публикации: 1899-06-17.

New pyrazolopyridine derivatives are p38 kinase inhibitors useful in medicaments for the treatment or prevention of e.g. cardiovascular diseases, neurodegenerative diseases and proliferative diseases

Номер патента: ES2214150A1. Автор: Marina VIRGILI BERNADÓ,Carmen Almansa Rosales. Владелец: J Uriach y Cia SA. Дата публикации: 2004-09-01.

Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Номер патента: AU2007200367B2. Автор: Norman Eugene Cameron,Mary Anne Cotter. Владелец: University of Aberdeen. Дата публикации: 2010-04-08.

SYSTEM AND METHOD FOR USING AN ANALOGY IN THE MANAGEMENT OF ASSETS

Номер патента: US20120246046A1. Автор: . Владелец: FANTASY FINANCE VENTURES, LLC. Дата публикации: 2012-09-27.

Security Architecture For Using Host Memory in the Design of A Secure Element

Номер патента: US20120297204A1. Автор: . Владелец: BROADCOM CORPORATION. Дата публикации: 2012-11-22.

APPARATUS AND METHODS FOR USING RECYCLED MATERIAL IN THE FABRICATION OF PRECAST ARCHITECTURAL PRODUCTS

Номер патента: US20130276406A1. Автор: Coate Mark. Владелец: PRESTIGE ARCHITECTURAL PRODUCTS. Дата публикации: 2013-10-24.

4,6,6,6-TETRAHALOGENCARBOXYLIC ACID ESTERS FOR USE AS INTERMEDIATE IN THE PREPARATION OF ESTERS OF DIHALOGENVINYL-CYCLOPROPANCARBOXYL ACIDS

Номер патента: NO148414C. Автор: Kiyoshi Kondo,Kiyohide Matsui,Akira Negishi,Yuriko Takahatake. Владелец: Sagami Chem Res. Дата публикации: 1983-10-05.

PANELS FOR USE WITH FORMWORKS IN THE CONSTRUCTION OF TABIQUES AND Slabs

Номер патента: AR107400A1. Автор: . Владелец: Gutierrez Eduardo Ramon. Дата публикации: 2018-04-25.

METHODS AND KITS USED IN IDENTIFYING GLIOBLASTOMA

Номер патента: US20120003209A1. Автор: . Владелец: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE. Дата публикации: 2012-01-05.

ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES IN TREATMENT OF ALS AND OTHER GDF-8 ASSOCIATED DISORDERS

Номер патента: US20120003212A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS

Номер патента: US20120003227A1. Автор: SUKHATME VIKAS P.,CHAN CHUNKONG BARDEN. Владелец: . Дата публикации: 2012-01-05.

Novel composition and methods for the treatment of psoriasis

Номер патента: US20120003246A1. Автор: . Владелец: . Дата публикации: 2012-01-05.

CB2 RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN

Номер патента: US20120004222A1. Автор: Wu Zhicai,Green Ahren I.,Hartnett Jonh C.. Владелец: . Дата публикации: 2012-01-05.

Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors

Номер патента: US20120004228A1. Автор: . Владелец: BIOLIPOX AB. Дата публикации: 2012-01-05.

Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors

Номер патента: US20120004244A1. Автор: NILSSON Peter,Pelcman Benjamin,Katkevics Martins. Владелец: BIOLIPOX AB. Дата публикации: 2012-01-05.

COMPOUNDS FOR THE TREATMENT OF POSTERIOR SEGMENT DISORDERS AND DISEASES

Номер патента: US20120004245A1. Автор: . Владелец: Alcon Research, Ltd.. Дата публикации: 2012-01-05.

OTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS OF THE INTERNAL AND EXTERNAL EAR IN MAMMALS

Номер патента: US20120003174A1. Автор: . Владелец: FORESIGHT BIOTHERAPEUTICS, INC.. Дата публикации: 2012-01-05.

AUTOANTIBODIES IN THE DETECTION AND TREATMENT OF CANCER

Номер патента: US20120003225A1. Автор: JR. Edward F.,Patz,Campa Michael J.,Gottlin Elizabeth B.. Владелец: Duke University. Дата публикации: 2012-01-05.

Compositions and Methods for the Treatment of Ophthalmic Disease

Номер патента: US20120003275A1. Автор: Donello John E.,Schweighoffer Fabien J.,Rodrigues Gerard A.,McLaughlin Anne P.,Mahé Florence. Владелец: . Дата публикации: 2012-01-05.

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

Номер патента: US20120004202A1. Автор: KLEY Joerg,ROTH Gerald Juergen,LEHMANN-LINTZ Thorsten,Park John Edward,Heckel Armin,CHAUDHARY Nveed. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2012-01-05.

Tapentadol for use in the treatment of irritable bowel syndrome

Номер патента: US20120004317A1. Автор: . Владелец: GRUENENTHAL GmbH. Дата публикации: 2012-01-05.

Catheter for Use in Revascularization Procedures and Method of Using Same

Номер патента: US20120004596A1. Автор: Thomas Jeffrey E.. Владелец: Neurodynamics, LLC. Дата публикации: 2012-01-05.

PREPARATION OF A SOLID BASED ON ZINC OXIDE FOR USE IN PURIFYING A GAS OR A LIQUID

Номер патента: US20120000855A1. Автор: Bazer-Bachi Delphine,Chiche David,Lopez Joseph,Lelias Marc. Владелец: IFP ENERGIES NOUVELLES. Дата публикации: 2012-01-05.

Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

Номер патента: US20120004312A1. Автор: Hewitt William,Vasella Daniel Lucius,Webb Randy Lee. Владелец: . Дата публикации: 2012-01-05.

COMPOSITIONS AND METHODS FOR USING NADH OXIDASES

Номер патента: US20120003688A1. Автор: Bommarius Bettina,Bommarius Andreas,Hirano Jun-Ichiro,Thangavel Vaijayanthi,Park Jonathan Taejoo. Владелец: GEORGIA TECH RESEARCH CORPORATION. Дата публикации: 2012-01-05.

Improvements in the Treatment of Mixed Sulphide Ores containing Lead and Zinc.

Номер патента: GB190002089A. Автор: George Edward Davis,Alfred Roland Davis. Владелец: Individual. Дата публикации: 1900-10-31.

Improvements in or relating to the treatment of textile and other materials

Номер патента: GB406686A. Автор: . Владелец: British Celanese Ltd. Дата публикации: 1934-02-27.

Improvements in the Manufacture or Treatment of Printed Yarns for use in Making Tapestry, Tapestry Velvet Carpets, Table Covers and similar Printed Fabrics and in Apparatus Employed in the said Manufacture or Treatment.

Номер патента: GB190410767A. Автор: James William Anderson,Alexander Fodd Inverarity. Владелец: Individual. Дата публикации: 1905-02-23.

Improvements in the Treatment of Coal Gas, or other Gases, containing Cyanogen, for the Obtainment of Soluble Cyanides therefrom, and the Preparation of Materials for use in such Treatment.

Номер патента: GB190210876A. Автор: Walther Feld. Владелец: Individual. Дата публикации: 1903-04-30.

Combination of antibodies, or antigen-binding fragments thereof, for the treatment of cancer and composition thereof

Номер патента: WO2024194490A1. Автор: Firas Bassissi,Bernard Vanhove,Odile DUVAUX,Carine CIRON. Владелец: XENOTHERA. Дата публикации: 2024-09-26.

Polymorph forms of aticaprant for use in treating major depressive disorder

Номер патента: AU2023232536A1. Автор: Mark Schmidt,Philippe Fernandes,Srihari Gopal,Wayne C. Drevets,Adam Savitz,Vanina Popova,Rama Melkote,Darrel Pemberton,Chakradhar Lagishetty,Iva Kezic. Владелец: Janssen Pharmaceuticals Inc. Дата публикации: 2024-10-24.

Treatment fluid for wells drilled in oil mud, in the form of a delayed effect water-in-oil emulsion

Номер патента: US20120000657A1. Автор: Dalmazzone Christine,Audibert-Hayet Annie. Владелец: . Дата публикации: 2012-01-05.

USE OF LACTULOSE IN THE TREATMENT OF AUTISM

Номер патента: US20120004192A1. Автор: . Владелец: Curemark LLC. Дата публикации: 2012-01-05.

TRIAZOLO AND TETRAZOLO PYRIMIDINE DERIVATIVES AS HNE INHIBITORS FOR TREATING COPD

Номер патента: US20120004203A1. Автор: MEIBOM Daniel,Li Volkhart Min-Jian,Delbeck Martina,LUSTIG Klemens,VON NUSSBAUM Franz,KARTHAUS Dagmar,ANLAUF Sonja. Владелец: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT. Дата публикации: 2012-01-05.

Plant-based medicament for the treatment of hepatitis c

Номер патента: MY144206A. Автор: Shouming Zhong,Hongwen Yu. Владелец: Phynova Ltd. Дата публикации: 2011-08-15.

USE OF VOLATILE LINEAR ALKANE(S) AND LIQUID FATTY ESTER(S) IN AN ANHYDROUS MEDIUM FOR THE TREATMENT OF KERATIN FIBRES, AND AN ANHYDROUS COMPOSITION BASED ON VOLATILE LINEAR ALKANE(S), LIQUID FATTY ESTER(S) AND PARTICULAR OIL(S)

Номер патента: US20120003172A1. Автор: . Владелец: L'OREAL. Дата публикации: 2012-01-05.

Improvements in the Treatment of Sewage and other Polluted Liquids and in Apparatus for Use in connection therewith.

Номер патента: GB190100517A. Автор: Frank Candy. Владелец: Individual. Дата публикации: 1901-12-14.

Improvements in Electrodes for use in the Treatment of Gases by Arc Discharges.

Номер патента: GB190618600A. Автор: Harry Pauling. Владелец: Individual. Дата публикации: 1907-07-25.

Improvements relating to assistants for use in the textile, leather, paper and like industries

Номер патента: GB456142A. Автор: . Владелец: IG Farbenindustrie AG. Дата публикации: 1936-11-03.

Бесплатный поиск патентной информации. Построение патентных ландшафтов и отчетов.

Главная
Проекты и услуги
Контакты

© 2021-2022 - All Rights Reserved - разработано Ecoruspace.me.